The Bovine Immune Response Following Brucella Vaccination and Infection and the Development of a Discriminatory Test. by MacMillan, Alastair.
U n iv er sity  of Su r r e y
School of B iological Sciences
T h e  B o v in e  Im m une R e sp o n se  F o l lo w in g  B r u c e l l a  
V a c c in a t io n  a n d  I n f e c t io n  a n d  t h e  D e v e lo p m e n t  o f  a
D isc r im in a t o r y  T e st
B y  A lastair  M acM illan
A thesis submitted for the degree of Doctor of Philosophy of the University of Surrey.
Guildford, June 1999
ProQuest Number: 27607809
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 27607809
Published by ProQuest LLO (2019). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 48106- 1346
nAbstract
Brucella abortus strain 19 vaccine (SI9) is used throughout the world to protect 
cattle from brucellosis. If used widely in a population it is extremely effective in 
rapidly reducing the prevalence of the disease. It suffers from a major 
disadvantage as vaccination stimulates an immune response indistinguishable, 
using classical tests, from that following infection with a virulent field strain of 
B.abortus. Consequently, veterinary authorities are inhibited from using it for 
fear of confusing the diagnosis of field infection.
Groups of animals were vaccinated with S19 and infected with a virulent strain to 
mimic the field situation. Both groups of animals responded as expected, but they 
could not be distinguished using classical tests or by ELISA using anti-isotype 
reagents.
A difference was observed in the normalised ELISA result when the animals were 
tested using lipopolysaccharide (LPS) antigens coated at different concentrations. 
This phenomenon was investigated further and a significant difference between 
the ELISA reactions of serum from vaccinated and infected animals was 
confirmed.
This difference in binding could not be attributed to a difference in the avidity of 
antibodies arising following vaccination and infection. A significant difference 
in the binding of monoclonal antibodies to high and low concentration antigens 
(conventional and modified ELISA) provided strong evidence that some O- 
polysaccharide epitopes were becoming obscured or their conformation was 
changing when the LPS was coated at a low concentration.
mValidation of the modified ELISA in field trials showed that the test had an 
excellent diagnostic sensitivity and specificity when used in non-vaccinated 
animals. In animals sampled immediately following vaccination with SI9, using 
a different cut-off, the diagnostic sensitivity and specificity were still good.
The modified ELISA is suitable for diagnosis world-wide where S19 vaccination 
is used in a controlled or an indiscriminate manner.
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1. In t r o d u c t io n
Bovine brucellosis has been for many decades and remains in many 
parts of the world a highly significant disease. The main method of 
control is the use of S I9 vaccine coupled with serological surveillance. 
Although the vaccine provides reasonable immunity and its use can 
result in a significant reduction in disease prevalence, animal health 
authorities are inhibited in using it as it gives rise to a humoral immune 
response detected by standard serological tests used for surveillance. 
There are currently no widely accepted or proven tests capable of 
discriminating a serum sample collected from an infected animal from 
one collected from a recently vaccinated animal. If such a test were 
developed, S19 vaccine could be more widely used resulting in more 
rapid progress towards control.
This thesis describes work which aims to develop such a method and 
elucidate its mode of action.
1.1 Bacteriology
The genus Brucella is composed of Gram-negative bacteria 
producing characteristic intracellular infections of animals. The 
organisms are obligate parasites and are not known to live 
independently. At present six species are recognised (Wundt and 
Morgan, 1975). Three species that were originally described are known
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as the 'classical' species: B.abortus, B.melitensis and B.suis and represent 
the greatest threat to the health of animals and man. They were first 
identified as separate organisms and no connection was thought to exist 
between them. Bruce (1887) isolated an organism from a patient who had 
died from Malta Fever which he named Micrococcus melitensis. This 
organism was subsequently isolated from the milk of local goats and the 
epidemiological link was established. Bang (1897) recovered what was 
described as Bacilus abortus from aborting cattle, although the isolation 
was not linked with disease in man. Finally Traum (1914) isolated 
similar organisms from porcine abortion which were later recognised as 
a separate species, B.suis.
The similarity of these strains in biochemical, cultural and serological 
tests was first noticed by Evans (1918), leading Meyer and Shaw (1920) 
to include them in a single genus. More recently, strains isolated from 
sheep, desert wood rats and dogs have been included as separate species, 
B.ovis, B.neotomae, and B.canis (respectively, Buddie, 1956, Stoenner 
and Lachman, 1957 and Carmichael and Brunner, 1968).
B.neotomae was accepted without question by the Subcommittee on 
the Taxonomy of Brucella since it has a smooth colonial morphology, 
fits other criteria by which Brucella are identified (Stoenner and
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Lachman, 1957) and also has a distinctive metabolic pattern (Cameron 
and Meyer, 1958).
The admission of the naturally rough species, B.ovis and B.canis to the 
genus caused much more controversy (Buddie, 1956, Carmichael and 
Brunner, 1968, Jones et a l, 1968, Meyer, 1969) as they differed 
markedly from existing accepted criteria, and from the resulting classic 
disease syndrome. The discovery that rough Brucella could infect 
animals also contradicted the belief that only smooth Brucella were 
virulent (Buddie and Boyes, 1953, Buddie, 1956, Carmichael and 
Brunner, 1968).
Hoyer and McCullough (1968) confirmed the homology within the 
genus using DNA-DNA hybridisation and they showed a similar 
cytosine and guanine base content (of between 56-58%) (Hoyer and 
McCullough, 1968) between all six species. B.ovis showed 94% 
homology with other members due to an apparent 6% deletion from the 
genome. More recently. Verger et a l, (1985) confirmed the DNA 
homology of a large number of strains representing all six species and 
their biovars. They questioned the earlier proposal of a large deletion in 
the genome of B.ovis given the margin for error (3%) in such studies. 
They therefore proposed that Brucella should comprise a single species, 
B.melitensis with the current species reassigned as biovars of
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B.melitensis. De Ley et a l, (1981,1987) confirmed without doubt the 
intimate genetic relatedness of the entire genus by demonstrating 100% 
homology in rRNA:DNA cross-hybridisation studies.
Several methods, mainly PCR-RFLP and Southern blot analysis of 
various genes or loci have been employed to find DNA polymorphism 
which would enable the molecular identification and typing of Brucella 
species and their biovars (Garin-Bastuji et a l,  1998). Southern blotting 
and probing for the IS711 (IS6501) insertion sequence is an effective, 
though time consuming method capable of the differentiation of the 
species of Brucella (Bricker and Hailing, 1994). Detection of 
polymorphisms by PCR-RFLP are easier to perform and can more easily 
be applied to large numbers of samples. The outer membrane protein 
(OMP) genes of Brucella have to date proved the best candidates for 
investigation as they show sufficient polymorphism to allow 
differentiation between Brucella species and some of their biovars 
(Cloeckaert et a l, 1996). By targetting the genes omp2a and omp2b it is 
possible to differentiate the six Brucella species and some of their 
biovars (Ficht et a l,  1990). The addition of primers for other genes such 
as ompSland dnaK improve the discrimination still further. 
Nevertheless, the pronounced homology of the genus hinder the 
development of genetic typing methods and currently they cannot yet
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achieve the same degree of discrimination as the classical bacteriological 
methods.
The Brucella Taxonomic Sub-Committee is reluctant to abandon the 
classical nomenclature Avhich is of such clinical, epidemiological and 
legislative value. The term nomen-species rather than species is now 
preferred reflecting the lack of convincing evidence for different genetic 
species.
For many years, the genus Brucella was included in the family 
Brucellaceae, (Breed et a l,  1957) which included many other genera 
such as Bordetella, Pasteurella, etc. The inclusion of the genus in the 
family was not supported by DNA-DNA hybridisation studies or G+C 
base ratio determinations. A more recent edition of Bergey's Manual 
(Buchanan and Gibbons, 1974) , includes the genus free floating in a 
group of Gram -ve rods and cocci and De Ley et a l, (1987) suggest that 
Brucella is most closely related to plant pathogens and symbionts of the 
Agrohacterium-Rhizobium complex. Currently, Brucella is included in 
the a-2 subclass of the class Proteobacteria which encompasses a variety 
of plant and animal pathogens that are characteristically associated 
pericellularly or intracellularly with eukaryotic cells (in the case of 
Brucella, Bartonella, Agrobacterium and the ricketsiae). Ochrobactrum 
anthropi was until recently considered the closest known relative of
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Brucella, but Velasco et al. (1998) have proposed some strains 
previously classified as O. anthropi as comprising a new species, O. 
intermedium which was very closely related to Brucella on the basis of 
16S rRNA sequencing.
1.1.1 Spéciation of the genus
Following the establishment of the genus, parameters were established 
for the definition of the species. These were firstly, the requirement for 
additional CO2 for growth, secondly, the production of hydrogen 
sulphide and thirdly,the ability to grow on media containing certain 
aniline dyes (Huddlestone, 1929), and reactions with adsorbed antisera 
(Wilson and Miles, 1932) (Table 1-1).
The differences between the species were largely quantitative rather 
then qualitative, and were dependant on techniques being well controlled 
and standardised and cultures being in the smooth phase. There were 
however some cultures which did not neatly fit the criteria.
On the whole, the species of Brucella remain host specific, although 
cross infections can occur. This host specificity is of considerable 
practical value in epidemiology.
Subsequently, biovars were established for the classical species when 
strains were isolated which differed in one or more characteristics from
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the initial definitions. Thus, seven biovars of B.abortus, three biovars of 
B.melitensis and five biovars of B.suis are currently accepted (Buchanan 
and Gibbons, 1974).
Table 1-1: Characters used in the differentiation of Brucella species and 
biovars
Species Blo-
var
HjS
prod
Growth with Ag^tfaiation with 
antisera
Lysis by phage 
at RTD
thionin* basic
fiichsin*
A M R Tb Bk2 Wb Fi
B.abortus 1 (+) + - + + - - L L L L
2 (+) + - - + - - L L L L
3** (+) + + + + - - L L L L
4 (+) + - +*** - + - L L L L
5 - - + + - + - L L L L
6** - (-) + + + - - L L L L
9 (-) + + + - + - L L L L
B.suis 1 - + + _**** + - - NL L L PL
2 - - + - + - - NL L L PL
3 - - + + + - - NL L L PL
4 - - + (+) + + - NL L L PL
5 - - + - - + - NL L L PL
B.mehtensis 1 - - + + - + - NL L NL NL
2 - - + + + - - NL L NL NL
3 - - + + + + - NL L NL NL
B.ovis + - + (-) - - + NL NL NL NL
B.canis - - + (-) - - + NL NL NL NL
B.neotomae - + -A - + - - PL L L L
* *
* * *
* Concentration = 1/50,000 w/v.
Lysis only non-smooth strains at RTD.
(+) = Most strains positive. (-) = Most strains negative.
thionin at 1/25,000 (w/v) is used in addition. 3 = +, 6 = -. 
Some strains of this biotype are inhibited by basic fuchsin.
**** Some isolates may be resistant to basic fuchsin.
A Not inhibited by thionin at 1/150,000 w/v.
B.abortus biotypes 7 and 8 are no longer recognised.
RTD= Routine test dilution 
Taken from Morgan et al, (1978)
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1.2 General properties o f Brucella
1.2.1 Morphology and ultrastructure
Brucella strains are small Gram-negative cocci, coccobacilli or rods 
0.6pm to 1.5pm long by 0.5pm to 0.8pm wide. The long axis is straight, 
the ends curved and the sides parallel or slightly convex. They may 
occur singly, in pairs, in small clusters or in short chains, end to end 
(Corbel and Morgan, 1982). The organisms stain red with 
Macchiavello's stain or with the modified Ziehl Neelsen procedure used 
by Stamp et ah, (1950). They are usually stained red by the modified 
Roster's method described by Christofferson and Ottosen (1941). 
Flagella, spores and true capsules are always absent.
The cell wall of Brucella differs from that of the Enterobacteriacea 
(Cherwonogrodski et ah, 1990) since:
♦ The peptidoglycan layer of Brucella is strongly associated with the 
outer membrane and contains far more 1-2 linked glycols than the cell 
wall of E.coli (Dubray, 1972).
♦ Brucella cells do not form spheroplasts under standard conditions 
(Moriyon and Berman, 1982).
♦ Nonionic detergents are far less efficient in extracting outer 
membrane proteins (OMP) of the Brucella cell wall compared to the 
OMP of E.coli (Moriyon and Berman, 1982, Verstreate et a l, 1982)
The major Omp of Brucella are porins of molecular mass 35-40 kDa, 
25-30 kDa, and a lipoprotein of 8 kDa, covalently linked to
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peptidoglycan, and possibly to smooth lipopolysaccharide (sLPS) 
(Dubray and Charriant, 1983, Moriyon and Berman, 1983, Verstreate and 
Winter, 1984, Gomez-Miguel and Moriyon, 1986, Verstreate et ah, 1982, 
Perera et ah, 1984, Moreno et ah, 1979).
The cell wall is composed of a triple layered lipopolysaccharide- 
protein outer membrane about 9nm thick. This outer membrane is linked 
internally to an electron-dense layer 3 to 5nm thick composed of the 
muramic acid-containing peptidoglycan layer responsible for the rigid 
structure of the cell wall. Beneath this is an internal layer which is of 
uniform low density and 3 to 6nm thick in S phase cells, but of variable 
density and between 3 and 30nm thick in R phase cells. The cytoplasm 
is relatively homogeneous with polysaccharide-containing granules 
dispersed throughout. Numerous vacuoles may be present in the 
cytoplasm, including the osmiophobic body corresponding to the nuclear 
vacuole, although the position of this can be difficult to define in some 
cells (Dubray, 1972, Peschkov and Feodorov, 1978, Bendayan and 
Zollinger, 1983).
1.2.2 Cultural properties
Brucella strains are aerobic, slowly growing, fastidious organisms. 
Growth on ordinary nutrient media is poor unless these are supplemented 
with blood, serum or tissue extracts. Serum dextrose agar containing 5
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to 10% v/v horse serum is generally recommended. After 48h incubation 
on serum dextrose agar colonies are usually between 0.5 and 1.0mm in 
diameter, raised, convex with a circular outline and an entire edge. In 
transmitted light, smooth colonies are a shiny, clear, pale yellowish 
colour but appear bluish-grey and slightly opalescent in reflected light.
1.2.3 Dissociation
Smooth Brucella strains may undergo dissociation to produce non­
smooth variants. This process is associated with changes in antigenic 
properties, virulence, colonial morphology and phage sensitivity. The 
smooth or S forms produce round, convex, translucent colonies with an 
entire edge and a smooth glistening surface after 2-3 d growth on serum 
dextrose agar. These colonies are easily emulsifiable, form stable 
suspensions in 0.15mol/litre NaCl, are not agglutinated by 0.1 w/v 
acriflavine or anti-R serum, but are rapidly agglutinated by antiserum to 
smooth Brucella strains. They have a slight bluish-white opalescence in 
reflected light, but are a transparent pale yellow colour in transmitted 
light. After staining with crystal violet, S colonies examined in reflected 
light appear unstained or show a slight bluish-green colour (White and 
Wilson, 1951).
Non-smooth forms produce colonies of a similar shape to the S forms 
but often slightly larger and with a more granular or slimy surface. The
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colonies are adherent to the agar, and difficult to emulsify. Suspensions 
are rapidly agglutinated by 0.15mol/l NaCl, 0.1% w/v acriflavine and 
anti-R serum (Corbel and Morgan, 1982). They may or may not be 
agglutinated by antisera to smooth Brucella strains. The colour of these 
colonies is usually darker than that of S forms, varying from off-white to 
brown in transmitted or reflected light. They are usually translucent, but 
may be opaque. They are easily differentiated from S colonies by 
examination under oblique illumination (Henry, 1933). After staining 
with crystal violet, the M or R colonies appear red, blue or purple in 
colour.
1.2.4 Host Range
In general. Brucella species infect a wide range of animals, including 
cattle, goats, sheep, pigs, dogs, horses, camels, reindeer, elk, bison, 
buffalo, moose, antelope, hares, rodents, marine mammals, a very broad 
range of wildlife, and of greatest significance, man (Davis and Adams, 
1990, Ross et ah, 1994). All of the Brucella species may produce 
infections in laboratory animals including guinea-pigs, mice and rabbits.
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1.3 The Disease
1.3.1 Source o f infection and means o f spread
Despite other species being a possible source of infection, by far the 
most important reservoir of B.abortus for cattle are cattle themselves. 
Infection is usually introduced into a herd or flock by the purchase of an 
infected female, whether pregnant, recently aborted or calved. 
(Crawford et ah, 1990).
The chief route by which man contracts the disease is by the 
consumption of animal products, largely unpasteurised dairy foods 
(Nicoletti et al, 1989). Occupational exposure is common for the 
veterinary profession whilst attending parturient animals (Garin and 
Verger, 1994), or through accidental self-inoculation with vaccine 
(Nicoletti et al., 1989). Similar infections may occur in farm, abattoir or 
laboratory workers. Human to human transmission is extremely rare.
Natural infection of cattle usually occurs via the naso-pharangeal or 
conjunctival mucosa when ingested bacteria invade the oral or 
pharangeal mucosa, resulting in infection of the local draining lymph 
nodes (Nicoletti and Milward, 1983). Following a period of 
consolidation, the organisms then break out to reach other organs via the 
haematogenous route (Nicoletti and Milward, 1983). Congenital 
infection is of major epidemiological significance and as high as 20% of
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heifer calves born to cows infected with B.abortus are persistently 
infected, although many may recover before they themselves calve. 
(Plommet et a l,  1973, Crawford et a l,  1986, Catlin and Shehan, 1986, 
Wilesmith, 1978).
1.3.2 Epidemiology
The exposure of animals to Brucella infection is the first necessary 
step in the transmission of the organism. The outcome of such exposure 
depends on the susceptibility of the host and on the level of exposure.
In most circumstances. Brucella are excreted at abortion or full term 
parturition in the uterine fluids or placenta. Large numbers of organisms 
(up to 1Q13 bacteria per gram (Verger et a l, 1989) are generally excreted 
in these materials. The viability of Brucella outside the host is 
influenced by prevailing environmental conditions. Numerous studies 
have been conducted which have been reviewed by Wray (1975). In 
general, viability is enhanced by cool temperatures, dark and moisture. 
Survival of the organism for up to six months has been recorded under 
ideal conditions.
The risk that a susceptible animal will be exposed to an infective dose 
of Brucella depends largely on the husbandry practices employed. For 
instance, if abortion occurs when animals are closely confined within a
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yard then the weight of exposure will be potentially much higher than if 
the herd of flock is extensively managed.
Brucella infection in bulls and rams produces an epididymo-orchitis 
and seminal vesiculitis and Brucella is often shed in the semen. 
However, these animals often remain functionally fertile and the risk of 
transmission to females at natural service is considered negligible 
(Rankin, 1965, King, 1940). On the other hand there is a significant risk 
of infection if semen from infected bulls is used for artificial 
insemination as in this case, the practice is to deposit the semen into the 
utereus (Manthei et a l,  1950, Bendixon and Blom, 1973).
There are a number of reports in the literature regarding factors that 
affect the spread of brucellosis and these have been reviewed by Salmon 
and Meyer (1984). The purchase of replacement animals is by far the 
most common means of introducing infection into a herd or flock. 
Frequency of purchases and health status of sources influence the risk of 
introduction (Nicoletti, 1981, Christie, 1969). Brucellosis may also 
spread following contact with stock in neighbouring premises, either 
across fences, or via shared grazing. There is some circumstantial 
evidence for dissemination along watercourses (Plommett, 1977, Ray, 
1977).
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1.3.3 Clinical signs
Infection of cattle with the various biovars of B.abortus or sheep and 
goats with those of B.melitensis seems to produce disease of an 
essentially similar character irrespective of the biovar involved.
Initial invasion is followed by colonisation of draining lymph nodes 
after which systemic spread occurs by a bacteraemia leading to 
localisation in the preferred sites, the tissues of the reproductive organs 
and the reticulo-endothelial system. Infection during pregnancy results 
in placental infection which frequently produces abortion. The 
organisms often localise in mammary tissue and may be excreted in the 
milk. Infections in the preferred host are often mild, clinical 
manifestations being largely confined to the pregnant animal.
Following infection, pregnant animals may show signs of impending 
calving such as vulval swelling, development of the udder and the 
relaxation of the pelvic ligaments. There may be a white, muco-purulent 
vaginal discharge preceding parturition. The amniotic fluid may be 
turbid containing purulent flakes, or it may be clear. The foetal 
membranes are often retained, particularly if parturition occurs near to 
term. After abortion, there is often a copious dirty grey or brownish red 
discharge, often continuing for some weeks. The first abortions may go 
unnoticed following the introduction of the disease into the herd or flock
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but they can be responsible for the massive spread of infection by the 
contamination of food, bedding and water supplies, or the direct 
transmission to animals through licking discharges or foetal membranes.
Depending on the stage of gestation of animals in the rest of the herd 
and the extent of the contamination, nothing further may happen for a 
matter of weeks or months. Sooner or later further abortions will occur 
causing even greater spread. In extreme cases, more than half the 
animals may abort within one year. In succeeding years, the disease may 
become chronic, with abortions occurring in primiparous animals only.
In the male, acute orchitis and epididymitis occur. Initially there is 
acute pain and testicular enlargement, but gradually the pain subsides 
leaving only enlargement and hardening of the testes. Semen appearance 
and volume may appear unaffected, but in some cases, sperm 
concentration and motility may be severely affected. Neutrophils may or 
may not be present.
The disease in man is represented by a diverse range of clinical 
symptoms and signs, the most important of which are fever, chills, 
sweats, weakness, myalgia, arthralgia, depression and anorexia. When 
the disease becomes chronic, a very wide range of pathological 
conditions may occur, including arthritis, endocarditis, spondilitis.
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neurological involvement and the formation of abscesses and 
granulomas.
1.3.4 Pathology and pathogenesis
The pathogenesis of brucellosis in various animals is remarkably 
similar due to common events surrounding the interaction of the bacteria 
with susceptible cells in their preferred host. The brucellae are 
facultative, intra-cellular. Gram-negative bacteria which have adapted to 
survival within host cells. Brucellosis is generally a chronic disease 
persisting for the life of the animal. Responses to infection are generally 
granulomatous, particularly within lymphoid or reticuloendothelial 
tissues. The localisation of the organism in these tissues follows a more 
generalised distribution in the early course of the disease. Localisation 
in the male and female reproductive tracts gives rise to the principle 
clinical symptoms, abortion and male infertility (Bendixon and Blom, 
1973).
In the days following the initial penetration, there is an acute local 
inflammatory reaction which is usually unsuccessful in preventing the 
further spread of bacteria to the regional lymph node and onwards via 
secondary haematogenous spread (Enright, 1990, Sutherland and 
Searson, 1990). Brucella are well adapted to intracellular survival and 
may utilise both neutrophils and macrophages during the period of
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haematogenous spread which occurs probably as early as two weeks 
following initial challenge (Duffield et ah, 1984, Cheville et a l,  1992). 
Following the bacteraemia, the organism spreads throughout the body, 
but is most frequently isolated from lymphoid tissues, the mammary 
gland and reproductive tract.
When Brucella infects the reproductive tract, extremely large numbers 
can be isolated from placental tissue. The organisms are located in the 
rough endoplasmic reticulum of the chorionic trophoblasts and the 
epithelial cells of the foetal placenta (Anderson et a l,  1986, Detilleux et 
a l,  1988, Enright, 1990). This is associated with local necrosis and 
ulceration accompanied by an inflammatory exudate composed of 
necrotic debris, macrophages and polymorphonuclear cells. Despite the 
severe placentitis, only mild inflammatory changes are seen within the 
endometrium, the endometrial epithelium remains intact and Brucella is 
not present in this site.
It is unlikely that abortion is caused by alterations in the passage of 
oxygen, nutrients and waste products across the damaged placenta. More 
likely. Brucella endotoxins effect a rise in prostaglandin production, and 
the initiation of delivery (Liggins, 1981).
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1.3.5 Current Distribution
1.3.5.1 World
Brucellosis is distributed throughout the world, except for a small 
number of countries where eradication has been achieved. In most 
developing countries, resources have not been sufficient to control the 
disease. Even in those countries that operate a national programme of 
control and eradication, infection is readily reintroduced by the 
uncontrolled movement of animals across international borders. This is 
particularly important where nomadic peoples migrate seasonally with 
their herds. The incidence varies considerably between regions, 
dependant on local environmental conditions and husbandry practices. 
Although information on prevalence is inadequate, there are indications 
of a very high incidence in many areas, particularly in the tropics and in 
countries that can least afford the losses in milk and meat production that 
accompany this disease.
1.3.5.2 Europe
Brucellosis control of bovine, ovine and caprine herds within member 
states is governed by EC Directives 64/432 and 91/242 and domestic 
legislation must comply with rules laid down in these. Some countries 
of Europe such as those that comprise Scandinavia, Switzerland and 
Austria have been free of brucellosis for over 30 years. Most, including
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those with which Britain trades most, are well on the way towards 
eradication, but foci of infection still persist. In France, for instance, the 
proportion of infected bovine herds is currently about 0.5% (Garin and 
Verger, 1994). In seven départements, mainly in the south east, more 
than 2% of herds are infected with Brucella. It is significant that the 
majority of strains currently isolated from cattle are B.melitensis, an 
organism which readily spreads from sheep and goats kept in close 
contact.
There has been a recent deterioration in the situation in Ireland, due in 
part to the introduction of suckler cow premiums promoting an increase 
in the amount of cattle movement. In, 1993, about 400 reactor herds 
were identified with 8000 animals slaughtered (Henighan personal 
communication). Most of the other member states are well on the way 
to eradication, but significant numbers of infected herds are to be found. 
In Eastern Europe, the situation is far from clear, but in most countries 
the prevalence of bovine brucellosis is quite high.
1.3.5.3 Great Britain
Great Britain remains free of brucellosis in cattle, but animals are 
fully susceptible and herds remain at risk from its réintroduction via 
imported animals. This possibility was amply demonstrated by the herd
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breakdown that occurred during, 1993 in Anglesey following the 
importation of an infected heifer from France (unpublished observation).
1.3.6 Public Health Significance
Infected farm animals, especially cows infected with B.abortus, even 
though they may abort only once, effectively remain carriers for the rest 
of their lives. During this time they excrete large numbers of organisms 
in their milk as well as in products of abortion or those of subsequent, 
apparently normal parturitions. Infection of man can therefore occur by 
the ingestion of raw milk or milk products such as cream or cheese or by 
the handling of infected animals, especially around the time of 
parturition. Pasteurisation effectively protects the urban population in 
most regions, but the stockowners and their families often drink raw 
milk and are at risk from direct contact with infected animals. In some 
communities, notably in the Arab world, pasteurisation or boiling is 
culturally unacceptable leading to very large numbers of the population 
being exposed and becoming infected (Cosivo, personal communication)
There has been a dramatic reduction in the number of human cases in 
those countries from which Brucella has been eliminated from the 
animal population. These data, although probably a considerable 
underestimate of the true incidence of disease, nevertheless indicate what 
is well recognised amongst farming communities and the veterinary
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profession, that there is no longer an occupational risk from working 
with cattle. This fact acts as a reminder of one of the primary objectives 
of attempts to improve the efficiency of diagnosis and control in 
domestic animals.
1.3.7 Bacteriological diagnosis
1.3.7.1 Microscopic examination
Smears of placental cotyledon, vaginal discharge and foetal lung, liver 
and abomasal contents can be stained by the modified Ziehl-Neelsen, 
Rosters', Gram or Macchiavello methods, or with a fluorochrome or 
peroxidase-labelled antibody conjugate. The presence of large 
aggregates of intracellular, weakly acid-fast organisms of Brucella 
morphology, or immuno-specifically stained organisms, is presumptive 
evidence of brucellosis. Care must be taken in the interpretation of 
results as other infectious agents may have similar morphology (e.g. 
Coxiella burnetii, Chlamydia) or immunological cross-reactivity (e.g. 
Yersinia) (MacMillan and Corbel, 1998).
1.3.7.2 Culture
The isolation of living Brucella from tissues or fluid samples has 
traditionally been regarded as the only unequivocal evidence of 
infection. The development of more effective cultural techniques for use 
with contaminated material has improved the sensitivity of this method
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(Mayfield et ah, 1990, Farrell, 1974) although some strains may be 
inhibited by some of the antibiotics used in the most selective media and 
the diagnostic sensitivity may be increased by using less selective media 
(Marin et ah, 1996).
Material such as placental cotyledon, vaginal discharge, foetal tissues 
or abomasal contents, or hygroma fluid can be cultured on selective 
media (Mayfield et a l,  1990, Corbel and Hendry, 1985, Hornitzky and 
Searson, 1986). Cultures can also be made from milk or colostrum and 
from samples of tissues collected post mortem, such as mammary gland, 
uterus, supramammary and internal iliac lymph nodes from the female, 
and testes, epididymides, seminal vesicles, accessory glands, external 
inguinal and internal iliac lymph nodes from the male. From either 
males or females the parotid, mandibular and retropharyngeal lymph 
nodes are good sources of the organism. Solid tissues should be well 
mascerated before culture. As the numbers of brucellae in these are 
likely to be lower than in abortion material and as contaminating bacteria 
may be present in milk, colostrum and some tissue samples, enrichment 
is advisable in liquid medium such as Brodie and Sinton medium 
(Mayfield et a l, 1990 Corbel and Hendry, 1985). The enrichment 
medium should be incubated for up to 6 weeks, with weekly subcultures 
on to solid selective medium. Alternatively, a biphasic system of solid
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and liquid selective medium in the same bottle (Castaneda, 1947) may be 
used to minimise sub-culture.
Any colonies of Brucella type (raised, convex, circular outline, 
transparent, smooth surface, slow growing) are checked by examining a 
Gram-stained smear. Organisms of Brucella morphology are tested for 
agglutination with Brucella-s^Qciiio, antisera monospecific for the A and 
M surface epitopes. Positive agglutination with a Brucella antiserum 
provides presumptive identification of the isolate as Brucella. 
Subsequent full identification is best performed by a reference 
laboratory.
A range of PCR techniques have been reported to give good 
sensitivity for the detection of Brucella DNA in pure cultures (Fekete et 
a l,  1990, Da Costa et a l,  1996, Bricker and Hailing, 1994), however, 
there are surprisingly few reports of their successful use on clinical or 
field material (Fekete et a l, 1992b, Rijpens et a l,  1996). The potential 
of the PCR for diagnosis is great, but there are currently no methods 
sensitive enough to surpass classical bacteriology.
1.3.8 Serological diagnosis
1.3.8.1 Classical Tests
Serological tests are widely used in the diagnosis of brucellosis using 
serum, milk, whey, vaginal mucus, and semen samples. At present, no
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test is available that is 100% sensitive and specific, although the use of 
multiple tests increases the confidence in the diagnosis and sequential 
tests over time give a better insight than single tests.
Commonly used serological tests currently available can be 
categorised as agglutination tests, buffered Brucella antigen tests, 
complement fixation tests, immunodiffusion tests and ELISAs. They 
are reviewed by MacMillan (1990) and Alton et ah, (1988).
1.3.8.1.1 Buffered Brucella Antisen Tests
The buffered Brucella antigen tests include the card test, the Rose 
Bengal plate test (RBPT) and the buffered plate agglutination test 
(BPAT). This group of tests relies on the principle that IgM antibodies 
(which are mainly responsible for false positive reactions) bind poorly to 
antigen is reduced in a low pH (Rose and Roepke, 1957). They play a 
major role in the serological diagnosis of brucellosis, as they are cheap 
and extremely rapid to perform making them excellent screening tests. 
These tests, like the majority of all serological tests in use, employ as 
antigens strains of B.abortus of low virulence such as strain 99. The 
Rose Bengal Plate Test is the version that has been widely used in 
Europe. The antigen consists of Brucella cells stained with Rose Bengal 
and suspended in a buffer at pH 3.65. The antigen is standardised 
against the 2nd International 2û[ï\\-B.abortus Serum (ISABS) (Hendry et
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a l,  1985). The test is usually carried out on enamelled metal strips, 
glass tiles or in a WHO haemagglutination plate. Thirty microlitres each 
of serum and antigen are mixed and the mixture rocked or occilated for 
four minutes after which the tests are read by examining for 
agglutination. The RBPT is an effective screening test although it lacks 
sufficient specificity to be used alone for diagnosis in individual 
animals, especially vaccinated animals which may remain positive for 
many months (Stryszak, 1986). In a trial published by Morgan (1977) 
using S19 vaccinated animals, a specificity of 98.82% was achieved in 
11000 sera from cattle presumed free from brucellosis. Samples from 
15000 animals in herds with brucellosis were tested using RBPT and 
complement fixation test (CFT). Eleven per cent were positive to the 
RBPT and of these, 61.6% were positive to the CFT. Of the 13350 
negative to the RBPT, 0.9% were positive to the CFT. This excellent 
measure of agreement between the two tests is due to the similarity of 
isotype sensitivity of the two tests (Nielsen, 1991).
1.3.8.1.2 Asslutination Tests
The serum agglutination test (SAT) introduced by Wright and Smith 
in 1897 has been widely used for diagnosis (MacMillan, 1990). Since 
this test detects antibodies of different isotypes compared to the RBPT 
and CFT, there is not always agreement between the results of the SAT
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and the other assays. Provided the antigen is properly standardised 
against the ISABS, the SAT can be useful in diagnosis, although it’s lack of 
sensitivity and specificity has led to the OlE no longer recommending it 
(Corbel and MacMillan, 1996). Studies have shown that 11% of culture 
positive animals were considered only suspect and 4% were passed as 
negative, demonstrating that this is not the most effective test for individual 
animals (Alton, Jones and Pietz, 1975). Dohoo et al, (1986) found a 
specificity of 99.5% in non-vaccinated but 97.5% in vaccinated cattle. The 
test is subject to the prozone phenomenon, which is due to high 
concentrations of non-agglutinating IgGi competing for binding with the 
agglutinating antibody lgG2^ leading to false negative reactions at the lower 
serum dilutions.
1.3.8.1.3 Complement Fixation Tests
The CFT (Hill, 1963) is regarded as the most reliable of the classical 
diagnostic tests in terms of sensitivity and specificity but it has the 
disadvantage of technical complexity (MacMillan, 1990).
The test relies on the ability of bovine IgGl to fix guinea pig 
complement when bound to antigen. The test is conducted in two phases. 
In the first. Brucella antigen, the serum under test and complement are 
mixed and incubated at 37°C. If specific antibody is present, the 
complement is fixed and effectively removed from solution. The second 
phase is a complement assay. Sheep red blood cells (SRBC) and a rabbit
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anti-SRBC antibody are mixed. If complement remains in solution (ie 
there was no Brucella specific antibody in the bovine serum sample), it 
is fixed and results in the lysis of the SRBC.
The sheer number of reagents, all requiring accurate titration, means 
that the test is only feasible in larger laboratories with well trained staff.
A system of international complement fixation test units has been 
developed using the ISABS, which allows a greater ease of 
standardisation. The CFT is much more effective at detecting antibodies 
arising from infection with Brucella rather than antibodies resulting 
from vaccination although samples taken following vaccination are 
positive for many months.
Nielsen and Duncan (1987) demonstrated that only bovine IgGl was 
able to fix guinea pig complement, and it was the lack of sensitivity to 
other bovine isotypes that led to the tests greater specificity. To cite a 
few reports from the literature, Alton et a l, (1975) found that all 
cuturally positive animals reacted in the CFT, while Nicoletti (1977b) 
reported that the CFT correctly identified 98% of culture positive cattle.
Anticomplementary activity in serum, usually due to bacterial 
contamination fixing complement by the alternative pathway may be a 
significant problem in some circumstances, and this together with the
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complexity of the test and the occurrence of the prozone phenomenon 
reduce the value of the test.
1.3.8.2 ELISA
1.3.8.2.1 Introduction
ELISAs have been extensively used in veterinary diagnosis since they 
were first described over 20 years ago (Engvall and Perlmann, 1971). 
They may be used for the direct detection of pathogens or for the 
detection of antibodies arising following infection. It is in this mode that 
they are most commonly used for the diagnosis of brucellosis and this 
review will focus primarily on such applications. ELISAs may be used 
for the diagnosis of brucellosis in all species, whether ruminants infected 
with smooth Brucella such as B.abortus or B.melitensis, or sheep 
infected with B.ovis.
1.3.8.2.2 History
The utilisation of enzymes as signal amplifiers in primary binding 
assays was first described in, 1971 by Engvall and Perlmann. The 
original enzyme linked immunosorbent assay, is only one of a diverse 
group of methods known collectively as enzyme immunoassays (EIA). 
In the intervening years, the ELISA methodology has been increasingly 
used for the detection of antibody to infectious diseases and the disease 
of brucellosis is no exception (Nielsen et al, 1988a). Indeed, the ELISA
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was first used as a routine test in an official eradication scheme in 
Canada about ten years ago (Fraser et a l, 1988). Since then, the 
literature abounds with reports of the use of this method world-wide 
(Limet at al, 1988, Grigor'eva and Ulitskaya, 1990, Reynolds, 1983, 
Albert and Blom, 1988, Wu and McKenzie, 1987, Placket and Stewart, 
1987, Hobbs, 1985) although, as is often the case, international 
agreement about standardisation is following much more slowly 
(MacMillan and Corbel, 1996).
1.3.8.2.3 Princivle and Classification o f ELISA
The large majority of EIAs in use in brucellosis diagnosis are indirect 
ELISAs (iELISA). ELISAs are methods that involve the immobilisation 
of one of the active components on a solid phase and iELISAs are those 
in which the antigen is bound to a solid phase. The latter is usually a 
polystyrene microtitre plate and antibody, if present in a sample, binds to 
the immobilised antigen. The resulting immune complex is detected by 
an appropriate anti-globulin-enzyme conjugate which, in combination 
with a chromogenic substrate, gives a coloured reaction indicative of the 
presence of antibody in the sample. It is this method that is now very 
familiar to most diagnosticians.
Another method which is gaining in prominence in the publications on 
brucellosis diagnosis is the competitive ELISA (cELISA) (Gorrell et a l.
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1984, Sutherland et a l,  1986b, MacMillan et a l, 1990, Greiser-Wilke et 
a l, 1991, Nielsen et a l, 1991a, Mathias et a l, 1994). In this. Brucella 
antigen is immobilised on the plate as with the indirect ELISA. 
Following that, the serum under test and a monoclonal antibody directed 
against an epitope on the antigen are co-incubated. This anti-Brucella 
monoclonal antibody is conjugated to an enzyme, the presence of which 
is detected if it binds to the antigen. This will only occur if there is no 
antibody in the serum sample which will bind preferentially. Thus, in 
this case, unlike the indirect ELISA, the presence of colour at final 
reading indicates a negative reaction.
The particle concentration fluorescence immunoassay (PCFIA) is a 
commercially produced immunofluorescence assay which is in 
apparently widespread use in the USA and elsewhere (Reynolds, 1987, 
Nicoletti and Tanya, 1993, Greenlee et a l,  1984).
The technique has much in common with the competitive ELISA in 
that antigen is immobilised on to polystyrene, except in this case it is in 
the form of sub-micron particles held initially in suspension. Serum is 
co-incubated with an anti-Brucella conjugate in the presence of the 
antigen coated particles, and they compete for binding. In this case, the 
antibody is labelled with a fluorescent probe. In this assay, the 
unreacted reagents are separated from the polystyrene particles which are
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themselves concentrated by filtration through a membrane at the bottom 
of each well. The commercial system claims the ability to analyse 550 
samples per hour.
1.3.8.2.4 Reasents and Methodolosv
The term ELISA covers a variety of possible reagent combinations 
which have a direct and significant effect on performance.
1.3.8.2.4.1 Antigen
A wide variety of antigen preparations have been used in the iELISA 
ranging from whole cells to crude and semi-purified smooth 
lipopolysaccharide (sLPS) preparations to polysaccharides and proteins 
(for a review see Wright et al, 1990). The antigens of sLPS are the most 
immunodominant and, coupled with the fact that they are very strongly 
adsorbed to polystyrene, they have become the antigens most widely 
used for routine diagnosis. Even in relatively crude extracts or when 
whole cells are used, it is the sLPS antigens which are most active 
(Cherwonogrodski et al., 1990, 1991).
The most diagnostically relevant epitopes reside on the chain 
component rather than the lipid A or core polysaccharides. The O-chain 
structure of all species of Brucella has been elucidated and has been 
shown to be a linear homopolymer of 4,6-dideoxy-4-formamido-a-D- 
mannose. (Perry and Bundle, 1990).
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Individual units are joined by either 1,2 or 1,3 glycosidic linkages and 
it is the relative proportion of these linkages in the 0-polysaccharide that 
differs between the Brucella species. The particular arrangement of 
these linkages gives rise to broadly three main epitopes: the A epitope, 
the M epitope and the common epitope, all of which occur (albeit in 
different proportions) on all Brucella species and infection gives rise to 
antibodies which bind to each of these epitopes (Bundle et a l,  
1987a,b,c, Miekle et a l, 1989). The structure of the 0-polysaccharide is 
described in more detail below in 1.4.2.2. Suffice it to say that in 
practice the use of an sLPS antigen derived from B.abortus or 
B.melitensis is adequate for the diagnosis of either organism, but there is 
some evidence that it is preferable to use a homologous antigen (Devi et 
a l,  1987). Recent work by Alonso-Urmeneta et a l, (1998) found no 
significant difference between antigens prepared from B.abortus or 
B.melitensis (whether LPS, 0-polysaccharide or native hapten) for the 
detection of brucellosis in vaccinated or non-vaccinated cattle.
Although it is recommended that purified sLPS antigen should be used 
in the iELISA, there is little doubt that less purified preparations such as 
autoclaved or sonicated cell extracts are adequate, at least for screening 
purposes (Cherwonogrodsky et a l,  1986, Nielsen et a l,  1988a, Nielsen 
et a l,  1983a, Berman et al, 1980).
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There is concensus that the purity of the antigen has little effect on 
the sensitivity of the assay, but as diagnostic specificity becomes 
increasingly important with the decreasing disease prevalence, less pure 
antigens may give rise to a slightly higher number of non-specific 
reactions. On the other hand, it is suspected that extremely pure sLPS 
has the tendency to form micelles in aqueous solution, causing it to 
adsorb irregularly to polystyrene, resulting in assay variation and high 
negative backgrounds (Nielsen and Wright, 1990). The hot water/phenol 
extraction method of Redfearn (1960) appears to be one of the best 
methods for antigen preparation currently in use.
1.3.8.2.4.2 Conjugate
Antibody isotypes produced in response to B.abortus infection in
cattle include IgM, IgGl, IgG2, and IgA. The specifics of the humoral 
response will be covered later, but suffice it to say that the IgG2 
response is much more variable than the IgGl response which is higher 
and more uniformly produced (Lawman et a l,  1985).
Again, all four isotypes are present in milk although again IgGl 
predominates. All isotypes are theoretically detectable in the iELISA 
depending on the immunological specificity of the anti-globulin used, 
and a search of the literature reveals that a wide variety of conjugates 
have been evaluated ranging from those of broad specificity to some 
reagents specific for a single isotype (Nielsen and Wright, 1990). The
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use of anti-y globulin reagents introduces a bias in favour of IgM, a class 
of antibody often associated with non-specific reactions in other assays. 
This bias can be reduced by using an anti-IgG (heavy and light chain) 
which would still be capable of detecting IgM as a result of its light 
chain specificity but would favour the detection of IgG isotypes which 
are likely to be more specific (Huang, 1987, Lamb et a l,  1979, Nielsen 
e ta l ,  1984, Wright and Nielsen, 1986).
The diversity and multiplicity of epitopes on sLPS make it likely that 
the immune responses to this antigen will be very heterogeneous in terms 
of their relative specificities and affinities. This has a significance in 
that there will be competition for a limited number of binding sites 
between antibodies of different isotypes. There is undoubtedly 
competition, both directly at a single epitope, but also as a result of the 
structure of the O-chain, by steric hindrance between antibodies binding 
to adjacent or overlapping sites. Thus it is theoretically possible that if a 
conjugate of high specificity for a single isotype was used in an assay, 
then it may fail to detect the presence of antibody should this isotype be 
prevented from binding to the antigen due to competition from others, 
giving spurious negative test results.
In general, anti-globulin conjugates specific for the animal to be tested 
should be used except that it may be possible that they might be used for
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closely related species. For instance, goat serum may be tested with an 
anti- sheep IgG conjugate. Batches of conjugates must be tested to 
ensure that such cross reactions occur.
1.3.8.2.4.3 Methodology
The vast majority of ELISAs involve a fairly standard methodology
utilising 96 well polystyrene plates. In the context of discussions of
mass screening as part of eradication campaigns this is to be encouraged
as it is so amenable to cost effective automation.
1.3.8.2.5 Lesislation
Member states of the European Union are bound by legislation 
covered in various Directives on animal health. In the case of bovine 
brucellosis. Directive 64/432 allows the use of the ELISA for the 
maintenance of Officially Brucellosis Free status herds. The 
methodology of the ELISA is defined in the Directive in fairly general 
terms, allowing a degree of variation in the technique.
1.3.8.2.6 Trials
There are numerous reports in the literature evaluating the 
performance of the ELISA in comparison to the classical tests. A 
detailed discussion of these will not be carried out here, but suffice it to 
say that in most cases, the ELISA has been found to detect a greater 
proportion of infected animals (sensitivity) than the CFT when used for
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the diagnosis of B.abortus or B.melitensis (Ruppaner et al., 1980, Hobbs, 
1985, Nicoletti and Tanya, 1977, Stemshorn et al., 1980). A recent large 
survey was reported by Vanzini et al. (1998) who carried out a field 
evaluation of the iELISA on calfhood-vaccinated dairy cattle in 
Argentina. They quoted a diagnostic sensitivity of 99.6% and a 
specificity of 98.6%.
At the September, 1994 meeting of the OIE Standards Commission, 
data were presented on an international trial on the performance of the 
iELISA in comparison to a variety of conventional methods. Four 
different ELISAs were evaluated, the best of which gave a specificity of 
97.8% relative to the CFT with a sensitivity of 92.9% (Edwards, personal 
communication).
It should be realised that it is unhelpful to simply quote sensitivity 
data as these are absolutely dependent on the population of animals on 
which they are measured, and thus it is impossible to compare sensitivity 
data of tests in different studies. There is some evidence that differences 
in the sensitivity of the CFT and ELISA, which may be quite similar 
when measured on experimentally infected animals receiving a large 
inoculation dose, may be much more pronounced in animals inoculated 
with a much smaller dose or in some field situations.
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In an eradication campaign, the detection of infected animals sooner 
rather than later, perhaps before they have aborted and spread the disease 
to a large number of others, will have a significant effect on the speed 
and cost of eradication.
1.3.8.2.7 Data Analysis
Many methods for the analysis of optical density (OD) data have been 
described ranging from the simple to the complex. In Canada, data are 
expressed simply in terms of the raw OD, but day to day variation in the 
speed of colour development is cleverly controlled for by test reading the 
plate after four minutes incubation, allowing the prediction of the 
incubation required for the positive standard to attain an OD of 1.00.
As defined in terms of Directive 64/432, on each plate is included a 
working standard calibrated against the International Standard serum. 
The OD of each sample under test is expressed as a percentage of this. 
Samples with a reading in excess of 10% are classified positive.
Using logistic transformation of a titration curve, it is possible to 
convert single dilution test ODs to standard units, allowing the accurate 
quantitation of the results of individual sera, and their comparison 
between laboratories using different methodologies.
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1.3.9 Test V alidation
Diagnostic tests developed from research activities need to be fully 
assessed for their effectiveness and feasibility for routine use. This 
allows predictions to be made about the health status of the subject 
within a known level of confidence. This assessment is termed 
validation and the process is gradually becoming standardised (Jacobson, 
1998). The process of validation is really a series of inter-related 
processes culminating in field trials during which the test can be 
assessed under conditions approaching those under which it will be used 
routinely.
Before validation can begin, the method must be well understood and 
have been tested in pilot studies. For the ELISA described in this thesis, 
such work is described in the preceding chapters. Factors that influence 
the capacity of the test result to accurately predict the infection status of 
the host are diagnostic sensitivity (DSn), diagnostic specificity (DSp) 
and the prevalence of the disease in the target population. DSn and DSp 
are derived from test results on samples from selected reference animals. 
The degree that the reference animals represent the population at large 
has a major impact on the accuracy of test result interpretation. 
Therefore, these parameters should in practice be determined regionally. 
There are at least four stages towards the validation of an assay:
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(i) Determination of the feasibility of the method for a particular use
A limited number of sera of a range of titres, divided into aliquots for 
repeated use should be used to assess the feasibility of the newly 
developed method. The use of a limited number reduces variation due to 
the samples used and helps focus on the performance of the test. This 
work has been carried out for the ELISA developed in this study and is 
described in the preceding chapters.
Methods for the normalisation of test results should be established. 
This adjusts the raw test results relative to the value of controls included 
in each test run and allows much more accurate inter-laboratory 
comparisons (as the tests may be used for international trade). Raw 
ELISA OD readings, for example, are absolute measurements that are 
influenced by ambient temperatures, test parameters and photometric 
instrumentation. To account for this variability, results are expressed as 
a function of the reactivity of one or more serum controls that are 
included on each run of the assay. Such data are said to be normalised or 
indexed to the control. Such normalisation can be achieved by a number 
of methods (Wright et ah, 1993). The most simple and useful, and that 
which has been described elsewhere in this thesis, expresses OD values 
as a percentage of a single positive control (PP) that is included on each 
plate.
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(ii) Optimisation and standardisation of reagents and protocols
Optimisation of assay parameters should follow pilot experiments that 
show that an assay is feasible. Optimisation should begin by 
comparisons of different reagents and concentrations by checkerboard 
titrations etc.. Optimum incubation times and temperatures and other 
assay conditions should next be determined. For ELISA, such 
optimisation is well described by textbooks such as Crowther (1995) or 
Tijssen (1988).
Preliminary estimates of repeatability by evaluating results of 
replicates within batches, between batches and between days are 
necessary to warrant further development. If excessive variation is 
apparent, then further development work should be carried out in an 
effort to reduce the figure.
(iii) Determination of the assavs performance characteristics
Estimates of DSn and DSp should be the primary parameters obtained 
and form the basis of the estimation of the usefulness of the assay. They 
are derived from the testing of a series of samples from animals of 
known disease status. Diagnostic sensitivity is the proportion of known 
infected animals that give positive results in the assay. Diagnostic 
specificity is the proportion of known disease free animals that yield
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negative results in the assay. The number and source of the reference 
samples are of paramount importance for proper assay validation.
The number of samples required for determination at a required level 
of confidence is determined by a calculation based on an estimate of the 
expected levels of the parameters (Hulley and Cummings, 1988).
The number of infected reference animals required to achieve an 
anticipated diagnostic sensitivity (± allowable error) can be 
approximated by the formula:
^_(DSn)(l-DSn)(c)^
where n is the number of known infected animals, e is the percentage 
of error allowed in the estimate and c is the confidence interval for the 
estimate. These calculations of sample numbers assume a normal 
distribution of values for each of a number of continuous variables that 
affect antibody production. The assumption of normality is less likely to 
be true when the sample size is small, so a practical minimum number of 
animals that should be included is about 300.
For example, at a diagnostic sensitivity of 96% (±2% error allowed), 
with a 95% confidence that the estimate is correct, the theoretical 
number of animals required is 369.
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In practice it is often very difficult to find a large number of samples 
from animals known to be infected or indeed known not to be infected. 
In these cases, samples should be acquired from other geographical 
regions or derived from experimental infections or judged in comparison 
to other assays. Much care should be devoted to include a representative 
range of breeds, ages, pregnancy status etc.. In each of these cases, the 
estimates generated are flawed to a greater or lesser extent. ‘Gold 
standard’ tests, established methods considered the best available at the 
time such as the CFT in brucellosis, can be used to establish the 
infection status of an animal.
The same formula can be used to estimate the number of uninfected 
animals required to estimate the DSp, but it is necessary to account for 
the increased variance which is a feature of negative populations. This 
suggests that testing from 1000 to 5000 known uninfected animals 
should be the goal to assure a very high level of confidence in the 
estimate of DSp (Jacobson, 1998).
It is often very difficult, if not impossible, to find large numbers of 
proven infected or uninfected animals from the target population. It may 
be necessary to begin validation studies with animals located in a 
geographically distinct region in which infection is known not to exist, 
or where sophisticated surveillance systems can confirm the status of
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individual animals by isolation of the organism. Data generated this way 
are of much less value and must only serve as the starting point of 
validation.
In the absence of animals of confirmed infection status, the 
performance of the new assay can be evaluated against gold standard 
tests to estimate the relative DSp or DSn. The gold standard tests will 
certainly have their own levels of false positivity or false negativity that 
will compound the errors in measuring the performance of the test under 
evaluation. Indeed, the new test may have higher levels of DSn and DSp 
than the existing tests.
The selection of the positive/negative threshold is essential before 
estimates of DSn and DSp can be made. There are several different 
methods used to achieve this, but the most simple is by visual inspection 
of a frequency distribution of normalised test results of samples from 
infected and uninfected animals. There is an overlap in most 
distributions, but the cut-off can be selected to give the best available 
DSn and DSp for the purposes for which the test is to be used (screening, 
confirmation, surveillance of free population or control programme 
(Jacobson, 1998).
Another useful tool is the use of the receiver-operator characteristic 
(ROC) curve (Zweig and Campbell, 1993). These are plots of sensitivity
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against 1-specificity using serum panels of infected and non-infected 
animals. The points that define the curve merely represent a series of 
cut-off values and one giving the best combination of sensitivity and 
specificity for the purpose can be selected. A modification of the ROC 
methodology has been devised to make the choice of cut-off more 
intuitive whilst remaining statistically accurate (Greiner et a l, 1995). 
The modified ROC plots the true positive rate (DSn) and the true 
negative rate (DSp) separately for each cut-off in a series of cut-offs that 
are represented by increasing intervals of test values on the horizontal 
axis.
In situations where known infected and uninfected animals are 
unavailable, it is possible to base the cut-off solely on endemic animals 
in the target population. If a bimodal distribution clearly separates the 
distributions of infected and uninfected animals, then this can be done 
visually. However, the data can still be analysed by using mixture 
distribution analysis techniques (Greiner et a l,  1994).
£iv) Continuous monitoring of the assavs performance
Once the assay is in routine use, internal quality control is 
accomplished by consistently monitoring the assay by recording the 
results of internal quality control sera and monitoring trends and 
changes. Reproducibility of test data between laboratories can be
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assessed by proficiency testing, that is the issuing of external quality 
control panels. These are tested blind in each laboratory and the results 
are referenced and collated by the administering Reference Laboratory. 
Those whose results fall within acceptable limits may be certified as 
official laboratories for that assay.
Tests, especially when they are to be used as the basis for national 
eradication schemes or for international trade, should be rigorously 
standardised. Correctly standardised tests provide a degree of 
confidence in their results and they allow inter-laboratory harmonisation.
The basis of test standardisation is the collection of International and 
National Standard Sera. International Standard Sera are primary 
reference standards that act as reference materials for the calibration of 
test methods and reagents and as prototypes for the calibration of 
National and Working Standards. The current OIE recommendation is 
that at least three Standard Sera should be produced: a Strong and a 
Weak Positive and a Negative Standard. Such Positive Standards should 
be produced from sera from animals exhibiting a typical immune 
response.
There are currently four International Standard Sera for brucellosis 
diagnostic tests. The Second International anti-B.abortus Serum was 
established many years ago and is used to standardise the classical
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serological tests. It is also currently used under Council Directive 
64/432 for the standardisation of the bovine ELISA. A Strong Positive, 
a Weak Positive and a Negative OIE Standard Serum have recently been 
adopted as Primary Reference Standards for the ELISA and their use for 
the standardisation of this test is described in the forthcoming edition of 
the OIE Manual of Standards (MacMillan, in press).
As Primary Reference Standards, these reagents are intended to be 
used by National Reference Laboratories to establish National Standards 
to be used in each country to standardise tests and antigens.
The aim of this chapter is to complete the validation of the ELISA 
developed in this project by evaluating it in field trials.
1.3.10 Control Measures
No reliable cure for brucellosis in farm animals has yet been 
developed and in fact attempts at cure are usually discouraged as leaving 
infected animals in the herd or flock will tend to lead to a greater rate of 
spread. Tetracycline alone or in combination with streptomycin 
(Nicoletti et al, 1989) may modify the course of the disease, but 
nevertheless, effective control must depend on vaccination and on 
sanitary methods designed to minimise the spread of the disease .
Prevention of transmission within the herd must include:
a) The identification and slaughter of infected animals
1-48
b) The isolation of all animals that have recently calved or aborted, or 
are about to abort
c) Adequate disinfection of isolation areas before other animals are 
introduced
d) The safe disposal of all products of abortion
e) The purchase of replacement animals from disease free sources
f) The isolation of pregnant replacement stock until after they have 
calved.
Prevention of transmission to contiguous herds necessitates:
a) The restriction and control of movement of animals through trade
b) Minimising contact by means of adequate fencing
Prevention and control are best conducted on a regional or country 
basis when they can be supported by an effective state veterinary 
infrastructure backed by legislation governing diagnosis, vaccination, 
surveillance, and the movement of animals and the compulsory slaughter 
of infected animals and their contacts. Effective education, information 
and advice to farmers and veterinarians is also an essential component. 
Such national campaigns must be compatible with international rules 
governing trade such as those defined by the OIE. (Corbel and 
MacMillan, 1996)
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Where the prevalence of brucellosis is high, a test and slaughter 
campaign would not be feasible as the costs of compensating farmers for 
their losses would be very high and there would be insufficient 
brucellosis free replacement stock available. In this situation, the 
widespread use of a licensed vaccine is a highly effective means of 
reducing the prevalence to a level at which test and slaughter would be 
feasible.
1.3.10.1.1 Humoral immune response
The bovine antibody response following S19 vaccination was studied 
by Nielsen et al., (1991). The results clearly show that there is a strong 
antibody response to LPS involving all four major isotypes. In general, 
IgM is produced first in very large quantities followed swiftly by IgGl, 
also produced in large quantities. About two weeks following 
vaccination, there is an IgG2 antibody response with a magnitude of 
approximately 50% of the IgGl response (Lawman et ah, 1985). A 
small but sustained serum IgA response follows. In calves the antibody 
response to B.abortus S19 lasts for approximately eight to ten months 
after which time antibody levels of diagnostic significance are not 
detectable. In adult cattle vaccinated with the standard dose of 3x10^ 
viable organisms, the antibodies follow a similar pattern except for two 
significant aspects. Firstly, the response is prolonged with detectable
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antibody still present in the serum one year after vaccination. Secondly, 
a percentage of animals became persistently infected with the vaccine 
strain resulting in antibody responses which appear similar to those of 
field infected cattle. Animals chronically infected with S I9 differed in 
that the IgG2 isotype response is very low while the IgM and IgGl 
responses are of very high magnitude and are sustained (Nielsen, 1983b).
The response of animals infected with a virulent field strain is initially 
similar to those vaccinated with S19 except that the levels of IgG2 and 
IgA may tend to be somewhat lower. However, over a longer period the 
levels of each isotype tend to be maintained. This is especially true of 
IgGl which persists for months, and often for years at a very high level 
(Nielsen, 1991a).
Nevertheless, it is apparent that in a field diagnostic situation it would 
appear impossible on this evidence to distinguish between antibody 
which has arisen as a result of vaccination or field infection. (Nielsen, 
1991a)
1.3.10.1.2 Vaccination
Of course, the interpretation of serological titres in vaccinated herds 
and flocks is one of the most difficult problems to be faced during an 
eradication campaign. The vaccination of stock is an essential part of at 
least the early phases of campaigns as it can rapidly reduce the level of
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infection in flocks and herds. However, vaccinates have the 
disadvantage that following vaccination high serological titres result that 
persist for some time. Strategies have been developed to minimise this 
effect such is limiting vaccination to young stock, using the conjunctival 
route, or vaccinating animals with reduced numbers of organisms (Alton 
efaA ,,1980).
There remains, however, a significant proportion of vaccinated
animals that are serologically positive at the time of routine testing, and 
these reactions compromise the diagnostic interpretation resulting in 
unneccessary slaughter (Nielsen et ah, 1991).
1.3.10.1.3 Use o f vaccination
Since the discovery of the cause of infectious abortion in cattle by 
Bang (1897), it was known that infected animals usually ceased to abort 
in subsequent pregnancies. Many workers conducted experiments using 
both live and dead cultures. The dead ones conferred poor immunity, 
whilst the live ones, usually virulent strains administered to non­
pregnant animals, provided good immunity against abortion, but
frequently led to excretion and spread to susceptible animals (Nicoletti, 
1990).
The description, by Buck (1930), of a strain of B.abortus of low
virulence but good immunising properties changed this situation, and
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although in the subsequent years many strains have been widely studied, 
none has proved as effective as a vaccine for cattle. This strain 19 (S I9), 
and the living strain Revl used in sheep and goats (Elberg, 1996), are 
still today the vaccines of choice and are used to vaccinate tens of 
millions of animals annually.
Ideal vaccines should confer long standing immunity, with little 
interference to diagnostic tests. They should be easy to produce with 
long stability and have a minimum of adverse effects in animals and be 
harmless to humans. Neither S19 or Revl fulfil all these requirements, 
although they are the best available.
1.3.10.1.4 Strain. 19
In 1930, Buck reported encouraging results of a vaccine of medium 
virulence called Bacterium abortus strain, 19 in a few heifers. The 
isolate was recovered from the milk of a Jersey cow in June, 1923 and 
was virulent. The culture was maintained at room temperature for over 
one year and, when tested in guinea pigs, had lost its virulence. It was 
the, 19th of the stock culture series isolated by Buck.
The outstanding characteristics of S19 are its low, stable pathogenicity 
and its relatively high immunogenicity. These characteristics were not 
altered by passaging through guinea pigs or through pregnant cattle 
(Mingle et a l, 1941, Wilson, Taylor and McDiarmid, 1949). Strain, 19
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has the cultural characteristics typical of B.abortus biovar 1, but differs 
in its requirement for CO2 and its sensitivity to thionin blue, penicillin, 
safranin O and erythritol. The significance of the sensitivity to erythritol 
is that this sugar, which promotes the growth of virulent strains, is 
present in high concentrations in ruminant placentas, the species in 
which placental localisation usually occur (Pearce et a l,  1962, Keppie 
et a l,  1965). A deletion in the region of the erythritol catabolic genes of 
S19 has been demonstrated which explains the strain’s sensitivity to 
erythritol (Sangari et a l, 1994). This character can be used as a means 
of identifying the vaccine strain (Sangari and Aguero, 1994). The gene 
responsible for metabolism of erythritol has been identified and deleted, 
but the resulting mutants do not appear to be significantly attenuated 
(Sangari a/., 1998).
S I9 has been shown to be less readily phagocytosed and survive less 
well intracellularly than virulent strains (Jones and Winter, 1992, 
Detilleux, Deyoe, and Cheville, 1990). Incubation of chorio-allantoic 
explants demonstrated the much lower cytotoxic effects of S19 compared 
to the virulent strain 2308 (Enright, 1990, Samartino and Enright, 1992). 
Bovine and caprine foetuses inoculated with S19 in late gestation were 
infected showing gross and histological lesions, but were carried to term 
whereas others, when inoculated with a virulent strain, were universally
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expelled early (Enright, 1990). These data serve to illustrate the reduced 
tendency of S19 to cause abortion in vivo (Alton et ah, 1980).
Strain, 19 was first used to produce a standardised liquid vaccine in 
the US in, 1939 and it was first used in the field in, 1941. When 
properly manufactured from recognised seed material (Alton et a l, 
1988) it completely protects 70% of animals, the remainder being partly 
protected. The organism has been shown to persist in only about 1 in 
50000 animals and there was no evidence of spread to in-contact animals 
(Mingle et a l, 1941). The incidence of hypersensitivity reactions was 
very small (Thomas, Bracewell and Corbel, 1981).
S19 still remains the vaccine most commonly used throughout the 
world although another vaccine, RB51 has been developed and 
introduced into routine use in the USA in 1997. This strain is a rough 
mutant of Brucella abortus biovar 1 and as such does not give rise to 
antibodies detected by conventional serological diagnostic tests. As such 
it has the advantage over S I9. However, it has a severe disadvantage 
that will probably prevent its licensing in Europe in that it is resistant to 
Rifampicin, one of the principle antibiotics used for the treatment of 
brucellosis in man. Attempts are being made to develop other vaccines, 
although as yet, none has reached the market (Adams, 1990).
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1.3.10.1.5 Immunity
The large number and variety of experiments which have been carried 
out to determine the immunity to infection conferred by S19 are 
summarised by Nicoletti (1990). In general, when S I9 was administered 
to calves above 2 months of age, few differences were found except in 
serological responses. Protection was greater when sexually mature 
cattle were vaccinated. No improved immunity on re vaccination was 
demonstrated and immunity persisted for at least 5 pregnancies. 
Protection following vaccination was directly related to the challenge 
dose. Manthei (1959) reported a series of controlled challenge 
experiments. A dose of 1.5x10^ virulent B.abortus which infected 100% 
of 210 controls, also infected 61% of 254 vaccinated animals with 
abortion rates of 100% and 47% respectively. However, reducing the 
challenge to 7x10^ resulted in 87% infection and 74% abortion in non­
vaccinated cattle and 26% infection and 20% abortions in vaccinates.
1.3.10.1.6 Effectiveness
Although the experiments described above point to the limited degree 
of immunity conferred to individual animals, field studies have 
confirmed the vaccine’s usefulness in producing a reduction in the 
prevalence of brucellosis. Mingle (1963) compared the numbers of 
reactors among a large number of cattle in several states in the USA.
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There were approximately 82% fewer reactors among vaccinated than 
unvaccinated cattle. Vanderwagen et a l, (1977) showed that the 
presence of unvaccinated animals in the herd increased 8-fold the 
numbers of reactors and doubled the quarantine period. Nicoletti (1979) 
showed a reduction of 85% in numbers of reactors in herds following the 
commencement of vaccination.
1.3.10.1.7Serolosical response and persistence
Following the subcutaneous administration of the standard dose of 
S I9, a response in the SAT appears at about 5-7 days, reaching a peak of 
around 2000iu at 2-3 weeks before declining at a rate largely dependant 
on the age of the animal. Reactions to the CFT appear at the same time 
or a little later but decline sooner (Hill, 1963, Hill, 1960, Burki, 1961, 
Burki, 1963, Cunningham, 1977). These positive reactions to the 
conventional serological tests in the days and weeks following 
vaccination are indistinguishable to those reactions observed in infected 
animals.
In the, 1950s it was found that vaccination of adult cattle often led to 
the production of persistent antibodies which made the interpretation of 
subsequent serological tests difficult (Nagy et a l, 1967, Duffield, 
Streeten and Spinks, 1984). In contrast, less persistent antibodies are 
produced when the vaccine is administered to calves before the age of 6
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months (Cunningham and O’Reilly, 1968, Morgan, 1971). One dose of 
vaccine in calfhood protects animals for at least five pregnancies 
(Manthei et a l,  1951, Hardenbergh, 1939, Buddie, 1948). When the 
standard dose of 8x10^^ organisms is administered to calves less than 6 
months of age, then approximately 99.5% of calves are serologically 
negative when tested at 12 months later, whilst only 80% of calves 
vaccinated between the ages of 6-9 months and 50% of calves vaccinated 
over 9 months of age will pass if tested 12 months following vaccination 
(King and Frank, 1961, Redman et a l,  1967).
When used in pregnant animals it may cause abortion, although this is 
rare (Nicoletti, 1977a) and has been shown to be associated with 
arthropathy, particularly of the stifle joint (Bracewell and Corbel, 1980, 
Wyn-Jones, Baker and Johnson, 1980).
A dose of 3x10^ administered during pregnancy has been shown to 
confer adequate protection whilst producing less persistent serological 
reactions and a marked reduction in abortions (Alton, Corner and 
Plackett, 1980). The vaccine can be administered by the conjunctival 
route, resulting in satisfactory immunity but with a reduced serological 
response (Plommet and Plommet, 1976) although it may result in a 
higher proportion of animals shedding the vaccine strain.
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1.3.10.1.8 Dilemma
Thus although the vaccine does confer reasonable immunity, and in 
the field is very effective in reducing the incidence of brucellosis, it 
suffers from the serious drawback that it causes serological reactions 
indistinguishable by conventional tests from those observed in infected 
animals, and in a certain proportion of cases these reactions may persist 
for many months. Thus, the principle means of identifying reactors for 
removal from the herd or to assess prevalence, serological testing, is 
severely compromised.
Whilst large scale vaccination of stock is well known to be the most 
effective means of rapidly reducing the incidence of disease, authorities 
are often inhibited from using it except as calfhood vaccination for fear 
of compromising diagnosis.
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1.4 Immunology and Molecular Biology
1.4.1 Immune Response
1.4.1.1 Cell Mediated Immune Response
As Brucella are facultative intracellular parasites, they are well 
adapted to intracellular survival, and in this site they are protected from 
the action of antibody. Thus the cellular immune response has an 
important role to play in the elimination of the organism. However, the 
persistence of the disease, often for the life of the animal, is strong 
evidence that this immunity is less than totally effective. Brucella are 
rapidly phagocytosed by polymorphic neutrophils (PMN) and 
macrophages, and they may be transported by these from the site of 
initial infection to distal sites. Within the cell, phagolysosome fusion, 
degranulation and the myeloperoxidase-hydrogen peroxide-halide system 
are all inhibited, particularly within the cells of naive animals 
(Anderson et a l,  1986, Detilleux et a l,  1988, Morrison and Ullevitch, 
1978). However, the action of specific T cells and macrophages 
mediated by a variety of cytokines, is at least partly successful in 
eliminating infection. Recent evidence points to the possibility that 
immunisation with O chain may induce protection without the induction 
of a detectable humoral response (Lord et a l,  1998).
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1.4.1.2 Humoral Immune Response
In cattle, IgM is the predominant antibody produced immediately 
after challenge and remains present generally for one to three weeks 
(Chappel, 1980, Rice et ah, 1966, Plackett, 1984). In those cattle that 
become infected, IgG soon becomes dominant, and there is generally a 
higher IgGl response than IgG2 (Chappel, 1980, Butler, 1981, Allan et 
ah, 1976). It has been reported (Lawman et a l,  1985), that there is often 
a significant IgG2 response in some infected cattle, and these authors 
suggest measuring this isotype as a means of discriminating infected and 
non-infected animals. The ratio of IgG2 to IgGl increases temporarily at 
parturition as the latter is actively secreted into the colostrum 
(Sutherland et a l, 1986a). Although the IgM response wanes quite 
rapidly, the IgG response is maintained for a prolonged period, although 
cyclical patterns in levels have been reported (Nielsen and Duncan, 
1987).
1.4.1.2.1 Bovine antibody isotvpes
Cattle possess the four major immunoglobulin classes, IgG, IgM, IgA 
and IgE and their basic characteristics resemble what has been described 
in other mammals. There are two IgG sub-classes, IgGl and IgG2 with 
the former being remarkable as being the predominant immunoglobulin
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in milk rather than IgA. IgG2 levels are highly heritable and vary 
considerably between animals (Tizard, 1996)
1.4.1.3 Antibodv class switching
During the course on an immune response, the class of antibody 
changes although its specificity does not. This class switch can be 
explained by the change in the genes transcribed by the jB-cell from Cp 
initially, through Cô (unknown in cattle) eventually to Cy, Ca, or Cs. 
Thus, there is an initial IgM response, soon largely superceded by one of 
IgA, IgG and IgE in a ratio most appropriate to meet the challenge. The 
class switch is regulated by cytokines, especially IL-4, TGF-|3 and IFN-y 
(Tizard, 1996).
1.4.1.3.1 Humoral immune response in brucellosis
Following infection with a virulent field strain, the organism 
multiplies rapidly within cells, some organisms are killed and a wide 
repertoire of antigens are presented resulting in a strong stimulation of 
the immune system. As the stimulation continues, affinity maturation 
occurs leading to the production of antibodies of high affinity. 
Following vaccination, the vaccine strain multiplies very little, 
remaining quiescent within cells. This results in only a low level of 
stimulation of the humoral immune system. It may be that only those
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epitopes present on the surface of the intact organism are responsible for 
the stimulation of antibody production (Nielsen et al., 1991a).
1.4.1.4 Kinetics and Affinity
Attractive interactions between non-polar residues of antibodies and 
antigen decrease with the inverse seventh power of the intermolecular 
distance (Tijssen, 1988). Thus, in practical terms, they interact over 
very small distances only and act additively. A high affinity interaction 
is the result of a multitude of weak interactions that require a close fit. 
A wide variety of factors affect the strength of these antigen-antibody 
interactions in different circumstances since the binding forces are quite 
heterogeneous. Such factors include pH, temperature, the ionic strength 
of the buffer used, and electrostatic forces acting at the matrix.
Affinity determines both the detectability and the specificity of 
immunoassays. The equilibrium between antibody (Ab), antigen (Ag) 
and immune complexes may be expressed as:
ka
Ab + A g o  Ab -  Ag
where kd and ka represent association and dissociation rate constants. 
The equilibrium (affinity) constant (K) may be established by 
determining the respective concentrations at equilibrium, according to 
the law of mass action:
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ka _ [Ab-Ag] 
kd [Ab][Ag]
Plotting the molar ratio of bound antigen/antibody against the 
concentration of free antigen yields a Scatchard plot. For monoclonal 
antibodies this is a straight line with slope K. For polyclonal antisera it 
may be a curved line. This is the classical method for measuring affinity 
as described by Scatchard (1949), but it is unsuitable for use in 
heterogeneous systems.
The terms affinity and avidity are frequently confused. Affinity is a 
thermodynamic measurement of the non-covalent interaction between 
one site on the antibody and the antigen. In contrast, avidity is an 
operational term representing the ability of an antiserum to bind antigens 
and depends therefore not only on affinity but also on valency. This is 
because the half-life of antibody-antigen interactions is short and results 
in continuous association-dissociation cycles during which the immune 
complexes become separated. However, in the case of multivalency, the 
multiple bonds do not separate synchronously making it less likely that 
the complex becomes separated. Indeed, the multi valent IgM molecule 
has an avidity 10^-10^ times greater than the affinity of the isolated Fab 
sites.
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Avidity is also an important characteristic of polyclonal antisera since 
they generally contain antibodies against all determinants of a given 
antigen. These sub-populations of antibodies contribute to avidity.
Antigens with multiple epitopes react with different antibodies of a 
polyclonal antiserum. However, despite the constant association- 
dissociation process at the individual epitopes the complex remains 
intact as each dissociation event takes place at different times. This 
effect also occurs where there are multiple repeating epitopes as on the 
Brucella 0-chain.
The importance of affinity in heterogeneous (solid-phase) 
immunoassays is widely underestimated. There is a certain maximum 
amount of antigen that can be adsorbed to the matrix limited by the 
surface area and the fraction of the ‘required’ antigen in the preparation 
(purity). The amount of antibody that binds to this immobilised antigen 
is dependant on the absolute amount present in the serum and, following 
the law of mass action, the avidity which affects the fraction of antigen 
sites that are bound. If low affinity antibodies are present, a vast excess 
of antibodies is required to obtain reasonable antigen site saturation. 
This effect is reinforced as lower avidity antibodies are much more 
quickly and readily lost from the immune complex (with a shorter half 
life) as equilibrium, dependant on the affinity constant is re-established.
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This is of great importance in practical ELISA-based assays where 
incubation times are of short duration and may not be sufficient to allow 
antibodies of low association rate constants to reach equilibrium and, 
with washing steps, may allow antibodies of high dissociation rate 
constants to elute to a significant degree.
ELISAs require the use of sophisticated statistical methods for the 
analysis of calibration curves due to the complexity of the molecular 
interactions and the possibility of errors as discussed above. The advent 
of computerised statistical packages has made this readily achievable. 
The main characteristics of ELISA calibration curves are as follows:
1) There is a non-linear relationship between response and calibrator.
2) No single unique line fits the data.
3) Relatively large assay errors which are not constant over the range of 
the curve.
Curve fitting can be carried out using a wide variety of mathematical 
methods each with its own advantages and disadvantages.
The logit function (Rodbart and Cooper, 1970) is a continuous 
sigmoidal function with a single point of inflection of the same general 
shape as immunoassay calibration curves. However, data for non­
specific binding cannot be included in this function and so Healy (1979) 
developed a model to improve logit transformation. The four parameter
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logistic function includes two more parameters to deal with the data for 
the assay zero and the non-specific binding (blank). The parameters are 
determined afresh for each assay.
The equation is:
y  =  a-\-
Table 1-2: Parameters resulting from logistic transformation and 
corresponding property
Parameter Property
X serum dilution or antigen concentration
y OD
a Baseline OD
b Maximal OD
• c Serum dilution or antigen concentration at 50% maximal OD
d Curvature factor
1.4.1.5 Experimental approaches
1.4.1.5.1 Measurement o f affinity hv serum dilution
An alternative method to Scatchard plotting (which is difficult and 
time consuming and may not be possible with large polyvalent antigens) 
has been described by van Heyningen et al. (1983) which allows the 
ranking of, or determination of, relative affinities of different antibody
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preparations. In this method, the antigen concentration is kept constant 
whilst the antibody dilution is varied. The dose response curve is then 
analysed. Maximum binding is observed at low antibody dilutions, 
whilst the antibody concentration at which 50% binding is achieved is 
indicative of avidity. This method is ideal for application in this study 
as it can be based on the ELISA technique used throughout. It is not 
necessary to measure absolute affinity, as the relative avidity of different 
preparations are to be compared. Here, the method can be used to 
compare the relative avidity at different antigen concentrations. Many 
samples can be compared under the exact conditions used elsewhere. 
Although the method is designed to measure avidity, it assumes that the 
antigen spectrum presented is identical at all antigen concentrations.
1.4.1.5.2 Measurement o f affinity usins a chaotrovic asent
An ELISA method for the direct determination of relative affinities of 
monoclonal antibodies has been described by Pullen et a l, (1986) and 
MacDonald et a l (1988). The procedure involves exposing replicate 
wells containing antibody bound to antigen to increasing concentrations 
of the chaotropic thiocyanate ion. Resistance to thiocyanate elution was 
utilised as a measure of affinity and an index representing 50% reduction 
in absorbance was used to rank the affinity of antibodies under study. 
Results obtained using this method were shown to be very closely
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correlated to those obtained using equilibrium dialysis MacDonald et a l 
(1988y
In this study it was decided to use this method to rank the relative 
avidity of samples obtained from infected and vaccinated animals as the 
methodology used was consistent with that used throughout this study 
and the results obtained could be compared to those obtained by antigen 
dilution.
Although the method described has considerable practical merit, it 
must be remembered that polyclonal sera contain wide spectra of 
antibody specificities, isotypes and affinities, and the effect of 
thiocyanate elution will necessarily reflect an additve effect. This will 
serve, however, as a practical overall measure of the relative functional 
avidity of different sera to aid comparison.
1.4.2 Molecular Biology
1.4.2.1 Proteins
Historically, protein antigens have been used to study the antigenic 
structure of Brucella cells, or the immune response of infected animals 
(Olitzki, 1970). Many of the studies of the protein antigens have 
concentrated on those isolated from the surface of the cell. These outer 
membrane proteins (OMP) form part of the outermost layer of the cell
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envelope, the part of the cell most accessible to the host's immune 
system during the early phases of disease (Cloeckaert et ah, 1992).
The outer membrane contains LPS, proteins and phospholipids 
(Dubray and Charriant, 1983, Moriyon and Berman, 1983, Verstreate et 
ah, 1982). The major OMP o f Brucella are porins of group 2 proteins 
(MW 35-40kDa) and group 3 proteins (MW 25-3 OkDa) (Dubray and 
Charriant, 1983, Moriyon and Berman, 1983, Verstreate and Winter, 
1984) and a lipoprotein (MW 8kDa) covalently linked to peptidoglycan 
(Gomez-Miguel and Moriyon, 1986). Group 1 proteins (MW 88-94kDa) 
are also found which may be covalently linked to LPS (Pererra et ah, 
1984, Moreno et ah, 1979).
1.4.2.2 Polvsaccharides
Very early in the course of brucellosis research it was recognised that 
although there was extensive cross reaction between strains of smooth 
Brucella (Orcutt, 1926, Weigmann, 1931, Kristensen, 1931) distinct 
antigens of B.abortus and B.melitensis were recognised (Evans, 1918, 
Orlitzki and Bromberg, 1931). In, 1932, Wilson and Miles designated 
these the A and M antigens (1932). Later, Redfearn (1960) and Diaz et 
ah (1968) identified these on smooth lipopolysaccharide (sLPS) 
extracted from the cell surface of Brucella. Using quantitative 
adsorption and agglutination, it was demonstrated that the A and M
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antigens were qualitatively similar but quantitatively different. Both 
B.abortus and B.melitensis expressed both A and M, but in different 
quantities.
Miles and Pirie (1939) fractionated what was subsequently shown to 
be LPS 0-chain by acid hydrolysis of water-soluble antigen. They 
identified a single sugar and a formyl component, features which have 
now been confirmed by the most modern analytical techniques (Caroff et 
a l, 1984a, L’vov et a l, 1985, Moreno et a l, 1987). In common with 
many other Gram negative organisms, sLPS from Brucella consists of a 
hydrophyllic 0-polysaccharide attached via a core oligosaccharide to the 
lipid A which anchors the molecule to the outer membrane. The major 
epitopes of the sLPS, and indeed of the cell, reside on this O- 
polysaccharide. Within the core region, one of the 3-deoxy-2- 
octulosonate (KDO) residues has a ketosidic linkage that is acid labile, 
and under conditions of mild acid hydrolysis (classical hydrolysis 
procedures result in extensive decomposition), is cleaved to release the 
0-polysaccharide along with the attached core sugars. Lipid A 
precipitates under these conditions (Luderitz et a l,  1971). Lipid A and 
core oligosaccharide are the main constituents of rough LPS, however 
even in rough strains some short surface and/or cytoplasmic O chain may 
also be present (Cloeckaert et a l,  1992).
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The identification of the genes coding for the enzymes necessary for 
the synthesis and expression of perosamine has been recently reported 
(Godfroid et ah, 1998). The low G+C content of this DNA region 
suggests that the genes may have originated from a species other than 
Brucella. Deletion of some of these genes affected the ability to survive 
in mice but not in macrophages.
The antigenic 0-polysaccharide of B.abortus biovar 1 was identified 
as a linear homopolymer of 1,2 linked 4,6 dideoxy-4-formamido-a-D- 
mannopyranosyl units linked via a - 1,2 glycocidic linkages (a  1,2 linked 
D-Rha4NFo residues) by Caroff et a l, (1984a). This structure was 
essentially identical to that of the 0-polysaccharide of Y.enterocolitica 
0:9 17 (Montarez et a l,  1984, L’vov et a l, 1985). Serological cross 
reactivity was confirmed by the use of monoclonal antibodies specific 
for both these antigens (Bundle et a l,  1984). Chain length was 
estimated to be approximately 100 glycose residues terminated by 
approximately 2% of core oligosaccharide.
The 0-polysaccharide structure of B.melitensis was found to be 
related to that o f B.abortus (and therefore Y.enterocolitica 0:9) in that 
both were homopolymers of 4,6 dideoxy-4-formamido-a-D- 
mannopyranosyl (L’vov et a l, 1985, Moreno et a l,  1987). This 
explained the cross reaction between the organisms, but did not account
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for the observed serological distinction of the A and M antigens. The 
optical rotations of the purified A and M 0-polysaccharides differed 
[water] for B.abortus biovar 1 0-polysaccharide and 
[a]i)+49° [water] for B.melitensis biovar 1 0-polysaccharide), and the 
iH- and NMR spectra of the B.melitensis 0-polysaccharide showed 
complex multiple signals around the resonant frequencies (Bundle et a l,  
1987a, Bundle et a l, 1987b, Cherwonogrodsky et a l,  1987). In 
addition, there were differences in the SDS-PAGE analysis of the native 
LPS with that from B.melitensis showing a ladder banding pattern 
consistent with a pentasaccharide repeating unit. It was deduced from 
these and other observations that while the A antigen is essentially a 
homopolymer of 1,2 linked 4,6 dideoxy-4-formamido-a-D- 
mannopyranosyl units, the M antigen is a linear polymer of a repeating 
pentasaccharide comprising one 1,3 and four 1-2 linked 4,6 dideoxy-4- 
formamido-a-D-mannopyranosyl residues (Bundle et a l,  1987a, Bundle 
et a l,  1987b, Bundle et a l,  1987c, Bundle et a l,  1989). Three 
dimensional models demonstrate how the introduction of a 1,3 linkage 
onto an otherwise 1,2 linked 0-polysaccharide alters the direction of 
chain propagation and hence the topography presented by the O- 
polysaccharide to specific antibodies.
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That the 0-polysaccharides of B.abortus and B.melitensis are the 
classic A and M antigens is based on the following: murine monoclonal 
antibodies or rabbit cross-absorbed serotype specific antisera for either 
A or M Brucella antigens will selectively bind the homologous sLPS 
coated on polystyrene plates, a reaction inhibited by pre-incubating the 
antisera with purified homologous O-polysaccharide (Cherwonogrodsky 
et a l, 1987, Meikle et a l,  1986).
Heterologous 0-polysaccharides also inhibit the binding of rabbit anti- 
A and anti-M antisera and some murine monoclonals probably as these 
antibodies have affinity for common structural entities within the O- 
polysaccharides (Cherwonogrodsky et a l, 1986, Cherwonogrodsky, 
1987). Subsequent analyses revealed that whereas Y.enterocolitica 0:9 
O-polysaccharide was an entirely 1,2 linked polymer, the B. abortus O- 
polysaccharide contained a very low percentage of 1,3 linked residues 
(e.g. the antigen contains a small proportion of M epitopes).
1.4.2.3 Discrimination/chemical structure
Attempts have been made at developing a test able to discriminate 
vaccinated from infected animals (Beltzer et a l,  1991). Using an 
immunodiffusion test, Diaz et a l, (1968, 1979, 1981) found that sera 
from recently vaccinated animals would precipitate sLPS but not a 
polysaccharide antigen, whilst sera taken from infected animals would
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precipitate both. This antigen, known as polysaccharide B (Poly B) was 
initially extracted with 0.2M trichloroacetic acid from the rough strain 
B115 of B.melitensis (Diaz et ah, 1968), but was later prepared with 
higher yield from smooth strains Diaz et a l, (1981). In the early years 
(and also in more recent papers) there was some confusion over the 
nomenclature of the various polysaccharide preparations described in the 
literature. However, more recently, by consensus the term Poly B has 
been reserved for those serologically reactive, non-LPS derived 
polysaccharides extracted from rough Brucella, and Native Hapten (NH) 
for those extracted from smooth strains and O chain polysaccharide (PS) 
for those obtained by acid hydrolysis of smooth LPS.
Early work indicated that native hapten, a component found in 
endotoxin preparations of Brucella was a polysaccharide-protein 
complex (Moreno et a l, 1981a, 1981b, Perera et a l,  1984). It was shown 
to have a high glucose content, could be isolated from both smooth and 
rough cells and was of cytoplasmic rather than cell wall origin (Jones et 
a l,  1980, Moreno et a l, 1981b)
Jones et a l, (1980) found that the immunodiffusion test using poly B 
antigen detected 90% of animals infected with B. abortus and although 
this was less sensitive than the CFT, it was more specific when used to 
test animals vaccinated with S I9.
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Lord et a l, (1991) found that 87% of culture positive cattle were 
identified by radial immuno-diffusion (RID), and 97% of infected cattle 
positive to other serological tests, whereas the test was consistently 
negative in vaccinated animals.
Zygmunt et a l  (1988) and Bundle et a l, (1987a, 1988) demonstrated 
that preparations previously described as Poly B when obtained from 
B.abortus biovar 1 was in fact a linear homopolymer of a-l,2-linked- 
4,6-dideoxy-4-formamido-D-mannopyrannosyl residues and therefore 
they claimed that it was the A polysaccharide, and when extracted from 
B.melitensis it was in turn the M polysaccharide. Their discovery, they 
suggested, of covalently bound monosaccharides characteristic of LPS 
inner core regions in highly purified preparations indicated that this 
polysaccharide is derived from LPS by hydrolytic conditions fortuitously 
generated during the extraction protocol. ‘True’ Poly B was a cyclic g- 
glucan of between 17 and 24 1,2 linked beta-D-glucopyranosyl residues, 
being essentially identical to cyclic D-glucans produced by other 
bacteria with no structural or serological relationship to A or M 
polysaccharides (Breedveld and Miller, 1994), its apparent activity in 
diagnostic tests of infected cattle being due to contamination with O 
polysaccharide. Recent evidence (Delannino et a l,  1998, Breedveld and
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Miller, 1994) shows that nevertheless this substance is probably a 
virulence factor.
This pure preparation is not antigenic and the previously described 
serological reactions were therefore probably due to the presence of 
contaminating O-polysaccharide in the preparations (Bundle et a l ,  1988, 
Cherwonogrodsky and Nielsen, 1988) These artefacts, previously being 
referred to as Poly B results from LPS hydrolysis under the extraction 
conditions used in their preparation poly B. Lord and Cherwonogrodsky 
(1991) demonstrated that as antigens ‘old’ poly B preparation and O- 
polysaccharide gave identical results, and the now characterised poly B, 
beta-glucan, was inactive.
Miles and Pirie (1939) identified a water soluble ‘native antigen’ 
which upon drying would dissociate into a free lipoid and a formyl 
derivative of an amino-polyhydroxyl compound. Native hapten (NH), as 
it was called, can be extracted from Brucella by mild methods unlikely 
to break the covalent bonds in the LPS. The identity of this substance 
remained controversial, and preparations described in the literature and 
bearing the name native hapten probably vary from each other. However 
it appeared to be O-polysaccharide associated in some way with protein 
and or core elements (Hoffman and Houle, 1986, Zygmunt and Dubray, 
1987, Moreno et a l,  1987, Zygmunt et a l,  1985)
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More recent work from Diaz’s group however has sought to refute 
these suggestions that earlier claims were inaccurate and to better 
elucidate the surface polysaccaride structures. This work, published by 
Aragon et ah, (1996), has shown by careful and convincing serological, 
chemical, physical and cytological analyses that NH is an sLPS- 
independent polysaccharide located on the surface of smooth Brucella, 
possibly anchored by non-covalent interactions with the O- 
polysaccharide chain of sLPS. Although NH appeared to possess the 
same a - 1,2- or a - 1,2- plus a - 1,3- linked -4,6-dideoxy-4-formamido-D- 
mannose as LPS O chain, it lacked LPS core markers characteristic of PS 
obtained by acid hydrolysis of LPS. They hypothesised that the NH was 
closely associated in the cell wall with LPS, and was particularly rich in 
outer membrane blebs released during cell growth. Nevertheless, 
although the picture is becoming clearer, great care must be exercised in 
interpreting experimental results and claims for serological properties of 
different polysaccharides prepared using different extraction methods.
Whilst immunodiffusion tests using NH or PS were promising, the 
nature of the test did not lend itself to screening on a large scale.
Alonso-Urmeneta et ah, (1988) found that they were unable to bind 
PS to polystyrene but this was facilitated by acylation with stearoyl
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chloride. In this form, however, they were unable to demonstrate any 
differences in binding of sera from vaccinated or infected animals. They 
concluded that the different precipitation patterns previously observed 
could be due both to differences in the affinity of antibodies arising 
following vaccination or infection and to differences in the physical state 
of aggregation of NH and LPS in aqueous solutions. Soon however, a 
method was found to passively attach unaltered O-polysaccharide to 
polystyrene microtitre plates (Nielsen et a l, 1989). They used an 
indirect ELISA to test serum samples from vaccinated and infected cattle 
and found that whilst the latter reacted with both O-polysaccharide and 
LPS antigens, serum from vaccinated animals did not bind to 0-chain 
except that from three animals persistently infected with S-19. Since the 
commencement of this work, a competitive ELISA using O- 
polysaccharide as antigen was developed by the same group (Nielsen et 
ah, 1991, Nielsen et a l, 1995) which showed similar discrimination. 
Although initially promising, field trials in several countries have failed 
to confirm such discrimination (unpublished observations, Herr et a l,  
1998, Gall et a l, 1998).
1.4.2.4 O chain epitopes
As already described above in 1.4.2.3, Diaz et a l, (1968, 1979, 
1981), confirmed by Cherwonogrodsky (Cherwonogrodsky and Nielsen,
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1988, Cherwonogrodsky et ah, 1984, 1986) reported that two precipitin 
patterns were observed with cattle sera in an immunodiffusion assay. 
Animals infected with field strains of B.abortus precipitated both sLPS 
and 'poly-B', whilst sera from Brucella S19 vaccinated cattle 
precipitated only sLPS. This pattern was used to classify murine 
monoclonal antibodies raised to B.abortus or Y.enterocolitica 0:9. Type 
1 monoclonals precipitated both O-polysaccharide and sLPS and Type 2 
precipitated only sLPS (Bundle et a l,  1984). Approximately half the 
monoclonals belonged to each type regardless of isotype.
It was speculated (Nielsen, 1991) that the mechanism for the 
differences in the patterns of precipitation may be due to epitope 
specificity. Type 1 monoclonals may bind to epitopes along the length 
of the O-polysaccharide chain, whilst Type 2 monoclonals might bind to 
an epitope situated at the end of the O-polysaccharide most distant from 
the Lipid A. Although Type 1 antibodies form a precipitate with either 
sLPS or O-polysaccharide, Type 2 antibodies can do this only with sLPS, 
and then merely due to the hydrophobic micelle formation by the lipid 
components. It is hypothesised that sera from cattle infected with field 
strains of B.abortus contain antibodies directed against both 'tip' and 
'length' epitopes, but sera from vaccinated animals contain those directed 
against the 'tip' only.
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It was proposed (Nielsen et ah, 1991) that two epitopes were exposed 
on the O-polysaccharide. Firstly, a number of ‘length’ epitopes along 
the length of the O-polysaccharide chain and, secondly, a ‘tip’ epitope 
exposed at the terminal region of the chain. They proposed that when 
the O-polysaccharide was presented in the form of LPS, the molecule 
bound with the ‘tip’ epitope exposed, whereas when the O- 
polysaccharide is presented as a pure polysaccharide, the molecule 
assumes a shape with the ‘tip’ epitope obscured. Infection with virulent 
field strains stimulates the production of antibodies to both ‘tip’ and 
‘length’ epitopes, whilst vaccination gives rise to antibodies directed at 
the ‘tip’ epitope only.
However, the existence of at least seven distinct epitopes has been 
proposed by Weynants et al. (1997) who developed a panel of 
monoclonal antibodies. They proposed epitopes; M, A, C(M>A) 
(common to Brucella - more reactive with M than A), C(M=A), 
C/Y(M>A) (common to Brucella and Yersinia - more reactive with M 
than A), C/Y(M=A) and C/Y(A>M). Although all bound to appropriate 
LPS when coated onto a polystyrene microtitre plate (at Ipg ml'^), 
monoclonal antibodies specific for M and A failed to bind to purified 
LPS adsorbed to polystyrene, and some others bound to a significantly 
reduced degree. However, all the monoclonal antibodies studied were 
inhibited from binding to appropriate LPS by the addition of PS,
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suggesting that they were capable of binding to PS when in solution thus 
implying that certain epitopes may be obscured when bound to 
polystyrene. These results support, in principle, Nielsen’s general 
hypothesis.
Cloeckaert et al. (1998) used the MAbs previously described to 
examine the binding to LPS in ELISA and cells in flow cytometry. 
There was a great degree of heterogeneity in epitope expression between 
strains in ELISA and, to a lesser extent in flow cytometry. Those Mabs 
directed to the C(M=A) and C(M>A) epitopes did not bind to B.suis 
biovar 2 and bound at lower titres to B.suis biovar 3 and B.neotomae 
than the other Brucella strains. The specificity of the MAbs measured 
using ELISA and flow cytometry gave conflicting results. Whereas in 
ELISA the Mab specific for the A antigen showed insignificant binding 
to Y.enterocolitica 0:9, this Mab bound strongly in flow cytometry. 
There was no significant difference in the expression of epitopes by S19 
from its parent biovar, B.abortus biovar 1. Thus, it is becoming more 
apparent that the expression of the various epitopes is complex, both in 
terms of their expression on various Brucella strains and depending on 
the matrix to which LPS is bound.
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It is suggested that C/Y type epitopes could depend on the number of 
a  1,2 linked D-Rha4NFo residues. Indeed, in an O chain where the 
percentage of a-1,3 links is important, (eg. PS of B.melitensis 16M) a 
structure formed around four residues with a - 1,2 links would be rarely 
present and thus it would be defined a C/Y(A>M) epitope. On the other 
hand, two or three a - 1,2 linked D-Rha4NFo residues could define the 
C/Y(A=M) epitope since this structure is common to A and M dominant 
Brucella and Y.enterocolitica 0:9. However, the presence of a 
C/Y(M>A) epitope also suggests that a - 1,2 links are not the sole 
structural feature for antibody recognition as monoclonal antibodies with 
this specificity bound better to M dominant Brucella than A dominant 
Brucella or Y.enterocolitica 0:9.
The four remaining epitopes were present only on Brucella. One 
(C(M=A)) appeared to be present in equal amounts on both A and M 
dominant strains whilst another (C(M>A)), although present on both, 
appeared to be in greater quantity on M dominant strains. Two other 
epitopes were detectable only on A dominant (A) or M dominant (M) 
strains. The structures of these four epitopes cannot be adequately 
explained by the presently known structure of the PS of Brucella or 
Y.enterocolitica 0:9. Although A dominant strains possess a-1,3 links 
(Meikle et a l,  1989), anti-M monoclonal antibodies are not able to bind
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to M dominant LPS, possibly due to the low density of M epitopes, or 
their inaccessibility. It was also established (Bundle et a l,  1987a, 
Bundle et a l,  1987b , Bundle et a l, 1987c, Bundle et a l,  1989) that the 
structure of the A epitope was a pentasaccharide or larger 
oligosaccharide composed of a - 1,2 linked D-Rha4NFo, although some 
monoclonal antibodies specific for this epitope would not bind to the 
LPS of Y.enterocolitica 0:9.
In conclusion, the classification of the epitopes along the O chain of 
Brucella appears to be more complex than was previously described and 
their structures are not entirely resolved.
The binding of most monoclonal antibodies to PS bound to 
polystyrene was reduced compared to LPS (Aragon, 1996).These 
monoclonal antibodies did not react with purified rough LPS and must 
therefore be directed to epitopes on the PS. The discrepancy of binding 
could be due to differences in antigen attachment to the polystyrene 
matrix as suggested by Nielsen et al. (1989) (see above). This 
hypothesis was supported by the ability of PS in solution to abrogate 
binding to adsorbed LPS.
Although Mabs have been produced which bind specifically to these 
O-polysaccharide epitopes, many of them, in turn, show almost complete 
competition with each other as most of these epitopes are overlapping
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structures (Weynants et ah, 1997). This limits the effectiveness of 
competitive ELISAs as even if ‘specific’ Mabs were used, there would 
undoubtably be strong competition from antibodies specific for other, 
though overlapping epitopes.
1.4.2.5 Cross reactions between species of Brucella
The A and M 0-polysaccharides consist of the same carbohydrate with 
most of the units linked in the same manner (i.e., a-1,2-linkage), and 
murine monoclonal antibodies and polyclonal antisera confirm the 
common epitopes. In, 1932, Wilson and Miles (1932) suggested that 
each bacterium has both antigens though in different amounts, B.abortus 
having predominantly the A antigen and B.melitensis the M antigen. The 
situation now is less clear cut with the identification of different biovars. 
For example, of the biovars of B.melitensis, biovar 1 expresses 
predominantly the M antigen, biovar 2 predominantly expresses the A 
antigen and biovar 3 expresses both the A and M antigen (Meikle et a l,
1986). In any event, the nearly identical antigen surface presented by 
the tetrasaccharide sequences exclusively involved in 1,2 linkages of the 
M antigen should be capable of reacting with a major sub population of 
antibodies generated in response to the Brucella A antigen. As a 
corollary, polyclonal antibodies generated by the M antigen would 
contain a significant proportion of antibodies cross reacting with the A
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antigen, in addition to antibodies specific for the unique structural 
features of the M epitope. Monoclonal antibodies generated to the 
Brucella A and M antigens do, in fact, show this pattern of reactivities 
(Bundle et ah, 1986, Cherwonogrodsky, 1986). Further studies on five 
of the six nomen-species of Brucella with SDS-PAGE, in conjunction 
with immunoblotting and immunostaining with specific A and M 
monoclonal antibodies showed banding patterns consistent with A, M, or 
mixed A and M antigens. A and M structural features were confirmed on 
analysis of the and i^C-NMR spectra of the LPS-O-polysaccharides. 
The A antigen was shown to possess a fine structure that involved, albeit 
at a low frequency of a-1,3 linked D-Rha4NFo residues, in an otherwise 
a - 1,2 linked polymer, a feature previously attributed to the Brucella M 
antigen. Since all biovars assigned as A+M- expressed one or two a-1,3 
linked D-Rha4NFo residues per polysaccharide O chain, the paradigm of 
Wilson and Miles that stipulated the presence of A and M epitopes on a 
single molecule is shown to be essentially correct. A-M+ biovars also 
possess epitopes in common with all A antigenic structures. B.canis and 
B.abortus 45/20, both rough strains, express A antigen on low molecular 
weight 0-chains.
The binding profiles of nine monoclonal antibodies generated in 
response to B.melitensis were characterised using the defined reference
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0-polysaccharides of B.abortus 1119-3, B.melitensis 16M, 
Y.enterocolitica 0:9 (Moreno et a l,  1987), and an extensive series of 
synthesised D-Rha4NFo oligosaccharide analogues of the A and M 
antigens (Bundle et ah, 1987, Cherwonogrodsky et ah, 1987). In 
competitive binding studies, three distinct binding patterns were 
characterised for the M and A antibodies. Antibody that was specific for 
the A antigen required at least five contiguous a - 1,2 linked D-Rha4NFo 
residues while antibodies that had an equal affinity for A and M epitopes 
were effectively inhibited by a-2 linked tri- and tetra-saccharides. 
Specificity for the M epitope correlated with binding that involved the 
crucial element a  D-Rha4NFo ( 1,3)-g-D-Rha4NFo- bracketed by a - 1,2 
linked D-Rha4NFo residues. Three monoclonal antibodies 
demonstrating these described binding specificities can be used as 
standards for the detection and identification of Brucella A and M 
antigens. Their analytical use confirmed the linkage distributions in 
Brucella O-polysaccharides found from the results of chemical studies 
(Perry and Bundle, 1990).
By SDS-PAGE analysis, convincing evidence was obtained for the 
heterogeneity of LPS among 16 smooth Brucella strains (Bundle et a l,
1987). Profiles present in biovars A>M were a close succession of
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regularly spaced narrow bands, whilst those present in biovars M>A 
showed regularly spaced doublets separated by barely visible bands.
There has been considerable debate in the past that, despite this 
considerable cross reaction, a homologous antigen should be used for 
serological diagnosis. For instance, Rojas et a l, (1990) reported that 
whilst 80% of sera from humans infected with B.melitensis could be 
detected with sLPS from either B.melitensis or B.abortus, the remaining 
20% could only be detected with B.melitensis sLPS.
1.4.2.6 Cross reactions between Brucella and bacteria of other genera
Serological cross-reactions between Brucella species and organisms or 
other genera have long been recognised as a potential cause of confusion 
in the diagnosis of brucellosis. Since this problem was first identified, 
numerous organisms have been reported to cause such reactions (for 
review see Corbel, 1985). Currently, there is adequate evidence of an 
antigenic relationship between smooth Brucella species and organisms of 
veterinary importance, namely the relevant serotypes of E.coli, 
P.maltophila, Salmonella, and Y.enterocolitica (Bundle et a l,  1986, 
Caroff et a l, 1984). Corbel et a l, (1983) reported that significant titres 
of cross-reacting antibodies could be evoked in cattle orally inoculated 
with S.urbana, E.coli 0:157 and Y.enterocolitica 0:9 (Bundle et al, 
1986).
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With the acquired knowledge of the structures of the Brucella O- 
polysaccharide A and M antigens, it is of interest to discover the 
structural reasons for the observed cross reactions recorded with other 
bacterial species. An analysis of the cross reacting bacteria revealed that 
in every case, the LPS O-polysaccharide were the antigens responsible 
for the cross reactions seen in the use of polyclonal antisera. From the 
structures of the respective LPS 0-chains shown below, it can be seen 
that a common feature is the presence of N-acyl derivatives of g-D- 
Rha4N residues in their repeating units and these units are almost 
certainly involved in the epitopes responsible for serological cross 
reactivities with Brucella antisera.
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Organism LPS O-polysaccharide Structure
B. abortus 2)a-D-Rha4NFo-(l-2) -a-D-Rha4NFo-(l-2) -a-D- 
Rha4NFo-(l-2) -a-D-Rha4NFo-(l-2) -a-D- 
Rha4NFo-G-
B.melitensis 2)a-D-Rha4NFo-(l-2) -a-D-Rha4NFo-(l-3) -a-D- 
Rha4NFo-(l-2) -a-D-Rha4NFo-(l-2) -a-D- 
Rha4NFo-(l-
Yersinia enterocolitica 0:9 2)ot-D-Rlia4NFo-(l-2) -ot-D-Rlia4NFo-(l-2) -oc-D- 
RJia4NFo“(l-2) -oc-D-Rlia4NFo-(l-2) -oc-D- 
Rha4NFo-U-
Escherichia coli 0157 -4-(3-D-Glcp-( 1 -3)-oc-D-GalpNAc-( 1 -2)-ot-D- 
Rlia4N Ac-( 1-3 )-oc-L“Fucp“( 1-
Salmonella Group N -4)P-D-Glcp-(l-3)-a-D-GalpNAc-(l-2)-a-D- 
Rha4NAc-( 1 -3)-a-L-Fucp-( 1 -
Pseudomonas maltophila 555 -3)-a-D-Rha4NAc-( 1 -3)a-D-Rha4NAc-( 1 -2)-a-D- 
Rha4N-(l-3)-a-D-Rha4NAc-(l 2
Vibrio cholerae -2)-a-D-Rha4N(3 -deoxy-L-tetronic acid)-( 1 -
Escherichia hermanii -2)-a-D-Rha4NAc-( 1 . -3)-a-D-Rha4NAc-( 1 -( 1:5 
and 1:6)
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The E.hermanii strains described were those that gave cross reaction 
with polyclonal E.coli 0:157 antisera, but not with specific monoclonal 
E.coli 0:157 antisera. It is interesting to note that these E.hermanii LPS 
0-chains show a close structural similarity to the Brucella M antigens 
although the amino groups of the common g-D-Rha4N residues are N- 
acetylated in the E.hermanii O chains and N-formylated in the case of 
the Brucella M antigens, and the ratio of 1,2 to 1,3 glycosidic linkages 
varied among different isolates (Perry and Bundle, 1990).
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1.5 Aims and Objectives
Although S19 vaccine does confer reasonable immunity, and in the 
field is very effective in reducing the incidence of brucellosis, it suffers 
from a serious drav^back. It causes serological reactions 
indistinguishable by conventional tests from those observed in infected 
animals, and in a certain proportion of cases these reactions may persist 
for many months. Thus, serological testing, the principle means of 
identifying reactors for removal from the herd or to assess prevalence, is 
severely compromised. Whilst large scale vaccination of stock is well 
known to be the most effective means of rapidly reducing the incidence 
of disease, authorities are often inhibited from using it, except for 
calfhood vaccination, for fear of compromising diagnosis.
The aim of this work was to develop a serological test for the 
diagnosis of brucellosis in cattle that is highly sensitive and specific and 
can discriminate between animals infected with Brucella and animals 
vaccinated with S19 vaccine.
The approach adopted was to obtain serial blood samples from cattle, 
either experimentally vaccinated with S I9, or infected with Brucella. 
Other serum samples would be collected from field-infected and 
brucellosis-free animals. The isotype responses and antibody specificity 
of the serum antibodies would be evaluated using these samples.
1-92
An ELISA based assay would be developed on the basis of differences 
between the binding of antibodies from the serum of vaccinated and 
infected animals.
Studies were carried out to establish whether the avidity of antibodies 
following vaccination was less than following infection, or whether 
vaccinated animals were responding to a more limited range of epitopes, 
in order to elucidate the test’s mode of action.
Finally, the molecular basis of this differential ELISA would be 
investigated in order to understand the underlying mechanisms involved 
in relation to antigen presentation and/or host immune response.
2. G e n e r a l  M a t e r ia l s  a n d  M e t h o d s
All Standard diagnostic methods described in this chapter comply with 
those recommended in the Office International des Epizooties (OIE) 
Manual of Standards (Corbel and MacMillan, 1996)
2.1 Control sera
The 2nd International Standard mti-B.abortus Serum (ISABS) was 
established in 1968 and is held at CVL. It was prepared from the serum 
of a cow which had been experimentally infected with B.abortus biovar 1 
six years previously and which had remained infected throughout that 
time. The serum is used to standardise the SAT and CFT and is said to 
contain 1000 International Units per millilitre in each test.
A pool of serum was collected from brucellosis free cattle to act as a 
negative control serum.
2.2 Serum agglutination test (SAT)
2.2.1 Reagents
Brucella abortus strain S99, a smooth strain of B.abortus used 
internationally, was grown in continuous culture and the SAT antigen 
was prepared and standardised by the Production Unit at CVL as
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described by Corbel and MacMillan (1996). It was standardised against 
the ISABS so that 50% (2+) agglutination occurred at a serum dilution of 
1/650. By using such a standardised antigen it was possible to 
determine the antibody content of sera in terms of International Units (iu) 
by reference to Table 2-1 (Hendry et a l, 1985). This was stored as a 
concentrated antigen and diluted before use in 0.15M saline containing 
0.5%w/v phenol.
Table 2-1: The conversion of SAT titre to International Units
Degree of agglutination
Dilution 2594 (+) 50% (++) 75% (+++) 100% (++++)
1/10 13iu 15.6 iu 18 iu 20.5 iu
1/20 25.5 iu 31.3 iu 36 iu 41 iu
1/40 51 iu 62.5 iu 72 iu 82 iu
1/80 102 iu 125 iu 144 iu 164 iu
2.2.2 Test procedure
The SAT was carried out according to the internationally accepted 
method described by Corbel and MacMillan, (1996). Briefly, 0.2ml of 
serum was added to 0.8ml of phenol saline in the first of five plastic 
tubes (PI019, Regina Industries, Newcastle). After mixing, 0.5 ml was 
transferred to the second tube and the procedure repeated to give a series 
of doubling dilutions. A 0.5 ml aliquot of the antigen suspension was 
added to each tube and mixed well. All tests were incubated in a
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humidified 37°C incubator and read after 20 hours of incubation (± 1 
hour).
Known negative and positive internal control sera were included with 
each batch of tests and titrated in the same way as the sera under test. 
The negative control serum was obtained from brucellosis free cattle and 
the positive control serum was obtained from an infected animal and 
standardised against the ISABS.
Opacity standard tubes, used for visual comparison with the test 
samples to aid the accurate reading of the tests, were set up each day and 
the tubes incubated with the tests. They comprised 0.5ml volumes of 
undiluted antigen, 3/4, 1/2, 1/4 dilutions of antigen in phenol saline and 
phenol saline alone representing 0%, 25%, 50%, 75%, and 100% 
agglutination (represented by -ve, 1+, 2+, 3+, 4+).
The degree of agglutination was read visually by comparing the 
opacity of the tubes with the opacity standard against a black background 
with a source of light coming from above and behind the tubes. A 
suitable reading box provided such conditions.
The titre of the serum was taken as the highest serum dilution giving a 
definite 1 + reading or more. Traces or less than 1 + readings were 
ignored.
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The titres were written to show the degree of agglutination 
(numerator) and the dilution (denominator). Thus 3/40 was 3+ (75%) 
agglutination at a dilution of 1/40. This titre was converted into 
international units using Table 2-1. The test was carried out in duplicate 
and the mean of the two titres was recorded as the result. If the result of 
the two tests differed by more than one degree of agglutination, the test 
was repeated.
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2.3 Complement fixation test (CFT)
2.3.1 Reagents
Brucella abortus strain S99, a smooth strain of B.abortus used 
internationally, was grown in continuous culture and the CFT antigen 
was prepared and standardised by the Production Unit at CVL as 
described by Corbel and MacMillan (1996). The antigen was obtained as 
a concentrated suspension in phenol saline and was diluted 1/10 
immediately before use in veronal buffered saline (VBS) (0.5% (w/v) 
sodium chloride, 2.8% (w/v) barbituric acid, 1.8% (w/v) sodium diethyl 
barbiturate, 1% (w/v) magnesium sulphate, 1.5% (w/v) calcium chloride 
and 0.16% (w/v) gelatine).
The source of complement was lyophilised guinea pig serum in 
Richardson's preservative (Tissue Culture Services, Swindon). 
Complement was diluted in VBS to give 1.25 minimum haemolytic dose 
(MHD), previously determined by titration as described by Morgan et al, 
(1978). The value of 1.25 minimum haemolytic dose (MHD) was 
selected so that the amount of complement is limiting.
Blood was collected from sheep maintained for the purpose at CVL. 
One hundred and thirty millilitres were taken into 270 ml of Alsever's 
solution (Tissue Culture Services, Swindon) and stored at 4° C for seven
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days before use. A 3% suspension of erythrocytes (SRBC) in VBS was 
used in the test.
Five MHD units of rabbit anti-SRBC (traditionally known as 
haemolytic Immune Body or HIB) (Tissue Culture Services, Swindon) 
were determined by titration as described by Morgan et a l, (1978). 
Equal volumes of HIB and the 3% suspension of SRBC were mixed to 
form the 'haemolytic system' and allowed to react at room temperature for 
30 minutes.
2.3.2 Test procedure
Using standard 96-well round-bottomed microtitre plates, 25pl of test 
serum (diluted in VBS) were placed in each well of the first and second 
rows and 25pl unit volumes of VBS were added to all wells except those 
of the first row. Serial doubling dilutions were then made by transfer of 
25pl volumes of serum from the second row onward. Volumes of 25pl of 
antigen diluted to working strength and 25pl of complement at 1.25 
MHD were added to each well. Control wells containing diluent only, 
serum + complement + diluent, antigen + complement + diluent, 
complement + diluent, were set up to contain 75pl total volume in each 
case, with the difference due to missing reagents being replaced by VBS. 
The plates were incubated at 37°C in a humidified atmosphere for 30
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minutes with agitation for the first 10 minutes. Twenty five microlitre 
volumes of sensitised erythrocyte suspension were added to each well 
and the plates re-incubated at 37°C for 30 minutes with occasional 
agitation for the first 10 minutes. The results were read after the plates 
had been allowed to stand at 4°C for 2-3 hours to allow unlysed cells to 
settle. The degree of haemolysis was visually compared with standards 
corresponding to 0, 25, 50, 75 and 100% lysis. Since the antigen was 
titrated so that the ISABS (containing 1000 international CFT units 
(icftu)) showed 50% fixation at a dilution of 1/200, titres were expressed 
in icftu by reference to Table 2-2.
The test was carried out in duplicate and the mean of the two titres 
was recorded as the result. If the result of the two tests differed by more 
than one degree of complement fixation, the test was repeated.
Table 2-2 The conversion of CFT titre to International Units
Degree of complement fixation (lysis)
Serum
Dilution
25% (+) 50% (++) 75% (+++) 100% (++++)
1/2 8.3 10 11.6 13.3
1/4 16.6 20 23.2 26.6
1/8 33 40 46.5 53.2
1/16 66 80 93 106
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2.4 Indirect ELISA 
2.4.1 Reagent titrations
One hundred microlitres of coating buffer (0.29% (w/v) sodium 
hydrogen carbonate, 0.16% (w/v) sodium carbonate and 0.02% (w/v) 
sodium azide (adjusted to pH 9.6) were added to all wells of two plates 
except those in column 1. The antigen was diluted 1/100 in coating 
buffer and 200pi added to all the wells in column 1 and then double 
diluted across the plate (Figure 2-1).
The plates were covered to prevent evaporation and incubated at 4°C ± 
2°C for 18-24 hours before being rinsed 6 times with washing solution 
(0.014% (w/v) di-sodium hydrogen orthophosphate and 0.01% w/v 
Tween-20). They were dried by tapping firmly onto a few layers of 
absorbent towel until no more liquid was removed.
One hundred microlitres of a 1/200 dilution of positive serum made in 
diluting buffer (PBS containing 0.5% (v/v) Tween 20 and 0.001% (w/v) 
phenol red (as a pH indicator)) was then added to all wells of one plate 
and similarly lOOpl of a 1/200 dilution of negative serum was added to 
the other.
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The plates were incubated for 30 minutes at room temperature (21°C ± 
6°C) on a rotary shaker (160 revs/min), after which they were washed 
and dried as above.
One hundred microlitres of diluting buffer was added to all wells 
except those in row A. A 1/100 dilution of conjugate (anti-bovine IgG 
(heavy and light chain) peroxidase conjugate (ICN)) was then prepared 
in PBS and added to all wells in row A and doubling dilutions were 
performed.
Figure 2-1: Plate layout for checkerboard titration
A
B
C
D
E
F
G
H
1 2 3 4 5 6 7 8 9 10 11 12
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
1/100
Conjugate
titration
1/12800
1/100
Antigen titration
-► 1/205x10
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The plates were incubated for 30 minutes at room temperature (21°C ± 
6°C) on a rotary shaker (160 revs/min), after which they were washed 
and dried as before.
The substrate solution was made up immediately prior to use. To 12ml 
of substrate buffer (1.7% (w/v) citric acid trisodium salt dihydrate and 
0.78% (w/v) citric acid pH 4.5-5.5) was added to 60pl of 3% hydrogen 
peroxide and 300pl of ABTS stock solution (40mM 2,2'-Azino-bis(3- 
ethylbenzthiazoline-6-sulphonic acid) diammonium (ABTS)). The 
solution was mixed and lOOpl dispensed into each well on the plate. The 
plate was left to react at room temperature for 15 minutes and was 
stopped by the addition to each well of 100 pi of ImM sodium azide 
(stopper reagent) to each well. The plate was read using a commercial 
ELISA plate spectrophotometer (Lab Systems), within 10 minutes, at 
405nm blanked on well H I2.
The optical density (OD) readings of each plate were measured using a 
commercial ELISA plate spectrophotometer (Lab Systems). The results 
were analysed by dividing the ODs on the positive plate by the 
corresponding ODs on the negative plate, thus giving a ‘binding ratio’ 
for each dilution of antigen and conjugate. For routine use, the optimum 
dilution for both antigen and conjugate was chosen. This was taken as 
that which gave the highest binding ratio between the two plates where
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the positive serum OD was between 1.000 and 1.500, and the OD of the 
negative serum was between 0.050 and 0.150; arbitrarily chosen ranges 
facilitating visual inspection. Often a number of antigen/conjugate 
combinations satisfied these criteria and then the most economical 
dilutions were selected.
2.4.1.1 Titration of antigen for the modified indirect ELISA
Briefly, the titration of antigen was carried out as described in 2.4.1 
but a single dilution of conjugate was used throughout (Figure 2-2). The 
ISABS, serum CF50/53 (collected from vaccinated animal CF50, 53 days 
after vaccination) and the negative standard serum were diluted 1/200 in 
diluting buffer and each was added to three rows of each plate (two rows 
for the negative serum). The latter were incubated for 30 minutes at room 
temperature on a rotary shaker and subsequently washed. Mean ODs 
were calculated before analysing as in 2.4.1 except that the optimal 
antigen dilution was taken as that which gave the greatest discrimination 
between ISABS and CF50/53.
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Figure 2-2 ELISA antigen titration
1 2 3 4 5 6 7 8 9 10 11 12
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F
G
H
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Serum
ISABS  
Q  C F50/53  
( 2 )  Negative
1/500 172048k
Antigen
2.4.2 Routine test procedure
Polystyrene microtitre plates (Dynatech 69620) were coated with 
100pi antigen diluted in coating buffer at a dilution determined by 
checkerboard titration (see Section 2.4.1). The plates were covered to 
prevent evaporation and incubated at 4°C ± 2°C for 18-24 hours. The 
plates were rinsed and dried six times as described in Section 2.4.1. If 
not used immediately, they were dried in a 37°C incubator for 30 minutes 
and stored at 4°C ± 2°C in the dark for up to twelve months.
A 1/40 dilution of the standard positive and negative sera and each of 
the test samples was made by adding 25pi of serum to 1ml of diluting 
buffer. The plates were prepared by adding 80pl of the diluting buffer to
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all wells. Twenty microlitres of the diluted positive reference serum 
(ISABS) was added to all the wells in column 11 giving a final serum 
dilution of 1/200. Twenty microlitres of the diluted negative reference 
serum was added to all the wells in column 12 except H I2, giving a final 
serum dilution of 1/200. H12 was used to blank the plate. Twenty
microlitres of each of the diluted test sera was added to the remaining 
wells. (Figure 2-3).
Figure 2-3 Layout of ELISA plate for routine test 
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Well
OTestOPositiveo Negativeo Blank
The plate was incubated for 30 minutes at room temperature (21°C ± 
6°C) on a rotary shaker (160 revs/min) after which it was washed and 
dried as before. The conjugate was prepared by diluting sufficient 
conjugate concentrate in 12ml of diluting buffer. One hundred 
microlitres of the working strength conjugate solution was added to each
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well on the plate and incubated for a further 30 minutes at room 
temperature (21°C ± 2°C) on a rotary shaker (160 revs/min) after which 
it was washed and dried as above. The substrate and chromogen were 
prepared and added and the plate read as described in Section 2.4.1.
2.4.2.1 Basic analvsis of the results
The mean OD of column 11 containing the ISABS positive standard 
was calculated and the ODs of each test serum was expressed as a 
percentage of that figure (PP).
The test was carried out in duplicate and the mean PP was recorded as 
the result. If the result of the two tests differed by more than 15%, the 
ELISA was repeated.
2.4.3 Four-parameter logistic model
Data were analysed by a commercial curve fitting program 
(Tablecurve) using the four-parameter logistic function, a commonly 
used function used throughout biology to analyse sigmoid relationships.
The equation used was:
y  = a +
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The function enables the estimation of parameters that are related to 
physical attributes of the ELISA titration curve from data that may not 
cover the complete range of the titration curve (Table 2-3). The 
parameters of greatest relevance to this study are the maximal OD (factor 
b) and the dose (antigen concentration or serum dilution) at 50% 
maximal OD.
Table 2-3: Factors resulting from logistic transformation and 
corresponding property
Factor Property
a Baseline OD
b Maximal OD
c Dose at 50% maximal OD
d Factor governing curvature
X Measured OD
y Estimated OD
2.5 Preparation o f lipopolvsaccharide
Three methods were used for the preparation of LPS antigens for the 
ELISA. They were autoclaving, phenol/water extraction and extraction 
with sodium dodecyl sulphate W"descfibed by "Chëfwônogrodsky and 
Stevens (1991). All methods used B.abortus S99 cells, grown in 
continuous culture, heat killed and harvested in 0.5% phenol saline as 
prepared and provided by the production unit at CVL.
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2.5.1 Autoclaving
A cell suspension of 6g wet weight of B. abortus S99 cells in 30ml 
phenol saline was autoclaved at 121°C for 30 minutes and allowed to 
cool to room temperature. The supernatant was removed following 
centrifugation at 10,000g for 30 minutes at 4°C. The supernatant was 
dialysed for 18-24 hours against two changes of 20 volumes of distilled 
water using dialysis tubing with a pore size of 1OOOMW.
2.5.2 PhenolAVater extraction
A cell suspension of 50g wet weight of B. abortus S99 cells was 
resuspended in 170ml of distilled water and warmed to 66°C in a water 
bath. One hundred and ninety millilitres of 90% w/v phenol (342g 
phenol in 380ml of distilled water) (pre-heated to 66°C) was added. The 
mixture was thoroughly shaken and then heated in the water bath for two 
hours with continuous mixing. The mixture was cooled to 4°C and 
centrifuged at 13,000g for 15 minutes at 4°C.
The supernatant was collected, filtered through a Whatman # 3 filter 
and placed into a separating funnel. It was left for 18-24 hours to 
separate into the water and phenol phases.
The phenol phase was collected and filtered through a Whatman # 3 
filter. Three volumes of methanol containing 1% methanol saturated
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with sodium acetate was then added. The mixture was stirred well and 
allowed to precipitate out at 4°C for 2.5 hours. After washing with 
methanol/acetate twice more the mixture was centrifuged at 6,000g for 
15 minutes at 4°C.
The pellet was recovered and resuspended in 80ml of distilled water. 
It was stirred continuously for 24 hours at 4°C. It was centrifuged again 
at 10,000g for 15 minutes at 4°C. The supernatant was filtered 
(Whatman # 3) into a separate container (supernatant A). The pellet was 
resuspended in 80ml of distilled water, stirred for one hour at room 
temperature and centrifuged again as above. The supernatant was 
filtered into a separate container (supernatant B). Both supernatants (A 
and B) were pooled together and filtered through a 0.3pi filter.
The pooled supernatants were then dialysed for 96 hours at room 
temperature using dialysis tubing with a pore size Of 1 OOOMW against 
several changes of distilled water before being freeze-dried.
2.5.3 SDS extraction
Fifty grams wet weight of Brucella S99 cells were mixed with 50ml of 
Laemmli buffer (0.0625M Tris buffer, pH 6.8) containing 10% sodium 
dodecyl sulphate (SDS). The solution was heated to 100°C for 10 
minutes and cooled to 55°C in a water bath. Five millilitres of 50mM
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magnesium sulphate was added and mixed well. Five hundred 
international units of DNase dissolved in 2ml of Laemmli buffer was 
added and heated at 37°C for 1 hour followed by five hundred 
international units of RNase dissolved in 2ml of Laemmli buffer. This 
was added and heated at 37°C for 1 hour. The solution was cooled to 
room temperature and 500iu lysosyme dissolved in 2ml of Laemmli 
buffer added and incubated at room temperature for 5 hours. Five 
hundred international units of Proteinase-K in 2ml of Laemmli buffer 
was added and the solution incubated at 55°C for 3 hours and then for 
18-24 hours (overnight) at room temperature (21°C ± 6°C). Five grams of 
SDS was mixed and the solution heated to 100°C for a further 10 
minutes. The solution was allowed to cool to 60°C and then it was 
centrifuged at 12,000g for 30 minutes. One volume of propan-2-ol was 
added to the supernatant and was allowed to stand for 30 minutes before 
centrifuging at 12,000g for 30 minutes. The precipitate was dissolved in 
100ml of distilled water and the LPS precipitated by the addition of an 
equal volume of propan-2-ol, collected by centrifugation at 12,000g for 
30 minutes and re-dissolved in the minimum volume of distilled water.
2-19
2.6 Vaccination and challenge
2.6.1 Strain 19 Vaccine
Strain 19 vaccine was obtained from Rhone-Merieux (Lyons), a 
commercial source of the vaccine used widely throughout Europe. The 
vaccine is produced and quality checked according to internationally 
agreed procedures as described by the WHO (Report 1970) and the OIE 
(Corbel and MacMillan, 1996). The vaccine is presented in individual 
dose vials each containing 5x10^® organisms.
2.6.2 B.abortus strain 544 Challenge Strain
B.abortus strain 544 challenge strain was obtained from the culture 
collection held at CVL. It is the reference strain of B. abortus biovar 1 
which is commonly used as the standard challenge strain in such 
experiments.
It was grown on serum dextrose agar for five days at 37°C and 
harvested in phosphate buffered saline pH 7.2. The suspension was 
adjusted to 3 x 10^  ^ organisms per millilitre and placed in individual 
dropper bottles delivering 30pl aliquots
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2.6.3 Vaccination
The vaccine was reconstituted with 5ml distilled water according to 
the manufacturer’s instructions. A single 5ml dose was administered by 
sub-cutaneous injection over the shoulder.
2.6.4 Challenge
The inoculum was prepared and placed in individual dropper bottles. 
Each dose was administered by instilling one 3 Dpi drop into the left eye 
within two hours of preparation.
2.6.5 Preparation o f blood samples
Freshly drawn, venous blood samples were incubated for one hour at 
37°C to allow maximal clot separation before collecting the serum by 
centrifugation at 10,000g for 10 minutes. Each serum sample was 
divided into smaller aliquots before storage at -20°C.
2.7 Statistical analyses
The Wilcoxsons Rank Sum Test was used to test for significance of 
difference of paired, non-parametric data. The Mann-Whitney U Test 
was used for unpaired data.
3. H u m o r a l  Im m u n e  R e s p o n s e
3.1 Introduction
In the field, cattle are usually infected with B.abortus via the oro­
pharynx or conjunctival mucosa. Virulent field strains rapidly invade and 
spread to organs of the reticulo-endothelial and reproductive systems 
where they multiply quickly and become established. On the other hand, 
animals vaccinated with S19 vaccine are inoculated via the subcutaneous 
route with an attenuated strain that does not multiply a great deal or 
become established but which persists in most animals for only a short 
period of time.
There are therefore significant differences in the way the host’s 
immune system is exposed to Brucella and it might be expected that the 
character of the response that it mounts in each case might differ 
significantly. Nevertheless, the Brucella genus as a whole is extremely 
homogeneous and certainly the immunodominant antigens of S19 
apparently do not differ from other B.abortus strains (Nicoletti, 1990).
The aim of these experiments was to study the humoral immune 
response of animals exposed in such a way as to mimic that which occurs 
in the field e.g. as calves conventionally vaccinated with S19 and adults 
infected with a virulent strain of B.abortus.
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3.2 Materials and Methods
3.2.1 Experimental infection and vaccination
All experimental work was carried out in secure animal 
accommodation at the CVL and was covered by the provisions of an 
appropriate Home Office Licence. For the vaccination experiment, six, 
five month old female Friesian cross calves (identified as CF45 to CF50) 
and for the challenge experiment, four 18 month old female Friesian 
cross heifers (identified as CH63, CH82, CH87 and CH505) were 
purchased from a single brucellosis free farm in Surrey. The animals 
were introduced to their accommodation two weeks before the start of 
the experiment for acclimatisation.
Prior to the commencement of the experiment, the animals were bled 
to establish that their serum lacked detectable antibodies to Brucella 
using conventional serological tests.
Vaccinated animals were housed individually in isolation boxes. 
Animals infected with B.abortus were housed individually in isolation 
boxes within Advisory Committee on Dangerous Pathogens (ACDP) 
Containment Level 3 accommodation. Animals were observed at least 
twice daily and any significant clinical findings were recorded.
3-3
The preparation of the S19 vaccine and the B.abortus strain 544 and 
the procedures for vaccination and challenge were as described in 
Section 2.6, Chapter 2.
Blood samples were collected from vaccinated animals daily for the 
first 14 days and then with decreasing frequency as the rate of change in 
the antibody response diminished. Samples were collected from 
challenged animals weekly throughout the experiment.
Serum samples from 133 cattle sampled under the routine brucellosis 
monitoring scheme and from which B.abortus biovar 1 had been isolated 
were collected. Serum samples collected from 171 cattle sampled under 
the routine brucellosis monitoring scheme from known brucellosis free 
herds and which were negative to conventional serological tests were 
collected. All serum samples were stored at -20°C until required.
3.2.2 Serological testing
The SAT, CFT and conventional indirect ELISA (iELISA) were 
carried out as described in Sections 2.2, 2.3 and 2.4, Chapter 2.
The antigen used in the iELISA was AS2 (supernatant) at a dilution of 
1/2000 .
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3.2.3 Isotype response
Individual serum antibody isotypes were measured using the standard 
iELISA but using a range of commercially available anti-isotype 
peroxidase conjugates in place of the usual anti-bovine IgG (H+L) 
conjugate. The plate layout, data analysis, and assay conditions were 
otherwise as described for the iELISA in Section 2.4.1, Chapter 2.
Peroxidase conjugates specific for bovine IgM, IgGl, IgG2, IgA as 
well as a conjugate specific for bovine IgG (H+L) were purchased from 
ICN.
Isotype conjugates were used at a concentration determined by 
checkerboard titration against the antigen, using both positive and 
negative standard serum as described in Section 2.1, Chapter 2. The 
antigen used for this experiment was batch AS2, as described in Section 
2.5.1, Chapter 2.
The standard serum ISABS was titrated over a range of dilutions from 
1/25 to 1/25600 using AS2 as antigen using the method described in 
Section 2.4.1, Chapter 2.
ELISA results were normalised by taking the OD of each well and 
expressing it as a percentage of the mean of the OD of the ISABS 
positive standard on each plate (PP) as described in Chapter 2. By
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normalising raw OD results with respect to a Standard on each plate, 
variation in colour development due to variations in temperature and 
other test parameters is reduced.
3.2.4 Antigen specificity
The iELISA was carried out essentially as described in Section 2.4.1, 
Chapter 2 using antigens AS2 at a dilution of 1/6000, PK2 at 1/1500 
and BIO at 1/1500. Each was produced by extraction from B.abortus 
strain 99 cells using methods described in Chapter 2 but are in brief: 
extraction by SDS/Proteinase K (PK2), extraction by hot phenol/water 
(BIO) and autoclaving (AS2). The preparations were denoted PK2, BIO 
and AS2 respectively.
The optimum combination of antigen and conjugate for use was 
determined by checkerboard titration using the method described in 
Section 2.4.1, Chapter 2.
As in the standard iELISA, ODs were expressed as a percentage of 
the mean OD of positive control wells (PP) as described in Section 2.4.1, 
Chapter 2.
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3.3 Results
The serological responses of the experimental animals were measured 
using classical serology to provide evidence of the typical nature of the 
humoral immune response.
3.3.1 Classical serology
3.3.1.1 Infected animals
Following conjunctival inoculation there was a rapid response to both 
the SAT and CFT in all animals commencing between days 7 and 14 
(Figure 3-1). The SAT reached a peak of between 205iu and 1641iu 
between days 14 and 63. The CFT peaked at around the same time at 
between 372icftu and 1491icftu. Following these peaks, the titres 
initially declined slowly but remained above diagnostically significant 
levels (SAT >60iu and CFT >20icftu) up to the end of the experiment at 
day 230 in three of the four animals. Animal CF87 remained positive to 
the CFT up to day 196 and in the SAT up to day 112.
The responses were as might be expected from non-pregnant animals; 
the titres in three were observed to decline gradually. In only a single 
animal did the titres remain elevated, indicating perhaps that the 
infection was persisting, as seen most frequently in pregnant cattle. 
Establishment of the infection was confirmed in all animals by the
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isolation of the infecting strain by blood culture on at least one occasion 
(Table 3-1).
Table 3-1: Results of blood culture in animals following challenge
Days post-challenge
Animal 2 7 14 21 28 35 42 49 56 63 70 78
CF63 - - - - - + + - - - - -
CF82 - + - + - - - - - - - -
CF87 - - - - - - - - + - - -
CF505 - + - - + - - - - - - -
R esults o f  blood culture collected weekly following experim ental infection using biphasic 
serum  dextrose agar. C ultures w ere incubated fo r up to  four w eeks (37®C/5%C02) and 
examined daily for grow th. + denotes Brucella  isolated. -  denotes Brucella  not isolated.
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Figure 3-1: SAT and CFT responses of animals experimentally infected 
with B. abortus strain 544
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Results o f  SAT and CFT testing o f  serial serum samples following the experim ental 
infection o f  four young female cattle. The tests w ere carried out using standard m ethods and 
results expressed in iu or icftu (as described in C hapter 2).
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3.3.1.2 Vaccinated animals
Following subcutaneous vaccination, there was a rapid response to 
both the SAT and CFT in all animals commencing around day four 
(Figure 3-2). The SAT reached a peak of between 7876iu and 1969iu 
between days eight and sixteen. The CFT peaked at around the same 
time at between 532icftu and 1280icftu. Following these peaks, the 
titres waned slowly and fell below diagnostically significant levels (SAT 
<60iu and CFT <20icftu) as early as 79 days following vaccination, 
although animal CF46 remained positive to the SAT up to the end of the 
experiment at day 237.
The responses observed were considered typical and as expected from 
previous experience in our laboratory. They certainly provided strong 
evidence that the vaccination had provoked a significant humoral 
immune response lasting in one animal as long as the end of the 
experiment when the animals were over one year old.
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Figure 3-2: SAT and CFT Responses of animals vaccinated with 
B. abortus strain 19
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Results o f  SAT and CFT testing o f  serial serum samples following the vaccination o f  six 
female calves. The tests  w ere carried out using standard m ethods and results expressed in iu 
or icftu (as described in C hapter 2).
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The humoral response as measured by the classical serological tests 
following vaccination both arose and fell more rapidly than following 
infection. This difference was statistically significant (P<0.05) for the 
CFT but not the SAT titres. However, in the field, animals are blood- 
sampled at an arbitrary (and unknown) interval following vaccination or 
infection. Therefore, for the discrimination of the infection/vaccination 
status it is insufficient for there to be merely differences at each point in 
time.
3.3.1.3 Culture-positive animals
Samples from 133 animals from which B.abortus biovar 1 had been 
isolated were tested by SAT and CFT. Their results are summarised in 
Table 3-2. The sensitivity estimate of the SAT is 79.7% and of the CFT 
is 96.24%. As expected, the sensitivity of the CFT was considerably 
better than the SAT (MacMillan, 1990). The range of titres observed 
following vaccination fell well within the range of titres given by sera 
collected from infected animals, confirming that individual samples from 
vaccinated or infected cannot be discriminated using the SAT or CFT.
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Table 3-2: Classical test results of culture-positive animals
CFT<20icftu CFT>20icftu Total
SAT<60iu 5 (3.75%) 22(16^M4) 27(20JP%)
SAT>60iu 0(0% ) 1 06(79 /^ 4) 106(79/^%)
Total 5 (3.75%) 128 (96.24) 133 (100%)
Results o f  SAT and CFT testing o f  serum samples collected from  Brucella  culture positive 
female cattle. The tests w ere carried out using standard m ethods and results expressed in iu 
or icftu (as described in Chapter 2). n=133.
3.3.1.4 Uninfected animals
Serum samples from 160 animals in brucellosis free herds were all 
negative to both SAT and CFT.
3.3.2 Conventional ELISA
The conventional ELISA used in this study was an indirect ELISA for 
the detection of serum antibody. The OD results were normalised in 
relation to a serum standard on each plate and expressed as percent 
positive (PP).
3.3.2.1 Infected animals
Following conjunctival inoculation, there was a rapid response to the 
ELISA in all animals, commencing between days 7 and 14 and reaching 
an initial peak of between 70 and 90%PP (OD expressed as a percentage 
of the positive standard) between days 35 and 49 (roughly corresponding 
with the peak of the SAT and CFT response). Following these peaks, the 
titres initially declined slowly in three animals, but rose in CH63 before
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falling away (Figure 3-3). It was this animal in which a persisting 
response was observed with the SAT and CFT tests.
Figure 3-3: Conventional ELISA responses of animals experimentally 
infected with B. abortus strain 544
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Results o f  indirect ELISA testing o f  serial serum samples following the experim ental 
infection o f  four young female cattle. The test was carried out using a partially purified 
LPS antigen (AS2 at 1/2000) and the results w ere norm alised to  a positive standard serum 
on each plate (PP).
3.3.2.2 Vaccinated animals
Following subcutaneous vaccination, there was a rapid response to the 
ELISA in all animals, commencing at about day four or five and reaching 
a peak of between 50 and 65%PP between days 14 and 21 (Figure 3-4). 
Following these initial peaks, the titres were maintained before 
beginning to fall at about day 63. Titres fell below the internationally 
accepted diagnostic threshold (10%PP) from day 164 following
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vaccination, although animals CF46 and CF48 remained positive up to 
the end of the experiment at day 237.
Figure 3-4: Conventional ELISA responses of animals experimentally 
vaccinated with SI9 vaccine
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R esults o f  indirect ELISA  testing o f  serial serum samples following the vaccination o f 
six female calves. The test was carried out using a partially purified LPS antigen (AS2 
at 1/2000) and the results w ere norm alised to  a positive standard serum on each plate 
(PP).
There was no significant difference between the ELISA response of 
vaccinated and infected animals at each point in time or for the 
maximum peak PP or duration (Table 3-3).
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Table 3-3: Summary statistics o f ELISA responses expressed in PP 
following vaccination or infection
Max (PP) Duration (d)
CH67 97 >230
1
CH82 71 230
1
CH87 92 230
CH505 86 224
CF45 58 164
CF46 70 237
ss
CF47 56 164
Ü
8 CF48 63 237
> CF49 64 208
CF50 52 237
Summary o f  indirect ELISA  testing o f  serial serum samples following experim ental 
infection and vaccination. The test w as carried out using a partially purified LPS antigen 
(AS2 at 1/2000) and the results w ere norm alised to  a positive standard serum  on each plate 
(PP). The maximum response is the peak response expressed in PP. The duration  is the  last 
bleeding date which exceeded 10%PP.
S.3.2.3 Culture-positive animals
All 133 samples from culture-positive animals exceeded the 
diagnostically significant level of 10%??, with the majority exceeding 
90%?? (Figure 3-5). These results confirm that the sensitivity of the 
conventional ELISA is very high.
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Figure 3-5: Frequency Distribution of ELISA results of Culture-positive 
Samples
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Results o f  indirect ELISA  testing o f  serum samples from 133 Brucella  culture 
positive female cattle. The test was carried out using a partially purified LPS antigen 
(AS2 at 1/2000) and the results were normalised to  a positive standard serum on each 
plate (PP),
3.3.2.4 Uninfected animals
One hundred and seventy one samples from uninfected animals were 
tested using the conventional ELISA. All fell below the diagnostically 
significant level of 10%PP indicating that the conventional ELISA has 
good specificity as well as good sensitivity (Figure 3-6).
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Figure 3-6: Frequency Distribution of Uninfected Sera
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Results o f  indirect ELISA  testing o f serum samples from 171 brucellosis free female 
cattle. The test was carried out using a partially purified LPS antigen (AS2 at 1/2000) and 
the results w ere normalised to  a positive standard serum on each plate (PP).
3.3.3 Isotype response
In the previous sections it has been shown that both vaccinated and 
infected animals responded strongly as measured by the classical and 
ELISA tests. A further experiment was designed to analyse this response 
in terms of individual isotypes.
3.3.3.1 Titration of reagents
Each isotype conjugate was titrated by checkerboard titration as 
described in Section 2.4.1, Chapter 2. Serum samples were diluted 
1/200 for test, except when using the anti-IgA conjugate when it was
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necessary to use a dilution of 1/16. The chosen dilutions are shown in 
Table 3-4.
Table 3-4: Working dilutions of antigen and conjugate (reciprocal)
Conjugate Conjugate Dilution Antigen Dilution Serum Dilution
IgM 1600 2000 200
IgGl 600 2000 200
IgG2 600 2000 200
IgA 250 2000 16
IgG(H+L) 600 2000 200
D ilutions o f  anti-isotype conjugates, antigen and serum  for use in indirect ELISA. They 
w ere selected following checkerboard titra tion  using a partially purified LPS antigen (AS2)
3.S.3.2 Titration of Standard Serum
The International Standard Serum (ISABS) was titrated from 1/25 to 
1/25600 as described in Section 2.4.1, Chapter 2 and tested using each 
anti-isotype conjugate. The raw OD results are presented in Figure 3-7. 
Both the maximum OD and curve characteristics varied between 
conjugates. The curves observed when using conjugates directed against 
IgA, IgG2 and IgM fell quickly, whilst those of IgG (H+L) and IgGl 
were maintained over a greater range of dilutions.
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Figure 3-7: Titration of standard serum ISABS with anti-isotype 
conjugates
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R esults (OD units at 405nm) o f  indirect ELISA  testing o f  serum ISABS. The tes t was 
carried out using a partially purified LPS antigen (AS2 at an appropriate dilution) and anti­
isotype conjugates. The results w ere normalised to  a positive standard serum on each plate 
(PP).
3.3.3.3 Infected animals
All animals except CH82 showed a rapid and early rise in IgM 
commencing between days 7 and 14, which fell and was maintained at a 
lower level for a prolonged period (Figure 3-8). Although the response 
of CH87 arose early, it rose only to a low level. Animal CH82 showed a 
much slower and less pronounced IgM response whilst in CH505 the 
response peaked at a very high level (mirrored by the SAT responses 
(Figure 3-1)). The rises in IgA and IgGl were similar, though less 
pronounced. In animal CH63, the level of IgGl rose to a particularly high
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level (comparable to the CFT response (Figure 3-1). IgG2 rose much 
more slowly but, like the other isotypes, was maintained for a prolonged 
period.
There was considerable variation between animals, in particular the 
relative responses of each isotype, and the response often appeared 
complex with episodic peaks.
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Figure 3-8: Isotype responses of animals experimentally infected with 
B. abortus strain 544
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Isotype ELISA results o f  testing serial serum samples following experim ental infection o f  
four young female cattle. The test was carried out using a partially purified LPS antigen 
(AS2 at an appropriate dilution) and anti-isotype conjugates. The results w ere norm alised to  
a positive standard serum on each plate (PP).
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3.3.3.4 Vaccinated animals
There appeared to be less variation between vaccinated animals than 
those which were experimentally infected.
A rapid IgM response was detected commencing on day 4 or 5 and it 
was notable that this mirrored the SAT but not the ELISA response 
(Figure 3-9, Figure 3-4)). In all animals this response increased rapidly, 
reaching a peak of 145-199%PP between days eight and sixteen and 
quickly falling to less than 50%PP in all cases. The initial response of 
IgGl and IgG2 was of a similar nature but IgG2 quickly fell to a lower 
level. The response was initially detectable between six and 10 days 
following vaccination and increased slowly, peaking somewhere between 
days 21 and 53 at levels of 40-66%PP (Figure 3-9). The IgGl responses 
were similar in nature to that of the CFT and of the conventional ELISA.
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Figure 3-9: Isotype responses of animals vaccinated with B.abortus strain 
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Isotype ELI SA results o f  testing serial serum samples following vaccination o f  six female 
calves. The test was carried out using a partially purified LPS antigen (AS2 at an appropriate 
dilution) and anti-isotype conjugates. The results w ere norm alised to  a positive standard 
serum on each plate (PP).
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There were no significant differences between the peak or duration of 
any of the isotype responses of infected and vaccinated animals (Figure 
3-8). The IgM responses of infected animals was very variable, only one 
showed the peak response as in the vaccinated animals. The IgA 
responses tended to be higher in infected animals than in vaccinated 
animals. The level of the various isotype responses varied from animal to 
animal. Nevertheless, for prolonged periods, they all exceeded the 
threshold giving 99% sensitivity in field-infected animals (Table 3-5).
3.3.3.5 Culture-positive animals
All the serum samples obtained from the 133 animals naturally 
infected with B. abortus biovar 1 gave PP greater than 10, except when 
tested with an anti-IgGl, or IgM conjugate (Table 3-5). The frequency 
distribution of the PP of these samples was similar for anti-IgGl and IgA 
conjugates with the greatest frequency being concentrated between 70- 
100%PP. The frequency distribution of anti-IgG(H+L) and IgG2 was 
similar in character but was positioned slightly higher for the former and 
lower for the latter conjugate. The distribution of PP of the anti-IgM 
conjugate was quite different, being more evenly distributed and 
extending higher and lower than that for the other isotypes (Figure 3-10).
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Table 3-5: Number of culture-positive samples at each PP interval
PP Isotype Conjugate
IgG(H+L) IgGI IgG2 IgM IgA
<10 0 I 0 12 0
10-20 I 2 5 19 2
>20 132 130 128 112 131
The number o f  positive samples o f  Brucella  culture positive female cattle tested  by 
isotype ELISA  at different cu t-o ff values. The test was carried out using a partially purified 
LPS antigen (AS2 at an appropriate dilution) and anti-isotype conjugates. The results were 
normalised to  a positive standard serum on each plate (PP). n=133
Figure 3-10: Frequency distribution of culture-positive samples for each 
isotype
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The frequency distribution o f 133 Brucella  culture positive female cattle tested  by isotype 
ELISA. The test was carried out using a partially purified LPS antigen (AS2 at an 
appropriate dilution) and anti-isotype conjugates. The results were normalised to  a positive 
standard serum on each plate (PP).
3-32
3.3.3.6 Uninfected animals
One hundred and seventy one samples from uninfected animals were 
tested using the isotype ELISA. The IgM ELISA showed higher 
reactions with a mean result of 8%PP and a maximum of 17%PP (Figure 
3-11). The spread of ELISA reactions using anti-IgM, and to a lesser 
extent anti-IgA conjugate was greater than the IgG isotype ELISA 
reactions which were concentrated at low levels.
The other tests all had mean reactions of 3%PP or less and maxima of 
13%PP or less (Table 3-6). The threshold PP below which at least 99% 
of the results fell was 15% for the IgM ELISA and 10% for the rest 
(Table 3-7).
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Figure 3-11: Frequency distribution of iso type ELISA reactions of serum 
from uninfected animals
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The frequency distribution o f  171 brucellosis free female cattle tested  by isotype ELISA. 
The test was carried out using a partially purified LPS antigen (AS2 at an appropriate 
dilution) and anti-isotype conjugates. The results were norm alised to  a positive standard 
serum on each plate (PP).
Table 3-6: Summary of isotype ELISA PP results testing sera from 
uninfected animals
IgM IgG(H+L) IgGI IgG2 IgA
Mean (%PP) 8 2 0 0 3
Minimum (%PP) 4 0 0 0 0
Maximum (%PP) 17 9 8 5 13
The mean, minimum and maximum PP o f  171 brucellosis free female cattle tested  by 
isotype ELISA. The test was carried out using a partially purified LPS antigen (AS2 at an 
appropriate dilution) and anti-isotype conjugates.
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Table 3-7: Specificity of isotype ELISAs at selected thresholds
Threshold
(%PP)
IgM IgG IgGI IgG2 IgA
20 100% 100% 100% 100% 100%
15 99% 100% 100% 100% 100%
10 79% 100% 100% 100% 99%
5 4% 98% 99% 99% 83%
The specificity o f  isotype ELISA s at different cu t-o ff values m easured by testing  171 
brucellosis free female cattle. The test was carried ou t using a partially purified LPS antigen 
(AS2 at an appropriate dilution) and anti-isotype conjugates. The results w ere norm alised to  
a positive standard serum on each plate (PP).
3.3.4 Antigen specificity
The data shown below arise from an experiment to evaluate LPS 
antigens prepared using different extraction methods.
3.3.4.1 Titration of reagents.
Each antigen was titrated against the anti IgG(H+L) conjugate and the 
conjugate/antigen dilution giving the highest ratio of OD between 
positive and negative standard sera was selected for further use as 
described in Section 2.4.1, Chapter 2. Serum was diluted 1/200 for 
testing. The chosen dilutions are shown in Table 3-8.
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Table 3-8: The dilutions of antigen and conjugates selected for use
Antigen Dilution Conjugate Dilution
AS2 1/6000 1/2000
BIO 1/3000 1/2000
PK2 1/1500 1/2000
D ilutions o f  conjugates and antigen fo r use in indirect ELISA. They w ere selected 
following checkerboard titration . The antigens w ere partially purified LPS extracted  by 
autoclaving (AS2), phenol/w ater (BIO) and SDS (PK2).
3.3.4.2 Infected Animals
The iELISA reactions to the three antigens were qualitatively similar 
in most animals although there was considerable quantitative variation 
(Figure 3-12). Animal CH87 showed a second peak to antigen PK2 not 
observed with the other antigens. The responses were similar to those 
observed previously using the same conjugate (Figure 3-3).
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Figure 3-12: ELISA responses of animals experimentally infected with 
B. abortus biovar 1 using different antigens
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Results o f indirect ELISA testing o f  serial serum samples following the experim ental 
infection o f  four young female cattle. The test was carried out using three partially purified 
LPS antigens and the results w ere normalised to  a positive standard serum on each plate (PP). 
The antigens used w ere PK2 at 1/1500, AS2 at 1/6000, BIO at 1/3000
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3.3.4.3 Vaccinated animals
The iELISA reactions to the three antigens was qualitatively similar, 
although the percentage binding to PK2 was consistently lower (although 
not significantly) at the peak of the response than the binding to either 
BIO or AS2 (Figure 3-13). The overall responses were however 
significantly (P<0.05) lower than those observed previously using the 
same conjugate on sera from experimentally infected animals (Figure 
3-4).
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Figure 3-13: ELISA responses of vaccinated animals using different 
antigens
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Results o f  indirect ELISA  testing o f  serial serum samples following the vaccination o f six 
female calves. The test was carried out using three partially purified LPS antigens and the 
results were normalised to  a positive standard serum on each plate (PP). The antigens used 
w ere PK2 at 1/1500, AS2 at 1/6000, BIO at 1/3000
3.3.44
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Culture-positive animals
All the serum samples obtained from the 133 animals naturally 
infected with B.abortus biovar 1 gave a PP greater than 10, the 
internationally accepted threshold (Corbel and MacMillan, 1996), except 
one animal which gave a PP of 7.5 when tested with PK2. The 
frequency distribution of the PP of these samples was similar for BIO 
and AS2 with the greatest frequency being concentrated between 90%PP 
and 110%PP. The frequency distribution of PK2 was quite different, 
being more evenly distributed. (Figure 3-14)
Figure 3-14: Frequency Distribution of Culture-positive Samples for 
Each Antigen
%
30
25
20
15
10
5
0
10 20 30 40 50 60 70 80 90 100 110 120 130 140
PK2A1
PP
The frequency distribution o f  the results expressed in PP o f  indirect ELISA testing o f 
serum samples from 133 Brucella culture positive female cattle. The test was carried out 
using three partially purified LPS antigens and the results w ere normalised to  a positive 
standard serum on each plate (PP). The antigens used were PK2 at 1/1500, AS2 at 1/6000, 
BIO at 1/3000
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3.3.4.5 Uninfected animals
The frequency distribution of reactions given by serum samples from 
uninfected animals was similar for each of the three antigens (Figure 
3-15).
Figure 3-15: Frequency distribution of uninfected sera
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The frequency distribution o f  the results expressed in PP o f  indirect ELISA  testing  o f 
serum samples from 171 brucellosis free female cattle. The test was carried out using three 
partially purified LPS antigens and the results were norm alised to  a positive standard serum 
on each plate (PP). The antigens used were PK2 at 1/1500, AS2 at 1/6000, BIO at 1/3000
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3.4 Discussion
Sera were collected from experimentally infected and vaccinated 
animals and from infected and uninfected animals in the field. 
Experimental infection produced a rapid response in the classical tests, 
peaking and then persisting to the end of the experiment in most animals 
(Figure 3-1). The initial response following vaccination was 
qualitatively very similar although titres rose faster and tended to wane 
and generally fell to diagnostically insignificant levels by the end of the 
experiment (Figure 3-2). These results were consistent with earlier 
observations worldwide (MacMillan, 1990). Testing culture-positive 
field-infected animals confirmed the good diagnostic sensitivity of the 
CFT (Table 3-2) and testing uninfected animals, its excellent specificity 
(3.3.1.4). The conventional ELISA results closely mimicked those of the 
CFT for the experimentally infected and vaccinated animals (Figure 3-3, 
Figure 3-4). The conventional iELISA was more sensitive and as 
specific than the CFT (3.3.2.3, 3.3.2.4). These results were consistent 
with previous observations (Ruppaner et a l, 1980, Hobbs 1985, Limet et 
ah, 1985, Nicoletti and Tanya 1993, Stemshorn et ah, 1980) and thus it 
was shown that the serum samples derived from these sources behaved 
typically and therefore were valid for further experiments. It was also 
apparent that it was not possible to distinguish between a single sample
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collected from an infected, or a recently vaccinated animal using any of 
the conventional tests. Animals in the field are bled at an arbitrary and 
unknown interval following infection or vaccination.
There were considerable differences in the isotypic responses of 
experimentally infected and vaccinated animals, perhaps reflecting the 
differing routes of administration or the behaviour of the strain. The 
experimental infection was carried out by instillation into the 
conjunctival sac and this may be expected to provoke an elevated IgA 
response which was in fact observed. The rapid but somewhat short 
lived IgM response was consistent with previous observations (Chappel 
1980, Rice et ah, 1966, Plackett 1984). There was generally a greater 
IgM response in the vaccinated animals which peaked at a high level 
aJthough4hera .was jconsiderable animal To animal.-varialion^F igure-l-&^ 
Figure 3-9). In infected animals, the IgGI response exceeded that of 
IgG2 as had been previously observed (Chappel 1980, Butler 1981, Allen 
et a l, 1976). Lawman’s observation (1985) that there was often a 
significantly higher IgG2 response in vaccinated animals which could be 
used for discrimination was not replicated. As would be expected from 
previous reports (MacMillan, 1990), the IgM responses generally 
mirrored the SAT reactions whilst the IgGI responses were comparable 
with those observed in the CFT.
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The anti-IgG (H+L) conjugate appeared to be the best at detecting the 
culture-positive animals although conjugates directed against IgGI, IgG2 
and IgA were nearly as effective (Figure 3-5). The conjugate raised 
against IgG(H+L) would be expected to detect both classes of IgG and its 
light chain activity would also lead to some cross reaction with other 
isotypes and it is this broader spectrum of activity that bestows the 
slightly greater ability to detect infected animals (Nielsen et ah, 1984, 
Wright and Nielsen 1986). The distribution of ELISA results when 
using the anti-IgG subclass specific conjugates was shifted to the left 
relative to the others. The mean and maximum results of the anti IgG 
(H+L) conjugate was higher, probably due to the light chain specificity 
(Figure 3-11, Table 3-5). The 10%PP threshold was, however valid for 
all the conjugates except that directed against IgM (Table 3-7). In 
conclusion, the considerable animal to animal variation and the similar 
overall responses of infected and vaccinated animals mean that the 
isotype responses cannot be used for discrimination between vaccinated 
and naturally infected animals.
There were quantitative differences between the responses of the 
experimentally infected animals to the three antigens tested, with 
responses to antigen PK2 tending to be higher than that to the other 
antigens tested. Interestingly, there appeared to be a unique second peak
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response in animal CH87 when tested using PK2 antigen, perhaps 
suggesting a later rise in antibodies with specificity for a different 
epitope (Figure 3-12). This profile was maintained when the samples 
were retested and appeared to be due to a peak in the IgGI response 
detected by this antigen alone (data not shown). The responses elicited 
in the vaccinated animals were again similar, but again there were some 
quantitative differences with the responses detected by antigen PK2 
being somewhat lower than that to the other antigens.
The frequency distribution of the results of the culture-positive 
animals was more widely distributed when using PK2 than the other 
antigens. Indeed, one animal fell below the 10%PP threshold whilst 
there were higher responses in others (Figure 3-14). It appeared that the 
lower PP was lowered and the higher PP raised when using PK2.
Of greatest potential significance was the difference observed when 
testing the sera from the vaccinated animals on two occasions using the 
same antigen. The iELISA carried out using AS2 gave a peak response 
of between 50-65%PP when originally carried out (at an antigen dilution 
of 1/2000) (Figure 3-4). When the test was repeated to compare the 
responses to the three antigens, the response was significantly lower 
ranging from 18-45%PP. The antigen used in the second experiment had
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been used at a lower concentration (at an antigen dilution of 1/6000) and 
this may explain the difference in the response.
4. A n t ig e n  C o n c e n t r a t io n  E x p e r im e n t s
4.1 Introduction
In the last chapter the observation that the use of different 
concentrations of antigen in the iELISA may have a differential effect on 
the binding of sera obtained from vaccinated or infected animals was 
described. This observation, if confirmed, might have important 
consequences for the development of a differential test, that could be 
optimised in such a way so as to offer discrimination between vaccinated 
and field-infected animals. Such a discriminatory test would prove 
invaluable for use where S19 vaccine is being widely used to control 
brucellosis, but it’s use is compromising diagnosis of disease.
The aim of this chapter is to describe experiments designed firstly to 
optimise test conditions, selecting different concentrations of antigens 
for further study in order to maximise and minimise the effect for 
comparison. Secondly, the observations described above will be 
confirmed by repeating tests using the same conditions on a larger 
number of serum samples.
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4.2 Materials and Methods
4.2.1 Antigen Titration
The serum sample collected from animal CF50 fifty-three days 
following vaccination with S19 (CF50/53) was used (as a control serum 
in titrations) in addition to the ISABS and negative standard serum as 
described in Section 2.4.1, Chapter 2. This sample was chosen because:
a) animal CF50 gave a response consistent with that of others in the 
group
b) day 50 was near the peak of the response
c) a large quantity of serum was available
The iELISA and titrations described in Section 3.2.3 were used for all 
experiments described in this chapter. Antigens AS2 and PK2, described 
in 3.2.4, were selected for further study as they appeared to have 
different characteristics, whereas antigen BIO appeared similar to AS2 
and was therefore not re-evaluated.
In order to carry out an antigen titration, antigens AS2 and PK2 were 
double diluted in coating buffer across all the twelve columns of two 
separate polystyrene ELISA plates as described in Section 2.4.1, Chapter 
2. The range of dilutions 1/500 to 1/1024000 was used for both 
antigens. Briefly, the plates were incubated at 4°C overnight, before
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being rinsed 6 times with washing solution and dried by tapping the 
inverted plates on a pad of absorbent paper. Dilutions (1/200) of the 
ISABS, serum CF50/53 and the negative standard serum were applied 
each to three rows of each plate (two rows for the negative serum) 
which were then incubated on a rotary shaker for 30 minutes at room 
temperature after which they were washed and dried as before.
One hundred microlitres of anti-bovine IgG (H+L) peroxidase 
conjugate solution (made up at a pre-determined dilution) was added to 
each well on each plate and incubated for a further 30 minutes at room 
temperature on a rotary shaker after which it was washed and dried as 
before. Substrate/chromogen solution was made up using hydrogen 
peroxide and ABTS as described in Section 2.4.1, Chapter 2 and lOOpl 
dispensed into each well on the plate. The plate was left to react at room 
temperature for 30 minutes (the increased time of 30 minutes is required 
to allow sufficient colour development at the higher antigen dilutions) 
and the reaction was then stopped by the addition of lOOpl of ImM 
sodium azide to each well. The plate was then read, at a wavelength of 
405nm without blanking the plate. The mean ODs of each serum/antigen 
combination were calculated.
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4.2.2 Selection o f antigen dilutions
Two appropriate dilutions of each antigen were chosen for further 
study. The criteria used were the selection of the dilution of antigen at 
which the PP of serum CF50/53 was at a minimum whilst the OD of the 
ISABS was greater than 1.5 OD units to facilitate visual inspection.
4.2.3 Serum samples
Those samples described in 3.2.1 were used. Briefly they were 
samples collected from six animals experimentally vaccinated with S19 
vaccine, four animals experimentally infected with B.abortus, 133 
naturally infected animals and 171 brucellosis free animals.
4.2.4 Evaluation o f the indirect ELISA using different antigen 
concentrations
Samples were tested using the conventional iELISA as described in 
Section 2.4.1, Chapter 2 except that antigens at the selected dilutions 
were used.
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4.3 Results
4.3.1 Antigen Titration
4.3.1.1 Antigen PK2
The ISABS, CF50/53 and the negative standard were applied to a 
microtitre plate coated with antigen PK2 titrated from a dilution of 1/500 
to a dilution of 1/1024000. The mean ODs of the three rows of ISABS 
fell from 3.3 at an antigen dilution of 1/500 to less than 0.1 at the most 
dilute antigen dilutions used in this experiment. The mean OD of 
CF50/53 fell from 1.1 at an antigen dilution of 1/500 reaching a 
minimum plateau OD at an antigen dilution of 1/800 and 1/1600. The 
mean OD of the negative serum did not exceed baseline levels at any 
antigen dilution.
The mean OD of CF50/53 expressed as a percentage of the mean OD 
of the ISABS (PP) at each corresponding antigen dilution fell from a 
maximum PP of 35% at an antigen dilution of 1/500 to a minimum PP of 
6% at antigen dilutions of 1/4000 and 1/8000 before rising again as the 
absolute OD of the ISABS fell to below 0.5 (Figure 4-1).
CL
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Figure 4-1 Titration of PK2 antigen using ISABS, CF50/53 and negative 
standard sera
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Indirect ELISA  antigen titra tion  o f  antigen PK2 using sera ISABS, CF50/53 and negative 
standard at a dilution o f  1/200 in w ith results expressed in OD and PP. The antigen was 
titra ted  from a dilution o f  1/500 to  1/1024 x 10^.
4.3.1.2 Antigen AS2
This experiment was repeated with antigen AS2. The mean OD of the 
ISABS fell from 3.3 at an antigen dilution of 1/500 to about 0.24 at the 
most dilute antigen dilutions used in this experiment. The mean OD of 
CF50/53 fell from 1.6 at an antigen dilution of 1/500 reaching a 
minimum plateau OD at about an antigen dilution of 1/6400 or 1/128000.
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The mean OD of the negative serum did not exceed baseline levels at any 
antigen dilution.
The PP of CF50/53 at the corresponding antigen dilution fell from a 
maximum PP of over 50% at an antigen dilution of 1/500 to a minimum 
PP of 7% at antigen dilutions of 1/32000 and 1/64000 before rising again 
as the absolute OD of the ISABS fell to an OD of belo^v 0.5 (Figure 4-2)
Figure 4-2: Titration of AS2 antigen using ISABS, CF50/53 and negative 
standard sera
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Indirect ELISA antigen titra tion  o f  antigen AS2 using sera ISABS, CF50/53 and negative 
standard at a dilution o f  1/200 in with results expressed in OD and PP.. The antigen was 
titra ted  from a dilution o f  1/500 to  1/1024 x 10^.
4-8
Thus, the observations described in Chapter 3 that the PP of serum 
from a vaccinated animal was dependant on the dilution of antigen used 
was confirmed for both antigens AS2 and PK2.
The character of the sigmoid antigen titration curves of the sera was 
similar for both antigens, although the curves for AS2 were shifted to the 
right relative to those of PK2. The maximum OD of the ISABS was 
similar for both antigens and greater than that of CF50/53. The slope of 
the linear part of the titration curves of the sera was similar for each 
antigen, being slightly greater for AS2, but that of serum CF50/53 was 
approximately two thirds that of the ISABS for each antigen (Table 4-1).
Table 4-1: The slopes of the linear part of the antigen titration curves
ISABS CF50/53 Ratio ISABS/CF50/53
AS2 0.749 0.468 0.625
PK2 0.689 0.420 0.608
Ratio AS2/PK2 1.087 1.11 1.027
Slopes o f  linear portion  o f  indirect ELISA  antigen titra tion  o f  antigens PK2 and AS2 using 
sera ISABS, CF50/53 and negative standard.
4.3.1.3 Selection of antigen dilutions
The optimal antigen dilution for the observation of the differentiation 
between vaccinate and infected sera was 1/4000 for PK2 and 1/32000 for 
AS2 (low concentration) taking into account the criteria for selection set 
out in 4.2.2. The conventional antigen dilutions (those used in the 
conventional ELISA giving no discrimination between vaccinate and
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infected sera) to be selected for further study were 1/500 dilution of PK2 
and 1/2000 dilution of AS2 (known hereafter as high concentration).
4.3.2 Evaluation o f the indirect ELISA using different antigen 
concentrations
4.3.2.1 Serum from experimentally infected animals
The four animals experimentally infected with B.abortus biovar 1 
responded qualitatively as expected and as described in the last chapter, 
with all four antigen/concentration combinations. There was a rapid 
response commencing around day 14, rising to a peak around day 42. 
After that point the response tended to plateau, although it fell in some 
animals.
As the response rose, the PP tended to be considerably higher when 
tested using the antigen at the low concentration compared to the 
corresponding high concentration (Figure 4-3).
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Figure 4-3: ELISA response of serum from experimentally infected 
animals when tested using antigens at different concentrations.
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Results o f  indirect ELISA  testing o f serial serum samples following the experim ental 
infection o f  four female cattle. The test was carried out using partially purified LPS antigens 
(AS2 and PK2) at tw o concentrations. The results w ere normalised to  a positive standard 
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P K 2= l/500  dilution, A S 2= l/2000 dilution. Low concentration PK 2= l/4000  dilution, 
A S2-1/32000 dilution.
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4.3.2.2 Serum from experimentally vaccinated animals
Serum taken from the six animals experimentally vaccinated with S19 
vaccine was tested using two antigens, each at two concentrations as 
described above (4.3.1.3). In the case of every animal, the expected 
response was seen when tested using either antigen at it’s conventional 
concentration, with the PP rising rapidly to a peak, before declining more 
slowly to base line levels. However, when tested using these antigens at 
a lower concentration, there was a much smaller, though concurrent rise 
in PP, which exceeded a PP of 10 on only a few occasions (Figure 4-4).
For those samples when the conventional test was positive (>10%PP) 
the differences in PP values obtained when testing the same serum with 
antigen at a high and low concentration is significantly greater (P=0.03) 
in vaccinated than infected animals.
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Figure 4-4: ELISA response of serum from vaccinated animals when 
tested using antigens at different concentrations.
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Results o f  indirect ELISA  testing o f  serial serum samples following the vaccination o f  six 
female calves. The test was carried out using partially purified LPS antigens (AS2 and PK 2) 
at tw o concentrations. The results w ere norm alised to  a positive standard serum on each 
plate (PP) The antigen concentrations used were: High concentration PK2= 1/500 dilution, 
A S 2= l/2000 dilution. Low concentration PK 2= l/4000  dilution, A S2= l/32000 dilution.
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4.3.2.3 Serum from field infected animals
All the sera obtained from the 133 animals naturally infected with 
B. abortus biovar 1 when tested using antigen used at the conventional 
high concentration gave a PP greater than 10, the internationally 
accepted diagnostic threshold for the ELISA (Corbel and MacMillan, 
1996), except one animal which gave a PP of 7.5 when tested with PK2.
When tested using the same antigens at the selected low
concentration, six samples fell below a PP of 10 for AS2 and seven for
PK2. The frequency distribution (Figure 4-5 and Figure 4-6) reveals 
that the PP of samples tested by antigens at the selected low 
concentration are distributed over a greater range; that is samples giving 
a high PP at the conventional high antigen concentration generally give 
an even higher PP when tested using the antigen at the low
concentration, and samples giving a low PP at the conventional high
antigen concentration generally give an even lower PP when tested using 
the antigen at the low concentration (Figure 4-5 and Figure 4-6).
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Figure 4-5 Frequency distribution of samples from culture positive 
animals for antigen AS2 at two concentrations
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Results o f  indirect ELISA testing o f  serum samples from 133 Brucella  culture positive 
female cattle. The test was carried out using a partially purified LPS antigen (AS2) at two 
concentrations. The results were normalised to  a positive standard serum on each plate (PP) 
The antigen concentration used was: High concentration =1/2000 dilution. Low 
concentration =1/32000 dilution.
4-18
Figure 4-6: Frequency distribution of samples from culture positive 
animals for antigen PK 2 at two concentrations
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Results o f  indirect ELISA  testing o f  serum samples from 133 Brucella  culture positive 
female cattle. The test was carried out using a partially purified LPS antigen (PK2) at tw o 
concentrations. The results w ere normalised to  a positive standard serum on each plate (PP) 
The antigen concentration used was: High concentration =1/500 dilution. Low  concentration 
= 1/4000 dilution.
The character of this phenomenon was slightly different with each 
antigen. With AS2, the PP of tests using the high concentration antigen 
was greater up to about 70% PP whilst, in the case of PK2 it was greater 
only up to about 20%PP (Figure 4-7)
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Figure 4-7: Comparison of PP culture positive samples tested using high 
and low antigen concentrations
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Results o f  indirect ELISA testing o f  serum samples from 133 Brucella culture positive 
female cattle. The test was carried out using a partially purified LPS antigen (AS2) at tw o 
concentrations. The results were normalised to  a positive standard serum on each plate (PP) 
The antigen concentration used were: High concentration P K 2= l/500  dilution, A S 2= l/2000  
dilution. Low concentration P K 2= l/4000 dilution, A S2= l/32000 dilution
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4.4 Discussion
The titration of antigens AS2 and PK2 with serum applied at a single 
dilution resulted in a fall in optical density with a classic sigmoid form 
(Figure 4-1, Figure 4-2). The maximal OD of serum ISABS was higher 
than that of serum CF50/53 (approximately twice)and can be seen most 
clearly for antigen AS2 with the range of dilutions used (Figure 4-2). 
There are indications that the same phenomenon occurred with antigen 
PK2, but that the maximal plateau was not directly observed with the 
concentration used. From a maximum, the OD reduces at a similar rate 
on both antigens with the slope of the titration curve when using serum 
from the vaccinated animal (CF50/53) being approximately two thirds 
that of the titration curve when using the serum from the infected animal 
(ISABS) (Figure 4-1, Figure 4-2). The curve for AS2 was shifted to the 
right, probably reflecting a more concentrated antigen preparation.
These results imply that firstly the total amount of functional antibody 
is significantly less in CF50/53 when compared to ISABS, but secondly 
the reduced slope implies that the avidity of the antibody is also reduced 
(Heyningen a/., 1983).
When expressed as a percentage of the OD (PP) of the well containing 
ISABS, the PP of the wells containing CF50/53 decreased with the
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decreasing antigen concentration, falling to a minimum before rising 
again as the OD of the ISABS wells fell to a low level (Figure 4-1, 
Figure 4-2). This later rise was much more pronounced when using AS2. 
This observation enabled the choice of optimal concentrations of 
antigens to observe possible discriminatory effects.
Using two antigen concentrations selected on this basis, serial blood 
samples taken from experimentally infected animals were tested in the 
iBLISA. The serological response followed a similar pattern, although 
higher PP peaks were reached using low antigen concentration (Figure
4-3). When sera from animals infected in the field were tested, there 
was a greater spread of results (Figure 4-5, Figure 4-6). The sensitivity 
of the ELISA using the low concentration of antigen was the same, or 
just below that when using the high concentration When the PP on low 
and high concentration antigens was plotted, it could be seen that the PP 
on the low dilution antigen exceeded that on the high dilution antigen up 
to a certain point (about 70%PP on AS2 and about 20%PP on PK2) 
before the reverse occurred (Figure 4-7). There was a bigger difference 
between the reactions of the vaccinated and infected animals on plates 
coated with PK2 than with AS2.
When serial blood samples from vaccinated animals were tested, 
however, the peak in PP observed when using high concentration
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antigens was much reduced with low concentration antigen (Figure 4-4). 
In other words, serum from vaccinated animals gave markedly reduced 
reactions in this modified ELISA. This observation, offers real promise 
for the development of a discriminatory test which could be used 
successfully immediately following vaccination.
5. M e a s u r e m e n t  OF A v id it y
5.1 Introduction
Results shown in the last chapter indicate that sera from vaccinated 
and infected animals show distinct binding patterns with respect to 
partially purified Brucella LPS antigens. Indeed, it was possible to 
select antigen concentrations of a variety of antigen preparations for use 
in an indirect ELISA to aid in the differentiation of vaccinated and 
infected animals.
There are two hypotheses that may explain these observations. Firstly, 
it may be that antibodies in the serum of vaccinated animals might be of 
lower avidity than those in the serum of infected animals that is reflected 
by reduced binding at low antigen concentrations. Secondly, epitopes 
may become obscured due to an altered presentation or conformation on 
the polystyrene surface as the antigen concentration is reduced (Figure
5-1). This is in effect an extension of Nielsen’s ‘tip and length’ 
hypothesis (1990) which proposed that vaccinated animals responded 
only to an epitope on the tip of the 0-polysaccharide which is obscured 
when PS (but not LPS) was used to coat the plate. What is proposed 
here is that epitopes could be lost not only by differences in orientation 
on the plate, but by changes in conformation of the 0-polysaccharide 
(Figure 5-2). At least seven epitopes are currently recognised bn the O-
5-2
chain and it is known already that antibody binding to some of these is 
reduced when the molecule is bound to polystyrene (Weynants, 1997).
Figure 5-1: Schematic representation of some epitopes (squares) 
becoming obscured as antigen presentation alters at different 
concentrations of antigen coating
High Concentration Low Concentration
Figure 5-2: Schematic representation of the loss of an epitope due to a 
change in O-polysaccharide conformation at different concentrations of 
antigen coating
Epitope
o  o  o  o  o
o  o  o  o  o
High Concentration Low Concentration
The epitope formed around the 1,3 linkage is lost as the bond angle, and therefore the 
angle o f  chain propagation alters
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Also, it is possible that there is a combination of both these effects 
such that antibodies of different antigen specificity may have different 
affinities, the resulting apparent avidity of the serum being enhanced as 
the range of epitopes that are expressed is reduced.
The aim of the studies described in this chapter was to test the 
hypothesis that serum antibodies from vaccinated animals have lower 
avidities than those from infected animals and that these differences can 
explain the observation that binding is reduced at low antigen 
concentrations.
Specifically, the objectives were to:
1. Establish the relative avidity of serum from vaccinated and infected 
animals at different antigen concentrations using the serum dilution 
method of van Heyningen et al (1983).
2. To measure the relative avidity of serum from vaccinated and infected 
animals at different antigen concentrations using the thiocyanate 
elution method of Pullen et al (1986).
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5.2 Measurement o f avidity by serum dilution
5.2.1 Materials and Methods
5.2.1.1 Checkerboard titration of infected and vaccinated serum
A checkerboard titration of antigen and serum dilutions was carried 
out essentially according to the method described in Section 2.4.1, 
Chapter 2. The antigens used for this experiment were PK2 and AS2 and 
serum samples were ISABS and CF50/53 as described in Chapter 4, 
Section 4.2.1.
Optical density readings for each serum titration at a certain antigen 
concentration were transformed using the 4-parameter logistic function 
as described in Chapter 2 (Equation 5-1), where y is the OD and x is the 
antigen concentration. Briefly, the function enables the transformation 
of data approximating to a sigmoid curve to produce four parameters. In 
this case, these parameters provide objective estimates of the maximal 
OD and the serum dilution at 50% maximal OD even where the titration 
curve is incomplete. These parameters are as detailed in Table 5-1.
Equation 5-1 : Four parameter logistic function equation
f
y =
5-5
Table 5-1: Parameters resulting from logistic transformation and 
corresponding property
Parameter Property
a Baseline OD
b Maximal OD
c Serum dilution at 50% maximal OD
d Curvature factor
The data were transformed using commercial software (Tablecurve).
Antigen was applied to the plate at either high or low concentration as 
defined in Chapter 4, Section 4.3.1.3. The dilutions used were as set out 
in Table 5-2.
Table 5-2: Selected antigen dilutions used to represent high and low 
concentrations
Antigen Low concentration High concentration
PK2 1/4000 1/500
AS2 1/32000 1/2000
Selected antigen dilutions for use in ELISA. As determ ined by titration .
The selected sera were double diluted down the rows of the ELISA 
plate. The rest of the test was carried out as for the checkerboard 
titration described in Section 5.2.1.1.
The antigen used for this experiment was PK2 as described in Chapter 
2, Section 2.5.1.
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5.2.2 Results
5.2.2.1 Checkerboard titration of infected and vaccinated serum
OD readings of the checkerboard titrations carried out using serum 
ISABS and CF50/53 and antigens AS2 and PK2 decreased as expected as 
both antigen and serum concentration decreased (Figure 5-3, Figure 5-4).
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Figure 5-3: Titration of standard sera at varions antigen dilutions
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Figure 5-4: Titration of antigens at various serum dilutions
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5.2.2.2 Serum titrations
The serum titrations at each antigen dilution are depicted as in Figure 
5-3. The OD readings fell with increasing serum dilution and the curves 
at each decreasing antigen concentration were reduced. There was no 
obvious qualitative difference between the curves of either antigen but 
the gradient of the reduction in OD appeared to be greater for the 
vaccinate serum.
5.2.2.3 Antigen titrations
The antigen titrations at each serum dilution are depicted as in Figure 
5-4. The OD readings fell with increasing antigen dilution particularly 
with the vaccinate serum and the curves at each decreasing serum 
dilution were reduced. The effect of decreasing antigen concentration 
appeared more pronounced with antigen PK2. With the vaccinate serum 
CF50/53, only the titration curves of the highest antigen concentration 
exceeded the baseline ODs.
5.2.2.4 Data anal vs is
Transformation of these data, gave rise to parameters a, b, c, and d 
(Table 5-1). The most important factors derived from the transformation 
were considered to be the maximal OD and the antigen 
concentration/serum dilution represented by factors b and c.
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5.2.2.4.1 Factor b
Following the serum titrations it was possible to calculate factor b 
which represents the maximal OD obtained at each antigen 
concentration, in this case at the optimal serum dilution. The change in 
b for each serum with respect to antigen concentration with each antigen 
is represented by Figure 5-5 and Figure 5-6. The value of b decreases 
with decreasing antigen concentration. Included in these is the ratio of b 
for serum CF50/53: serum ISABS. This ratio is directly linked to the 
fundamental question under study, the apparent change in relative 
binding of antibody arising from vaccination and that arising from 
infection with decreasing antigen concentration. The rise in ratio 
observed using both antigens is consistent with this observation.
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Figure 5-5: Relationship between factor b and AS2 antigen dilution using 
serum samples ISABS and CF50/53
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Factor b (representing maximal OD) for sera ISABS and CF50/53 at each antigen dilution 
calculated by 4-param eter logistic transform ation o f  ELISA  data. Antigen AS2. D ilution 
range 1/500-1/128000
Figure 5-6: Relationship between factor b and PK2 antigen dilution 
using serum samples ISABS and CF50/53
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At every antigen dilution the value of factor b for serum ISABS is 
greater than that for serum CF50/53. The ratio of the two changes, 
however, such that at an antigen dilution of 1/2000, the ratio of the two 
is 1.7, whilst at a dilution of 1/32000 it has risen to a ratio of 5.6, even 
though the OD of the ISABS is 1.2. The reciprocal of this ratio is in fact 
equivalent to the PP at each antigen dilution. A similar effect was seen 
with antigen PK2 with the ratio of factor b rising from 1.7 at an antigen 
dilution of 1/1000 to a ratio of 6.3 at a dilution of 1/16000.
5.2.2.4.2 Factor c
Factor c represents in this case the serum dilution at which the OD is 
half the maximum obtained and therefore represents an estimate of the 
relative avidity of each serum (van Heyningen et ah 1983). Relative 
avidity is higher for serum ISABS at each antigen dilution. The ratio 
remains relatively constant at the highest antigen concentrations before 
increasing at the lower concentrations. This effect is most pronounced 
with antigen PK2 where the ratio rises from a value of about 2 at the 
highest antigen concentration to about 5 at the lowest antigen 
concentration (Figure 5-7 and Figure 5-8). This change in ratio is due to 
a rise in the value of c for serum ISABS and a reduction in the value of c 
for serum CF50/53. These data imply that the relative avidity of serum 
CF50/53 is reduced at lower antigen concentrations.
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Figure 5-7: Relationship between factor c and AS2 antigen dilution
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Figure 5-8: Relationship between factor c and PK2 antigen dilution using 
serum samples ISABS and CF50/53
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5.2.2.5 Individual animal testing
Serum titrations on both high and low antigen concentrations of PK2 
antigen were carried out for serum from both experimentally infected and 
vaccinated animals, early and late in the response. The resulting OD 
data were transformed as before to arrive at factor c which represents a 
measure of relative avidity (Table 5-3).
Table 5-3: Individual and mean readings of factor c for infected and 
vaccinated animals, early and late in the immune response using high and 
low concentrations of PK2 antigen
Class of animal High
concentration
Low concentration
Sample c Mean c Mean
Infected
early in response
63-23 5.0
5.6
8
8.65
82-23 4.9 9.1
87-23 5.4 8.7
505-23 6.9 8.8
Infected
late in response
63-84 8.2
6.68
9
7.00
82-84 5.7 6.0
87-84 6.9 7.2
505-84 5.9 5.9
Vaccinated 
early in response
45-8 2
3.88
1.4
2.73
46-8 4.2 2.2
47-8 3.8 2.4
48-8 4.7 4
49-8 3 1.4
50-8 5.6 5.0
Vaccinated 
late in response
45-79 7.6
5.15
2.9
3.01
46-79 8 3
47-79 5.2 3.2
48-79 3.2 2.9
49-79 3.7 3
50-79 3.2 3.1
Factor c (representing relative avidity) calculated by 4-parameter logistic transformation 
o f serum titrations in ELISA using antigen PK2 at two concentrations: (dilution o f
l/4000=low concentration, dilution o f l/500=high concentration). Sera used were collected 
from experimentally infected and vaccinated animals at arbitrary times early and late in their 
response
5-17
When using the conventional high concentration of antigen, relative 
avidity is greater late in the response for three out of the four infected 
animals and four out of six vaccinated animals. Relative avidity late in 
the response in some of the vaccinated animals is greater than that early 
in the response of the infected animals.
The differences between the infected and vaccinated animals are not 
significant when using the high concentration of antigen, but are 
(P<0.05) when using the low antigen concentration.
When using the low concentration of antigen, relative avidity is 
greater late in the response in only one out of four infected animals. 
However, it is greater late in the response in the same four out of six 
vaccinated animals as with the high antigen concentration. There was no 
overlap however in the relative avidity of vaccinated and infected 
animals. The avidity of the vaccinated sera was significantly lower 
(P<0.05) when measured on a low compared to a high concentration of 
antigen.
For infected animals, relative avidity is lower when using the 
conventional high concentration of antigen then when using the lower 
concentration. For vaccinated animals the reverse is true.
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5.3 Measurement o f avidity using chaotropic agent
5.3.1 Materials and methods
The ELISA method used was as described in Chapter 2 Section 2.4.1 
with the inclusion of an extra step. Each serum to be tested was added to 
the plate at a dilution of 1/200 in every well of a column. After the plate 
was washed following the serum incubation, ammonium thiocyanate in 
0.1 M phosphate buffer (pH 7.2) was added to the appropriate wells, at 
concentrations determined in pilot experiments (ranging from 0 to 10 
M). The plates were allowed to stand for 15 min at room temperature 
before washing as at the other stages in the ELISA. The OD of the wells 
treated with different concentrations of ammonium thiocyanate was 
expressed as a percentage of that of the wells to which PBS had been 
added. (Pullen et a/., 1986 and MacDonald et ah, 1988) .
The ELISA was carried out using antigen PK2 at high (1/500) and low 
(1/4000) antigen concentrations. Samples from each experimentally 
infected and vaccinated animal collected early and late in the response 
were selected for study. The bleeding dates in each group were selected 
subjectively based on the average response of each group (Chapter 3 
Section 3.3.2) and on the volume of sample available for testing (Figure
3.3 and 3.4). This necessarily resulted in the selection of different dates 
for infected and vaccinated animals as the timing and character of the
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response of each was different. The bleeding dates selected are detailed 
in Table 5-4.
Table 5-4: Bleeding days post-treatment selected to represent early and 
late humoral response
Infected animals Vaccinated animals
Early response 23d 8d
Late response 84d 79d
5.3.2 Results
The OD readings in the absence of thiocyanate were assumed to 
represent effective total binding of specific antibody. Absorbance 
readings in the presence of increasing concentrations of thiocyanate were 
converted to the appropriate percentage of this total bound antibody. 
The data were fitted to a graph of percentage maximal binding against 
molar concentration of ammonium thiocyanate. The avidity index, 
representing the molar concentration of thiocyanate required to reduce 
the maximal OD by 50% was estimated using both high and low antigen 
concentrations (Figure 5-9-Figure 5-16).
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Figure 5-9: The effect of the molarity of ammonium thiocyanate on
antibody binding of serum from animals vaccinated 11 days previously
using a high antigen concentration.
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The relative avidity o f  sera from  vaccinated animals calculated using ELISA  incorporating an 
incubation step following the serum incubation. Ammonium thiocyanate in 0.1 M  phosphate 
buffer (pH 7.2) was added at concentrations ranging from 0 to  10 M. The m olarity at which 
the maximal OD (w ithout ammonium thiocyanate) is reduced by 50% is recorded as 
representing the relative avidity. The antigen used was PK2 at a dilution o f  1/500
Figure 5-10: The effect of the molarity of ammonium thiocyanate on 
antibody binding of serum from animals vaccinated 78 days previously 
using a high antigen concentration.
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The relative avidity o f  sera from vaccinated animals calculated using ELISA  incorporating 
an incubation step following the serum incubation. Ammonium thiocyanate in 0.1 M 
phosphate buffer (pH 7.2) was added at concentrations ranging from 0 to 10 M. The m olarity 
at which the maximal OD (w ithout ammonium thiocyanate) is reduced by 50% is recorded as 
representing the relative avidity. The antigen used was PK2 at a dilution o f  1/500
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Figure 5-11: The effect of the molarity of ammonium thiocyanate on
antibody binding of serum from animals infected 23 days previously
using a high antigen concentration.
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The relative avidity o f  sera from infected animals calculated using ELISA  incorporating an 
incubation step following the serum incubation. Ammonium thiocyanate in 0.1 M  phosphate 
buffer (pH 7.2) was added at concentrations ranging from 0 to  10 M. The m olarity at which 
the maximal OD (w ithout ammonium thiocyanate) is reduced by 50% is recorded as 
representing the relative avidity. The antigen used was PK2 at a dilution o f  1/500
Figure 5-12: The effect of the molarity of ammonium thiocyanate on 
antibody binding of serum from animals infected 98 days previously 
using a high antigen concentration.
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The relative avidity o f  sera from infected animals calculated using ELISA incorporating an 
incubation step following the serum incubation. Ammonium thiocyanate in 0.1 M phosphate 
buffer (pH 7.2) was added at concentrations ranging from 0 to  10 M. The m olarity at which 
the maximal OD (w ithout ammonium thiocyanate) is reduced by 50% is recorded as 
representing the relative avidity. The antigen used was PK2 at a dilution o f  1/500
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Figure 5-13: The effect of the molarity of ammonium thiocyanate on
antibody binding of serum from animals vaccinated 11 days previously
using a low antigen concentration.
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The relative avidity o f  sera from vaccinated animals calculated using ELISA  incorporating an 
incubation step following the serum incubation. Ammonium thiocyanate in 0.1 M phosphate 
buffer (pH 7.2) was added at concentrations ranging from 0 to  10 M. The m olarity at which 
the maximal OD (w ithout ammonium thiocyanate) is reduced by 50% is recorded as 
representing the relative avidity. The antigen used was PK2 at a dilution o f  1/4000
Figure 5-14: The effect of the molarity of ammonium thiocyanate on 
antibody binding of serum from animals vaccinated 78 days previously 
using a low antigen concentration.
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The relative avidity o f  sera from vaccinated animals calculated using ELISA incorporating  an 
incubation step following the serum incubation. Ammonium thiocyanate in 0.1 M phosphate 
buffer (pH 7.2) was added at concentrations ranging from 0 to  10 M. The m olarity at which 
the maximal OD (w ithout ammonium thiocyanate) is reduced by 50% is recorded as 
representing the relative avidity. The antigen used was PK2 at a dilution o f  1/4000
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Figure 5-15: The effect of the molarity of ammonium thiocyanate on
antibody binding of serum from animals infected 23 days previously
using a low antigen concentration.
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The relative avidity o f  sera from infected calculated using ELISA  incorporating an incubation 
step following the serum incubation. Ammonium thiocyanate in 0.1 M phosphate buffer (pH
7.2) w as added at concentrations ranging from 0 to  10 M. The molarity at which the maximal 
OD (w ithout ammonium thiocyanate) is reduced by 50% is recorded as representing the 
relative avidity. The antigen used was PK2 at a dilution o f  1/4000
Figure 5-16: The effect of the molarity of ammonium thiocyanate on 
antibody binding of serum from animals infected 98 days previously 
using a low antigen concentration.
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The relative avidity o f  sera from infected calculated using ELISA incorporating an incubation 
step following the serum incubation. Ammonium thiocyanate in 0.1 M phosphate buffer (pH
7.2) was added at concentrations ranging from 0 to  10 M. The molarity at which the maximal 
OD (w ithout ammonium thiocyanate) is reduced by 50% is recorded as representing the 
relative avidity. The antigen used was PK2 at a dilution o f  1/4000
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Using a high concentration of antigen, post-vaccination samples 
showed an increase in the avidity index in each animal between 
bleedings taken 11 and 78 days after vaccination. However, the degree of 
increase varied from animal to animal. Animals CF45, 46 and 49 rose to 
or above the maximum measurable in this experiment, whilst CF47, 48 
and 50 rose only slightly between the two bleedings (Figure 5-9, Figure 
5-10, Table 5-5).
Table 5-5: The avidity indices of experimentally vaccinated animals using 
a high antigen concentration
Animal Days post-vaccination
11 79
45 2.1 10
46 4.7 >10
47 4.2 5.8
48 5.0 6.7
49 3.5 >10
50 5.2 5.8
The relative avidity o f  sera from vaccinated animals calculated using ELISA  incorporating 
an incubation step following the serum incubation. Ammonium thiocyanate in 0.1 M  
phosphate buffer (pH  7.2) w as added at concentrations ranging from 0 to  10 M. The m olarity 
at which the maximal OD (w ithout ammonium thiocyanate) is reduced by 50% is recorded  as 
representing the relative avidity. The antigen used w as PK2 at a dilution o f  1/500.
Using the low concentration of antigen, the binding of antibody from 
animals vaccinated eleven days previously is relatively labile with the 
exception of animal CH50 whose binding is not reduced below 50% 
maximum over the range of thiocyanate concentrations used largely 
because the initial OD was low. After 78 days the relative avidity 
appeared to have risen slightly (Figure 5-13, Figure 5-14, Table 5-6).
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This pattern is dissimilar to that exhibited by the same sera using the
higher antigen concentration (Figure 5-9 and Figure 5-10).
As was seen when using the high antigen concentration, when tested 
using the low antigen concentration, post-vaccination samples showed an 
increase in the avidity index in each animal between the bleedings taken 
at 11 and 78 days after vaccination. Although the degree of increase 
varied from animal to animal, the rise in avidity tended to be greater than 
with the high antigen concentration. There was varying differences 
between the avidity indices of samples at each bleeding when measured 
using high or low antigen concentrations (Table 5-6).
Table 5-6: The avidity indices of experimentally vaccinated animals using 
a low antigen concentration
Animal Days post- 
11
vaccination
79
45 2.0 3.1
46 1.8 2.8
47 2.0 3.1
48 3.5 2.9
49 1.6 3.1
50 >10 3.0
The relative avidity o f  sera from  vaccinated animals calculated using ELISA  incorporating 
an incubation step following the serum incubation. Ammonium thiocyanate in O.I M  
phosphate buffer (pH 7.2) was added at concentrations ranging from  0 to  10 M. The m olarity 
at which the maximal OD (w ithout ammonium thiocyanate) is reduced by 50% is recorded as 
representing the relative avidity. The antigen used was PK2 at a dilution o f  1/4000.
In experimentally infected animals, using the high antigen 
concentration, the majority of the avidity indices were higher early in 
the response than those in vaccinated animals. However, in only one.
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CH63, did the index rise markedly. In the other animals it rose only 
slightly (CH87) or fell (Figure 5-11, Figure 5-12, Table 5-7). Previous 
observations in Chapter 4 had shown that animal CH63 had 
demonstrated a persistently high titre, unlike the other three infected 
animals in which it was falling significantly at the end of the experiment.
Table 5-7: The avidity indices of experimentally infected animals using a 
high antigen concentration.
Animal Days pos
23
t-infection
98
63 5.3 » 1 0
82 5.1 4.2
87 5.3 6.4
505 6.7 4.7
The relative avidity o f  sera from  infected animals calculated using ELISA  incorporating  an 
incubation step following the serum incubation. Ammonium thiocyanate in O.I M  phosphate 
buffer (pH 7.2) was added at concentrations ranging from  0 to  10 M. The m olarity at which 
the maximal OD (w ithout ammonium thiocyanate) is reduced by 50% is recorded as 
representing the relative avidity. The antigen used w as PK2 at a dilution o f  1/500.
It is notable that the avidity indices of serum samples taken late in the 
response of vaccinated animals is higher in the majority of cases than all 
samples from experimentally infected animals, suggesting an apparently 
higher avidity.
Again when using antigen at the lower concentration, early in the 
response following infection, the avidity indices of experimentally 
infected animals were all higher than those experimentally vaccinated 
animals at a similar stage in the response. In only one however, CH63,
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did the index rise markedly. In the other infected animals it fell
dramatically (Figure 5-15, Figure 5-16, Table 5-8).
Table 5-8: The avidity indices of experimentally infected animals using a 
low antigen concentration.
Animal Days pos
23
t-infection
98
63 9.0 >10
82 >10 2.2
87 >10 1.8
505 >10 2.0
The relative avidity o f  sera from infected animals calculated using ELISA  incorporating an 
incubation step following the serum incubation. Ammonium thiocyanate in O.I M  phosphate 
buffer (pH 7.2) was added at concentrations ranging from  0 to  10 M. The m olarity at which 
the maximal OD (w ithout ammonium thiocyanate) is reduced by 50% is recorded as 
representing the relative avidity. The antigen used w as PK2 at a dilution o f  1/4000.
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5.4 Discussion
The method of Van Heyningen et al., (1983) whereby serum is titrated 
and the dilution at which 50% maximal binding is observed was chosen 
as it is based on ELISA technology. This method was therefore 
consistent with the ELISA methodology employed elsewhere in this 
study. Two sera were chosen for initial evaluation based on results 
obtained in tests described in Chapter 3. One serum was collected from 
a vaccinated animal at the peak of its humoral response and another 
collected from a chronically infected animal, although results obtained 
later showed that there was considerable variation between animals and 
therefore all animals were subsequently tested.
It can be seen from the results of the antigen titrations that the slope of 
the reduction in the OD of the vaccinate serum is much greater than that 
of the reduction in the OD of the infected serum as the antigen 
concentration fell. This could be explained either by differences in the 
avidity of the sera or by epitopes becoming obscured at the lower antigen 
concentrations.
Serum titrations confirmed the increase in ratio of the ODs of serum 
collected from an infected and a vaccinated animal as the antigen 
concentration fell. This coincided with an apparent rise in ratio of 
relative avidity. Subsequent measurements using sera from all 
experimental animals showed considerable variation and the behaviour
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of the particular serum selected for this part of the study was not 
necessarily typical. The results obtained when using a high 
concentration of antigen appeared to suggest that although the relative 
avidity of serum collected from vaccinated animals is generally less than 
that of serum collected from infected animals, there is some overlap. 
The relative avidity of serum collected from several of the vaccinated 
animals, particularly later in the response, exceeded that of the serum 
collected from some infected animals. This was not the case when using 
a low antigen concentration when the relative avidity of all infected 
animals exceeded that of all vaccinated animals.
The avidity of vaccinate serum was significantly lower when measured 
on the low rather than the high concentration of antigen. This could 
suggest that if, as in the second hypothesis, some epitopes are obscured 
at the lower antigen concentration, antibody affinities to those epitopes 
that are presented is lower than to those epitopes that are lost.
The sensitivity of antibody binding to thiocyanate is thought to 
represent a good measure of relative avidity. The method described by 
Pullen et al (1986) allows the measurement to be made in situ under the 
conditions of the conventional indirect ELISA. Measurements can be 
made at each antigen concentration using a single serum dilution without 
requiring titration. Using the conventional high antigen concentration, 
the relative avidity of the serum from vaccinated animals tended to
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increase later in the response, although there was considerable variation 
between animals. In some infected animals the relative avidity rose and 
in others it fell. The relative avidity of antibody from some vaccinated 
animals exceeded that of some infected animals. The fall in relative 
avidity observed in some infected animals was surprising as during the 
course of infection, avidity would be expected to rise as the response 
matured. There was evidently no consistent difference between the 
avidity of vaccinated and infected animals. In general the estimate of 
relative avidity obtained using this method agreed with that obtained by 
van Heningen’s method.
On plates coated with a low antigen concentration, the relative avidity 
of the serum from vaccinated animals increased significantly later in the 
response. In infected animals the relative avidity fell in all except one 
animal. This could be explained by the infected animals responding to 
different epitopes; those that stimulate maturation becoming obscured as 
the antigen concentration is reduced. Late in the response, the relative 
avidity of serum from vaccinated animals was the maximum measurable 
and exceeded that of many infected animals.
The apparently lower avidity of vaccinate serum in the presence of low 
concentrations of antigen suggests that the avidity of those antibodies 
specific for epitopes detected under such conditions may be lower than 
for to epitopes detected at higher antigen concentrations.
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The relative avidity estimates obtained using the two methods agreed 
in the majority of cases. The converse was true with sera collected from 
infected animals late in the response. These discrepancies may be due to 
the effect proposed in the second hypothesis, that epitopes become 
obscured with decreasing antigen concentration, which will be tested in 
the next chapter.
6. P r e s e n t a t io n  OF EPITOPES
6.1 Introduction
It has been shown that antibodies following vaccination bind less well, 
as evidenced by a lower PP, to plates coated with a low concentration of 
antigen than plates coated with a high concentration. Two hypotheses 
are proposed to explain this observation. The first hypothesis is that 
these antibodies are of lower avidity than those arising following 
infection. In the last chapter two techniques were used to measure the 
apparent avidity of serum samples taken from infected and vaccinated 
cattle. The results obtained failed to support the first hypothesis as in 
many vaccinate sera, the relative avidity exceeded that of sera following 
infection (Table 5-3, Table 5-6).
The second hypothesis is that as the antigen concentration at the 
polystyrene surface is reduced, there is a change in the presentation of 
some epitopes so that they are no longer accessible. It is postulated that 
vaccinated animals respond to a different repertoire of epitopes than 
infected animals and that more of the epitopes to which vaccinated 
animals respond are masked at low antigen concentrations resulting in 
reduced binding.
The aim of the work described in this chapter is to test this second 
hypothesis using three approaches. Firstly, to compare the effect on
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antibody binding of changing the concentration of Brucella LPS antigen 
simply by diluting in buffer, or by diluting in an ‘inert’ LPS, keeping the 
overall LPS concentration constant.
Secondly, to measure the binding of 0-polysaccharide specific 
monoclonal antibodies to LPS antigen bound to polystyrene ELISA plates 
at different concentrations. Lastly, to measure antibody binding to the 
LPS of Brucella and bacteria of other genera known to express a 
restricted range of epitopes.
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6.2 Inert LPS
In order to determine if an alteration of epitopes available for binding 
is affected by the overall density of LPS molecules attached to the matrix, 
LPS prepared from Aeromonas salmonicida (which is not known to 
infect cattle) was used to titrate Brucella LPS whilst maintaining the 
overall LPS concentration.
6.2.1 Materials and Methods
6.2.1.1 ELISA procedure
The ELISA method was as Section 2.4.2, Chapter 2, but with antigen 
mixtures used for coating the plate (Table 6-1). Each serum to be tested 
was added to the plate at a dilution of 1/200 in every well of a pair of 
columns (Figure 6-1).
Table 6-1: The mass of Aeromonas and Brucella LPS applied to wells on 
the plate
Row Antigen Row Antigen
Aeromonas
Iig
Brucella
)^ g
Aeromonas
Hg
Brucella
Ug
A 0 1 I 0 1
B 0.5 0.5 J 0 0.5
C 0.75 0.25 K 0 0.25
D 0.87 0.13 L 0 0.13
E 0.93 0.07 M 0 0.07
F 0.96 0.04 N 0 0.04
G 0.98 0.02 0 0 0.02
H 1 0 P 0 0
6-4
1 2 3 4 5 6 7 8 9 10 11 12
A © © o o o o 1 OOOOOO
B OO0_Q0Q_ J OOOOOO
C OÔÔOÔÔ K OOOOOO
D OOOOOO L OOOOOO^
E OOOÜOO M 0 0 )0 0 0 0 ^
F OOOOOO N 0 0 T ) 0 0 0
G OOOOOO 0 O^ O^ 'OO'^ OO
H OOOOO'O p OOOCJOO^
O ISABS o CF50/53 C 3  Negative
Figure 6-1: Plate layout to measure effect of inert LPS
Each serum/antigen combination was carried out in duplicate wells
and on two separate plates. The mean OD readings of these four wells 
were calculated for further analysis.
6 . 2 . 1.2 Antigen and serum
The Brucella antigen used in this experiment was PK2. Aeromonas 
LPS (kindly donated by Dr Tony Moran) was prepared by phenol/water 
extraction of Aeromonas salmonicida.
Serum samples ISABS, CF50/53 and negative serum were used as 
described in Section 2.4.2, Chapter 2.
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6.2.2 Results
The OD readings of the antigen titrations using PK2 and Aeromonas 
are presented below. Those using serum ISABS are presented in Figure
6-3 and those using serum CF50/53 in Figure 6-4.
The presence of Aeromonas LPS did not have a dramatic effect on the 
OD readings of the ELISA tests, but appeared to slightly depress the OD 
readings, having the effect of shifting the titration curve left.
Figure 6-3: ELISA results of serum ISABS tested on different 
concentrations of Brucella LPS diluted in buffer or Aeromonas LPS
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-Aeromonas 
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Brucella LPS (meg)
OD results o f  indirect ELISA  testing o f  serum ISABS on different Brucella  antigen 
concentrations. The test was carried out using a partially purified Brucella  LPS antigen 
(PK2) diluted in buffer or in buffer containing varying quantities o f  A erom onas LPS (0-1 pg 
per ml) so that the overall LPS concentration remained constant ( Ip g  per ml).
6 -6
Figure 6-4: ELISA results of serum CF50/53 tested on different 
concentrations of Brucella LPS diluted in buffer or Aeromonas LPS
Brucella LPS (meg)
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0.131 0.5 0.25 0.07 0.04 0.02 0
OD results o f  indirect ELISA testing o f  serum CF50/53 on different Brucella  antigen 
concentrations. The test was carried out using a partially purified Brucella  LPS antigen 
(PK2) diluted in buffer or in buffer containing varying quantities o f  Aerom onas LPS (0-1 pg 
per ml) so that the overall LPS concentration rem ained constant ( Ip g  per ml).
There was an interesting differenee between the behaviour of the 
vaccinate and infected sera if, for each Brucella LPS concentration, the 
OD of serum CF50/53 was expressed as a percentage of that of serum 
ISABS, (effectively giving the percentage positivity for each Brucella 
LPS concentration). It can also be seen from Figure 6-5 that at the 
highest antigen concentrations, the PP values were highest when the 
Brucella LPS had been diluted in buffer. Conversely, at the lower 
concentrations, they were higher when the total LPS concentration was 
maintained by adding Aeromonas LPS. For instance, at a Brucella LPS
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concentration of 0.4|ag, the PP is 9%PP but is 26%PP in the presence of 
Aeromonas LPS.
Figure 6-5: ELISA results of serum CF50/53 tested on different 
concentrations oï Brucella LPS diluted in buffer or Aeromonas LPS 
expressed as percent positivity (PP)
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Results o f  indirect ELISA  testing o f  serum CF50/53 on different Brucella  antigen 
concentrations. The test was carried out using a partially purified Brucella  LPS antigen 
(PK2) diluted in buffer or in buffer containing varying quantities o f  Aeromonas LPS (0-1 pg 
per ml) so that the overall LPS concentration remained constant (0-1 pg per ml). ELISA  as 
described in C hapter 2. OD results expressed as PP (relative to  ISABS under same 
conditions)
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6.3 Monoclonal antibody binding
At least seven epitopes are currently recognised on the O-chain and it 
is known that antibody binding to some of these is reduced when the 
molecule is bound to polystyrene (Weynants, 1997). Indeed, it has been 
shown that epitope expression differs when bound to polystyrene, in 
solution or when measured by flow cytometry (Cloeckaert et ah, 1998).
Experiments were carried out to identify the expression of these 
epitopes on plates coated at different antigen concentrations using MAbs.
6.3.1 Materials and Methods
BLISAs were carried out essentially according to the method described 
in Section 2.4.2, Chapter 2 except that anti-murine IgG-peroxidase 
conjugate was used in place of anti-bovine IgG peroxidase conjugate.
The antigen used for this experiment was PK2 coated at the high and 
low concentration as described in Section 4.3.1.3 Chapter 4. MAbs 
listed below (Table 6-2) were kindly donated by Dr Axel Cloeckaert and 
Dr Vincent Weynants or produced locally (Mathias et ah, 1990).
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Table 6-2: Monoclonal antibodies included in the study
Monoclonal Published specificity^
12G12 C(A=M)
07F09 C(A=M)
15B10 C(M>A)
12B12 C(M>A)
04F9 C/Y(A>M)
18H08 C/Y(A=M)
BMIO C/Y(M>A)
2E11 M
BM2 A
Optical density readings were normalised, as before, by expressing 
them as a percentage of the positive standard serum (ISABS) included on 
each plate.
6.3.2 Results
The results of testing the MAbs by ELISA using two antigen 
concentrations are presented in Table 6-3.
* C=common to all Brucella species and biovars. C/Y= binds to Y.enterocolitica 0:9  too. 
(A>M)=binds preferentially to A dominant strains 
(M>A)=binds preferentially to M dominant strains 
(A=M)=binds equally to A and M dominant strains
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Table 6-3: Percent positivity (PP) of monoclonal antibodies using high 
and low concentrations of PK2 antigen
MAb specificity MAb Antigen concentration
1pg/ml 1 0.1pg/ml
PP
C(A=M) 12G12 97 66
C(A=M) 07F09 106 53
C(M>A)) 15B10 84 6
C(M>A) 12B12 100 8
C/Y(A>M) 04F9 88 90
C/Y(A=M) 18H08 81 50
C/Y(M>A) BMIO 94 9
M 2E11 9 5
A BM2 91 93
All MAbs bound strongly to the plates coated with antigen PK2 at the 
high concentration with the exception of 2E11 which has M specificity 
(this MAh bound strongly to an LPS antigen prepared from an M 
dominant strain of B.melitensis). The MAbs varied in the relative 
binding to high or low concentrations of antigen. The PP of MAb 04F9 
(C/Y(A>M)) and BM2 (A) appeared considerably higher at the low 
antigen concentration than at the high antigen concentration. However 
the PP of 15B10 (C(M>A)), 12B12 (C(M>A)) and BMIO (C/Y(M>A)) 
decreased significantly (P<0.05). The PP of the other MAbs decreasing 
less substantially.
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6.4 B.suis biovar 2 Yersinia enterocolitica 0:9 and E.hermannii
If, as is proposed, the sera of vaccinated animals lack antibodies with 
specificity for some epitopes, it may be expected that binding will be 
reduced on antigens devoid of some of these epitopes. B.suis biovar 2 is 
reported to have much reduced expression of the C(M=A) and 
C/Y(M>A) epitopes and is devoid of the C(M>A) epitope (Cloeckaert, 
1998). The LPS of Escherichia hermannii is reported to show a close 
structural similarity to the Brucella M epitope, although the amino 
groups of the common g-D-Rha4N residues are N-acetylated in the 
E.hermannii O chains and N-formylated in the case of the Brucella M 
antigens, and the ratio of a - 1,2 to a - 1,3 glycosidic linkages varied among 
different isolates (Bundle et ah, 1987c). Indeed, polyclonal sera raised 
to Brucella and MAbs specific for the Brucella M epitope have been 
reported to bind to O-polysaccharide extracted from some strains of 
E.hermannii (Perry and Bundle, 1990). The O-polysaccharide of 
Y.enterocolitica 0:9 is reported to be composed of an identical 
homopolymer to that of Brucella , but is entirely a - 1,2 linked (L’vov et 
al 1985, Moreno et al 1987).
If, as the hypothesis proposes, the antibody specificity of serum 
collected from vaccinates and infected animals is different, then it would 
be expected that each would bind to each of these antigens to a different 
degree.
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6.4.1 Materials and Methods
Strains of Y.enterocolitica 0:9, E.hermannii and B.suis biovar 2 were 
obtained from the culture collection of CVL. LPS was extracted from 
Y.enterocolitica 0:9, E.hermannii and B.suis biovar 2 using the 
SDS/Proteinase K method as described in Section 2.5.2, Chapter 2. 
ELISAs were carried out essentially according to the method described in 
Section 2.4.2, Chapter 2 including ISABS serum on each plate so that 
OD readings of test sera could be converted to PP.
Sera from all the vaccinated and experimentally infected animals were 
tested early and late in the immune response as described in Section 5.7, 
Chapter 5. Also the MAbs described above in Section 6.3.1 were 
included.
6.4.2 Results
Only MAbs 04F9 (C/Y(A>M)), 18H08 (C/Y(A=M)) and BMIO 
(C/Y(M>A)) all bound strongly to the LPS antigen prepared from 
Y.enterocolitica 0:9 and B.suis biovar 2. MAb BM2 also bound strongly 
to B.suis biovar 2 antigen but not to Y.enterocolitica 0:9. All MAbs 
bound moderately to E.hermannii (Table 6-4).
6-13
Table 6-4: Percent positivity (FF) of monoclonal antibodies using LFS 
prepared from Y.enterocolitica^ EMermannii and B.suis biovar 2
MAb specificity MAb Antigen
Y.enterocolitica 0:9 E.hermannii B.suis 2
C(A=M) 12G12 4 20 3
C(A=M) 07F09 5 25 6
C(M>A)) 15B10 3 35 2
C(M>A) 12B12 2 37 5
C/Y(A>M) 04F9 102 22 89
C/Y(A=M) 18H08 89 22 92
C/Y(M>A) BMIO 94 37 28
M 2E11 2 45 2
A BM2 5 12 28
R esults o f  indirect ELISA  testing  o f  M Abs on different antigens. The test w as carried out 
using partially purified Brucella  LPS antigen prepared from  Y .enterocolitica 0 :9 , 
E.herm annii and B .suis biovar 2.
Samples collected from all the infected animals both early and late in 
the response bound strongly to LPS extracted from Y.enterocolitica 0:9, 
E.hermannii and B.suis biovar 2. There was some variation, but 
individual sera tended to bind to each antigen to a similar degree.
Serum samples collected from most vaccinated animals, particularly 
later in the response, bound strongly (>30PP) to E.hermannii. There was 
also strong binding to B.suis biovar 2, but this tended to be lower in each 
animal than to the former antigen. Binding to Y.enterocolitica was 
consistently low (<10PP) (Table 6-5).
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Table 6-5: Percent positivity (PP) of serum from infected and vaccinated 
animals using LPS prepared from Y.enterocolitica^ E.hermannii and B.suis 
biovar 2
Class of animal Antigen
Sample 7. enterocoUtica E.hermannii B.suis 2
Infected 
early in response
63-23 27 21 29
82-23 23 19 21
87-23 26 23 19
505-23 63 43 52
Infected 
late in response
63-84 72 66 61
82-84 51 42 47
87-84 48 37 27
505-84 80 67 51
Vaccinated 
early in response
45-8 8 31 18
46-8 7 40 21
47-8 4 11 3
48-8 6 24 8
49-8 5 26 15
50-8 2 13 9
Vaccinated 
late in response
45-79 7 36 15
46-79 8 54 23
47-79 6 47 15
48-79 6 54 23
49-79 7 56 49
50-79 5 38 22
R esults o f  indirect ELISA  testing o f  serum from  vaccinated and infected animals on 
different antigens. The test was carried out using partially purified Brucella  LPS antigen 
prepared from  Y .enterocolitica 0 :9 , E .herm annii and B .suis biovar 2.
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6.5 Discussion
In the last chapter, it was shown that the reduced binding of antibodies 
in the serum of vaccinated animals could not be explained by reduced 
avidity. Experiments described in this chapter were designed to test an 
alternative hypothesis, namely that some O-polysaccharide epitopes 
become obscured as the antigen concentration is reduced. For the 
hypothesis to hold true then the spectrum of antibodies in the serum of 
vaccinated animals must be restricted to those that are obscured.
It may be that epitopes become obscured by the altered presentation of 
the antigen on the polystyrene matrix as the density of the molecules is 
reduced. Thus it was decided to test this by carrying out the ELISA on a 
reducing concentration of Brucella LPS but replacing this with LPS from 
an unrelated organism so that the overall concentration of LPS remained 
constant. The problem with this approach was that although the 
concentration of LPS in the coating buffer is controlled, the amount that 
attaches to the matrix is unknown. The relative avidity of the Brucella 
and Aeromonas LPS to bind to polystyrene may be different and so the 
resulting ratio of the antigens coating the plate may be quite different to 
that applied in the buffer. Nevertheless, there was a similar reduction 
(expected sigmoid relationship) in OD as the concentration of Brucella 
LPS was reduced whether diluted in buffer or with the addition of 
Aeromonas LPS. In fact where Aeromonas LPS was added, the CDs
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were reduced slightly for most of the titration curve with both the serum 
from the infected and the vaccinated animal (Figure 6-3 and Figure 6-4). 
If at each antigen concentration however, the OD of serum CF50/53 was 
expressed as a percentage of the OD of serum ISABS, in other words the 
percent positivity (PP), the results are interesting. The PP of serum 
CF50/53 reduces as the antigen concentration is reduced. However, at 
the higher antigen concentrations, the PP of the serum tested on Brucella 
LPS diluted in buffer is higher than when it is diluted in buffer 
containing Aeromonas LPS. At the low antigen concentrations the 
reverse is true (Figure 6-5). For instance at a Brucella LPS 
concentration of 0.4pg, the PP is 9%PP if the antigen has been diluted in 
buffer and 26%PP if it has been diluted in a buffer containing 
Aeromonas LPS. One explanation for these findings is that firstly, 
whether diluted in buffer or in buffer containing Aeromonas LPS, the 
Brucella LPS adsorbs to the plate to a similar degree, although 
somewhat reduced presumably by the competitive binding of Aeromonas. 
However, the binding of the vaccinate serum relative to the serum from 
the infected animal was reduced less at the lower concentrations in the 
presence of Aeromonas, possibly because its presence was maintaining 
the presentation of the Brucella antigen and preventing epitopes 
becoming obscured.
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The O-polysaccharide epitopes A and M are each detectable only on 
certain species and biovars of Brucella. Other epitopes have been 
proposed, due to differential binding of MAbs (to Brucella and 
Y.enterocolitica 0:9) in ELISA assays. These putative epitopes are 
expressed by all species and biovars of Brucella and by Y.enterocolitica 
0:9 in some cases. Five epitopic specificities have been identified in this 
group: C(M>A), C(M=A), C/Y(M=A), C/Y(M>A) and C/Y(A>M). 
MAbs indicated as C are specific for Brucella, whilst those indicated as 
C/Y also cross-react with Y.enterocolitica 0:9. The preferential binding 
to A or M dominant strains, or to both equally are indicated as A>M, 
M>A and A=M respectively. It has been suggested from data of 
competitions between MAbs that the different O-polysaccharide epitopes 
are probably overlapping structures (Weynants, 1997). Although all 
antibodies bound to appropriate LPS when coated onto a polystyrene 
microtitre plate, monoclonal antibodies specific for M and A failed to 
bind to purified O-polysaccharide (PS) adsorbed to polystyrene, and 
some others bound to a significantly reduced degree. However, all the 
monoclonal antibodies studied were inhibited from binding to 
appropriate LPS by the addition of PS, suggesting that they were capable 
of binding to PS when in solution, thus implying that certain epitopes 
may be obscured when bound to polystyrene. Several O-polysaccharide 
epitopes are recognised and they are thought to consist of three to six
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units with a - 1,2 or a - 1,3 bonds at various positions. It is suggested that 
C/Y type epitopes could depend on the number of a - 1,2 linked 4,6 
dideoxy-4-formamido-a-D-mannopyranosyl units (a -1,2 linked D- 
Rha4Nfo) residues (Caroff et ah, 1984a, b). Indeed, in an O chain where 
the percentage of a - 1,3 links is important (eg. PS of B.melitensis 16M), a 
structure formed around four residues with a -1,2 links would be rarely 
present and thus it would be defined a C/Y(A>M) epitope (Weynants,
1997). On the other hand, two or three a -1,2 linked D-Rha4NFo 
residues could define the C/Y(A=M) epitope since this structure is 
common to A and M dominant Brucella and Y.enterocolitica 0:9. 
However, the presence of a C/Y(M>A) epitope also suggests that a -1,2 
links are not the sole structural feature for antibody recognition as 
monoclonal antibodies with this specificity bound better to M dominant 
Brucella than A dominant Brucella or Y.enterocolitica 0:9. The a - 1,3 
bonds cause an alteration in the direction of chain propagation and hence 
affect the shape of the epitope (Bundle et ah, 1989, Peters et ah, 1989a,
b).
The four remaining epitopes were present only on Brucella . One 
(C(M=A)) appeared to be present in equal amounts on both A and M 
dominant strains whilst another (C(M>A)), although present on both, 
appeared to be in greater quantity on M dominant strains (Weynants et 
al., 1997). Two other epitopes were detectable only on A dominant (A)
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or M dominant (M) strains. The structures of these four epitopes cannot 
be adequately explained by the presently known structure of the PS of 
Brucella or Y.enterocolitica 0:9. Although A dominant strains possess 
a -1,3 links (Meikle et al. 1989), anti-M monoclonal antibodies are not 
able to bind to M dominant LPS, possibly due to the low density of M 
epitopes, or their inaccessibility. It was also established that the 
structure of the A epitope was a pentasaccharide or larger 
oligosaccharide composed of a -1,2 linked D-Rha4NFo, although some 
monoclonal antibodies specific for this epitope would not bind to the LPS 
of Y.enterocolitica 0:9.
If one hypothesises that certain epitopes become obscured as the 
antigen concentration on the plate is reduced, then the binding of MAbs 
specific for those epitopes will be reduced relative to the binding of 
MAbs specific for other epitopes as the antigen concentration is reduced.
By using MAbs specific for all the recognised O-polysaccharide 
epitopes it was shown that the binding of some was markedly reduced at 
the low antigen concentration whereas the binding of others was 
maintained. The implication of this is that at the low antigen 
concentration these epitopes have been obscured. It is notable that those 
MAbs whose binding to the low concentration of LPS antigen was most 
markedly reduced were those specific for the (M>A) or M type epitopes. 
It is these epitopes that are presumed to involve a - 1,3 bonds. It is these
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that alter the direction of chain propagation and it may be that the 
topology of this is changed when binding to polystyrene under some 
circumstances.
The O-polysaccharide of Y.enterocolitica 0:9 is identical to that of 
Brucella but contains no a - 1,3 bonds and hence is devoid of some 
epitopes dependent on this structure (L’vov et al 1985, Moreno et al 
1987). The O-polysaccharide o f E.hermanii is reported to show a close 
structural similarity to the Brucella M epitope (and presumably (M>A 
epitopes) (Bundle, 1990a). B.suis biovar 2 is reported to have much 
reduced expression of the C(M=A), C/Y(M>A) epitopes and is devoid of 
the C(M>A) epitope (Cloeckaert, 1998).
Binding of the MAbs to Y.enterocolitica 0:9, E.hermannii and B.suis 
biovar 2 was as expected from previous studies (Perry and Bundle, 
1990). Antibodies in infected serum bound strongly to antigens prepared 
from all three organisms. Antibodies in vaccinate serum also bound well 
to E.hermannii and B.suis biovar 2 although there was more individual 
variation than was observed with the serum from infected animals. 
Binding to antigen prepared from Y.enterocolitica 0:9, however, was 
poor. These observations are consistent with the proposal that antibodies 
specific for epitopes containing only a - 1,2 bonds are present in only 
small amounts in serum collected from vaccinated animals.
7. V a l id a t io n  a n d  F ie l d  t r ia l s
7.1 Introduction
Diagnostic tests developed from research activities need to be fully 
assessed for their effectiveness and feasibility for routine use. This 
allows predictions to be made about the health status of the subject 
within a known level of confidence. This assessment is termed 
validation and the process is gradually becoming standardised (Jacobson,
1998). The process of validation is discussed at length in Chapter 1 and 
is really a series of inter-related processes culminating in field trials 
during which the test can be assessed under conditions approaching those 
under which it will be used routinely.
The initial stages of validation are described throughout this thesis and 
this chapter describes field trials carried out to estimate the diagnostic 
sensitivity and specificity of the modified ELISA.
The aim of this chapter is to complete the validation of the ELISA 
developed in this project by evaluating it in field trials.
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7.2 Materials and Methods
7.2.1 Serum samples
Limited numbers of reference sera, collected and archived, have 
enabled initial feasibility, reagent optimisation and performance 
measurement. The validation of diagnostic tests usually requires 
evaluation against two populations of animals, namely uninfected and 
infected. The assay under study here was developed to discriminate 
between vaccinated and infected animals and so a population of animals 
recently vaccinated with S19 vaccine has been included.
7.2.1.1 Number of samples required for validation
As described in 1.3.9 (iii), a minimum number of sera should be 
collected depending on the expected levels of sensitivity or specificity, 
the allowable error and the confidence required.
The expected diagnostic sensitivity (DSn) is approximately 95% and 
the expected diagnostic specificity (DSp) is approaching 100% as was 
determined in Chapter 4.
Using the equation:
^ _ (DSn)(l-DSn)(c)-
where n is the number of known infected animals, e is the percentage 
of error allowed in the estimate and c is the confidence interval for the
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estimate, the minimum number of samples that should be tested to 
determine the DSn is 456 and the minimum to determine DSp is 95 with 
an allowable error of 2% at a confidence limit of 95%.
If the allowable error was reduced to 1% and the confidence limit to 
99% then the minimum number of samples that should be tested to 
determine the DSn is 3152 and the minimum to determine DSp is 652.
7.2.1.2 Source of serum samples
The freedom of Great Britain from brucellosis necessitates the 
collection of larger numbers of sera from infected animals from outside 
our shores to fully evaluate the test. Sera are of course available from 
British brucellosis free animals including a proportion that have given 
false positive results to currently used serological tests. Such false 
positive reactions are evidenced by positive test reactions given by sera 
from animals proved brucellosis free by extensive surveillance activities.
Serum samples were necessarily obtained from a number of sources 
(Table 7-1):
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Source Number 
of animals
History
Northern Ireland 10 Herds illicitly vaccinated with 819 and infected herds
Macedonia 616 Vaccinated and infected herds
South Africa 1249 Vaccinated and infected herds
Eritrea 500 Infected herds
Great Britain 1013 Brucellosis free herds
Table 7-1: Source of serum samples included in study
The samples collected from Northern Ireland were collected from
herds from which 819 had been isolated. The 819 had been illicitly 
administered in order to cause animals to react to diagnostic tests 
resulting in compensation being paid to the herd owner. Also included 
were samples from naturally infected herds from which Brucella abortus 
biovar 1 had been isolated.
Samples from Macedonia, South Africa and Eritrea were collected 
from naturally infected herds from which various biovars of Brucella 
abortus had been isolated. Samples were also received from Macedonia 
and South Africa collected from calves vaccinated with the standard dose 
of 819 between six and twelve weeks before sampling. For analysis, 
irrespective of origin, the samples were grouped according to class: 
uninfected, infected and vaccinated.
All serum samples were stored at -20°C before testing.
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7.2.2 Testing
All samples were tested using the conventional iELISA utilising a high 
concentration of PK2 antigen and the modified ELISA utilising a low 
concentration of PK2 antigen as described in Chapter 4.
7.2.3 Selection o f cut-off
The cut-off selected for use elsewhere in this thesis is the 
internationally accepted level of 10%PP. Results reported in Chapter 4 
following the use of both the modified and conventional iELISA 
indicated that this cut-off appeared satisfactory for initial trials. Part of 
the validation process reported here is the determination of the optimum 
cut-off based on field trials.
7.2.4 Determination o f sensitivity
Appropriate cut-offs for both tests were determined by plotting the 
modified ROC curve using test data from infected and uninfected 
animals (Greiner et ah, 1995). For each test, using the cut-offs 
determined in this way, test results were classified into positive or 
negative categories. The positive/negative data are recorded with the 
known status in a two-way table to highlight false positive (FP) and false
negative (FN) sera. DSn is calculated using the formula: — —-----
TP + FN
expressed as a percentage where TP are true positives and FN are false
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negatives (Jacobson, 1998). For this study an additional column was 
included for data from vaccinated animals.
7.2.5 Determination of specificity
The estimation of specificity was made using a similar two by three 
way table as in 7.2.4 above and calculated from the number of true
negatives (TN) and false positives (FP) using the formula: —p L .—  . 
where TN are the true negatives and FP are false positives.
An estimate of the specificity of the tests when used in the population 
of vaccinated animals was made using the same methodology.
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7.3 Results
7.3.1 Determination of cut-off
The results of testing the serum samples from infected (n=1128) and 
uninfected animals (n=1013) are presented as a combined frequency 
distribution of the normalised test values (PP) in Figure 7-1 and Figure
7-2.
Figure 7-1: Frequency distribution of normalised PP values from sera of 
infected and uninfected animals using the modified ELISA
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Frequency distribution o f  modified ELISA  results expressed as PP. Samples from  infected 
and uninfected non-vaccinated animals w ere tested . Infected n=1128. U ninfected n=1013. 
A ntigen used was PK2 at a dilution o f  1/4000
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Figure 7-2: Frequency distribution of normalised PP values from sera of 
infected and uninfected animals using the conventional ELISA
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Frequency distribution o f  conventional ELISA results expressed as PP. Samples from 
infected and uninfected non-vaccinated animals w ere tested. Infected n=1128. Uninfected 
n=1013. Antigen used was PK2 at a dilution o f  1/500
The frequency distributions of test results given by the modified and 
conventional ELISAs were similar. There was a clear overlap in both 
instances of data from infected and uninfected animals showing that no 
cut-off will achieve both 100% DSn and DSp.
By counting at each potential cut-off, the proportion of infected and 
uninfected animals giving positive test results, it is possible to calculate 
DSn and DSp data and these are recorded in Table 7-2.
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Table 7-2: Diagnostic sensitivity and specificity values for each cut-off 
value in the modified and conventional ELISA in non-vaccinated herds
Cut-off
(PP)
Modified ELISA Conventional ELISA
DSn DSp DSn DSp
0 100.0% 0.0% 100.0% 0.0%
1 100.0% 12.8% 100.0% 10.9%
2 100.0% 28.4% 100.0% 26.5%
3 100.0% 42.4% 100.0% 40.3%
4 100.0% 57.8% 100.0% 56.5%
5 99.7% 70.3% 100.0% 68.3%
6 99J% 84.2% 100.0% 83.1%
7 98.4% 91.0% 9&9% 89.0%
8 97.2% 95.5% 98.0% 95.0%
9 9&1%» 97.7% 97.0% 97.5%
10 95.7% 98.8% 96.4% 98.5%
11 94.6% 99.4% 95.1% 99.3%
12 9L3% 99.6% 9L3% 99.6%
13 93J^& 99.9% 94.1% 99.8%
14 93.0% 99.9% 93.9% 99.9%
15 92.9% 99.9% 93.2% 99.9%
16 92.8% 99.9% 92.6% 99.9%
17 92.1% 99.9% 92.0% 99.9%
18 91.3% 100.0% 91.3% 100.0%
19 90.8% 100.0% 90.7% 100.0%
20 90.2% 100.0% 9&1%» 100.0%
Plotting the modified ROC curve (Greiner et ah, 1995) enables the 
choice of suitable cut-off to be made. The curve of both the modified 
and conventional iELISA are similar and the cut-off at which maximum 
accuracy is achieved (i.e. DSn and DSp are maximal) are identical and 
that at which DSn and DSp are equal is also identical for both tests 
(Figure 7-3, Figure 7-4). If a cut-off of 10%?? was chosen, the DSp
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values were 98.8% and 98.5% and the DSn values were 95.7 and 96.4% 
for the modified and conventional ELISAs respectively.
Figure 7-3: Modified ROC analysis of modified ELISA
100°/
u
^  95%
&
(A
1  90%
(S
^  85%
Maximum
accuracy
s
S 80%u DSn=DSp
i  75% -O)
.S
°  70% -
0 5 10 15 20
•DSn
•DSp
Intervals of PP
M odified ROC analysis o f  modified ELISA  results at a cu t-o ff o f  10%PP. Samples from 
infected and uninfected non-vaccinated animals w ere tested. Infected n=1128. Uninfected 
n=1013. Antigen used w as PK2 at a dilution o f  1/4000
Figure 7-4: Modified ROC analysis of conventional ELISA
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If the data collected from testing recently vaccinated animals (n=l 145) 
are plotted in a similar way, then the diagnostic specificity in vaccinated 
herds (DSp’) can be assessed (Table 7-3,Figure 7-5, Figure 7-6).
Table 7-3: Diagnostic sensitivity and specificity values for each cut-off 
value in the modified and conventional ELISAs in vaccinated herds
Cut-off
(PP)
Modified ELISA Conventional ELISA
DSn DSp DSn DSp
0 100.0% 0.0% 100.0% 0.0%
1 100.0% 3.2% 100.0% 0.5%
2 100.0% 8.8% 100.0% L3%
3 100.0% 16.0% 100.0% 2.3%
4 100.0% 26.5% 100.0% 3.8%
5 99.7% 39.1% 100.0% 5.6%
6 99J% 48.8% 100.0% 7.0%
7 98.4% 61.9% 98.9% 8.9%
8 97.2% 71.5% 98.0% 10.3%
9 96.1% 83.6% 97.0% 12.9%
10 95.7% 88.4% 96.4% 17.0%
11 94.6% 93.2% 95.1% 22.6%
12 9L3% 95.3% 94.3% 30.3%
13 93T96 96.1% 94.1% 40.3%
14 93.0% 97.7% 93.9% 51.2%
15 92.9% 98.6% 93.2% 61.1%
16 92.8% 98.8% 92.6% 64.6%
17 92.1% 98.9% 92.0% 70.0%
18 91.3% 98.9% 91.3% 74.1%
19 90.8% 98.9% 90.7% 76.4%
20 90.2% 99.0% 90.1% 78.0%
30 99.7% 88.9%
40 99.9% 99.5%
50 100.0% 100.0%
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Figure 7-5: Modified ROC analysis of modified ELISA in vaccinated 
herds
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Figure 7-6: Modified ROC analysis of conventional ELISA in vaccinated 
herds
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There is a marked difference in specificity between the two tests, and 
only at a cut-off of 40%PP was the specificity in the conventional ELISA 
equal to that achieved at a cut-off of 10%PP with sera from uninfected 
animals. In comparison, this specificity was achieved at a cut-off of 
15%PP in the modified ELISA. It is significant that a specificity of 
100% was only achieved with a cut-off of 50%PP as in the modified 
ELISA particularly there were a small number of samples with high PP 
values.
7.3.2 Determination o f sensitivity and specificity
The internationally accepted cut-off of 10%PP for the conventional 
ELISA is therefore confirmed by analysis of these field trial data. A cut­
off of 15%PP however appears to give improved specificity when testing 
vaccinated animals. The DSn, DSp and DSp’ (specificity for vaccinates) 
for each test using these cut-offs can be demonstrated in two by three 
way tables as described above in 7.2.4 and 7.2.5 (Table 7-4, Table 7-5).
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Table 7-4: Diagnostic sensitivity and specificity of modified ELISA at a 
10%PP cut-off
Reference animals
Infected Uninfected Vaccinated
Test Result Positive 1079 12 145
Negative 49 1001 1102
DSn=95.65% DSp=98.8% DSp’=88.4%
Table 7-5: Diagnostic sensitivity and specificity of conventional ELISA at 
a 10%PP cut-off
Reference animals
Infected Uninfected Vaccinated
Test Result Positive 1087 15 212
Negative 41 998 1035
DSn=96.40% DSp=98.5% DSp’=17.00%
In both cases, the diagnostic specificity in the vaccinated herds (DSp’) 
was not high, although that given by the modified ELISA was 
significantly better than that of the conventional ELISA. If a cut-off of 
15%PP was chosen the DSp’ of the modified ELISA was much improved 
with only a 3.5% loss in sensitivity (Table 7-6, Table 7-7). Even at this 
cut-off, the DSp’ of the conventional ELISA was only 61.1%.
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Table 7-6: Diagnostic sensitivity and specificity of modified ELISA at a 
15%PP cut-off
Reference animals
Infected Uninfected Vaccinated
Test Result Positive 1048 1 18
Negative 80 1012 1129
DSn=92.9% DSp=99.9% DSp’=98.6%
Table 7-7: Diagnostic sensitivity and specificity of conventional ELISA at 
a 15%PP cut-off
Reference animals
Infected Uninfected Vaccinated
Test Result Positive 1051 1 485
Negative 77 1012 762
DSn=93.2% DSp=99.9% DSp’=61.1%
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7.4 Discussion
The validation of diagnostic tests is a process where their 
effectiveness for routine use is measured giving an estimate of the 
confidence that should be placed in predicting the infection status of 
animals from their results. The process of validation is gradually 
becoming established and has been well described by Jacobson (1998). 
Validation is really a series of inter-related processes; the earlier stages 
of which are described in other chapters in this thesis. The process 
culminates in field trials during which the test can be assessed under 
conditions approaching those under which it will be used routinely and 
assessments of DSn and DSp can be made.
Ideally, reference samples should be sourced from the population in 
which the test is intended to be used. In this study, they were obtained 
from a number of sources due to the difficulties in acquiring sufficient 
numbers from a single source and this must be remembered when 
interpreting the results. Secondly, they should ideally be collected from 
animals of known infection status. In this study, samples from 
uninfected animals were obtained from Great Britain where surveillance 
systems are sufficiently advanced to guarantee their brucellosis freedom. 
Samples from vaccinated animals were procured from Northern Ireland, 
Macedonia and South Africa. In every case, the provenance of the 
samples was impeccable.
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Obtaining samples from large numbers of known infected animals is 
always problematic. The ‘gold standard’ in brucellosis normally refers to 
the identification of such animals by the bacteriological isolation of 
Brucella. In the case of the animals included in this study, some were 
culture positive but the majority were identified as reactors to multiple 
classical tests and originating from countries where vaccination had 
never been used. In fact, even the use of ‘gold standard’ methods of 
identification may be less than as perfect as originally thought. For 
example, if only those animals excreting Brucella in sufficient numbers 
to be recovered on culture were selected, these may not represent a 
typical sample of the entire population of infected animals.
Thus again, the deficiencies in selection of reference animals must be 
borne in mind whilst interpreting the results.
The number of samples available has a direct bearing on the accuracy 
and confidence of the estimates of DSn and DSp calculated (see 7.1.1.3). 
A total of 1128 samples collected from presumed infected animals were
tested. From the formula n = — DSn)(c) calculated that
e
the estimate of sensitivity arrived at will have a maximum error of ± 1 % 
with a confidence of 99%. The estimate of DSp will have similar levels 
of error and confidence although the increased levels of variance
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observed in negative populations will tend to reduce the confidence that 
should be assumed (Jacobson, 1998).
The currently internationally accepted cut-off for the conventional 
ELISA is 10%PP and this appeared to be reasonable from results 
obtained in Chapter 4. Using these field trial data the cut-off was re­
evaluated using the modified ROC characteristic (Greiner et a l, 1995) 
which plots sensitivity against specificity. A cut-off for both modified 
and conventional ELISAs was selected as giving the best combination of 
sensitivity and specificity. The cut-off used has a direct effect on the DSn 
and DSp and consequently different epidemiological circumstances will 
require alteration in the cut-off to render the test more sensitive or more 
specific. Thus, selection of the cut-off will be influenced by whether the 
test is to be used for screening, requiring high sensitivity, or to be used 
for confirmatory purposes, when good specificity is the major factor.
At a cut-off of 10%, the sensitivity and specificity estimates of the 
tests of infected and uninfected, unvaccinated animals are given in Table 
7-8. The DSn of the conventional ELISA appears marginally superior but 
the DSn is less good although the overlap of each is within the margin of 
error.
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Modified ELISA Conventional ELISA
Sensitivity 95.65± 1% 96.4± 1%
Specificity 98.8± 1% 98.5± 1%
Table 7-8: Diagnostic sensitivity and specificity estimates of modified and 
conventional ELISAs while testing samples from unvaccinated animals
Every care should be exercised when comparing performance data 
from different studies but the performance of both tests is very good in 
comparison to the published performance data of classical tests 
(MacMillan, 1990) and more recently developed ELISA tests (Gall et ah, 
1998, Vanzini et al., 1998).
When a 10%PP cut-off is applied to tests carried out on samples from 
vaccinated animals much greater differences are observed (Table 7-9).
Modified ELISA Conventional ELISA
Sensitivity 95.65± 1% 96.4± 1%
Specificity 88.4%± 1% 17.0± 1%
Table 7-9: Diagnostic sensitivity and specificity estimates of modified and 
conventional ELISAs at a cut-off of 10%PP while testing samples from 
vaccinated animals
At the 10%PP cut-off, 83% of recently vaccinated, uninfected animals 
are positive to the conventional ELISA compared to 11.6% for the 
modified ELISA. However if a cut-off of 15%PP is used, the DSn’ of the 
modified ELISA can be improved considerably, although that for the 
conventional ELISA is not increased to the same extent (Table 7-10). 
There is naturally some loss of sensitivity at these higher cut-offs. 
Interestingly, further increases in the cut off would not result in major
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improvements in the DSn’ of the modified ELISA due to small numbers 
of vaccinated animals giving high PP values. These animals may be 
persistently infected with S19 as has been suggested by Nielsen and 
Wright (1990).
Modified ELISA Conventional ELISA
Sensitivity 92.9± 1% 93.2± 1%
Specificity 98.6%± 1% 61.1%± 1%
Table 7-10: Diagnostic sensitivity and specificity estimates of modified 
and conventional ELISAs at a cut-off of 15%PP while testing samples 
from vaccinated animals
For animals known or suspected as having been vaccinated, it would 
appear appropriate to designate two cut-offs, one at 10%PP below which 
samples would be designated negative and a cut-off of 15%PP above 
which samples would be designated positive. Samples giving a result in 
between these values would be designated as suspicious so that the 
animal could be re-bled later for the detection of seroconversion.
This assay would appear to be ideally suited for use in a region where 
S I9 vaccination was in use, even if such use was insufficiently 
controlled. There are many such situations where vaccination of both 
adults and young stock is carried out in an indiscriminate manner, 
resulting in seroconvertion that cannot normally be distinguished from 
field infection. As the DSn’ (the specificity in recently vaccinated 
animals) and the DSn are good, the test would enable positive serological 
reactions following vaccination to be discriminated from those due to
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field infection with reasonable confidence enabling appropriate action to 
be taken. The DSn’ value of the conventional ELISA is only 61.1% 
rendering the test useless where vaccine had been used.
In other circumstances, vaccination is not used, or it’s use is confined 
to young animals to avoid the confusion of diagnostic tests. In many 
instances, such widespread vaccination would result in a rapid reduction 
in disease prevalence and the inhibition of the use of vaccination for this 
reason will significantly delay progress towards control and final 
eradication. As this serological test can be used in recently vaccinated 
animals, widespread vaccination could be practised whilst still carrying 
out serological surveillance.
8. F in a l  C o m m e n t s  a n d  C o n c l u s io n s
8.1 Introduction
S I9 vaccine has been used for a considerable time as a means of 
controlling brucellosis in cattle. It is being superseded in some regions 
now by the more recently developed RB51 vaccine, but there is no doubt 
that S19 will continue to be used for many years in the majority of 
countries attempting to fight the disease. It confers reasonable 
immunity, and when used widely in the field, is very effective in 
reducing the prevalence of brucellosis. However, one serious drawback 
is that it causes serological reactions indistinguishable by conventional 
tests from those observed in infected animals. In a certain proportion of 
cases these reactions may persist for many months (MacMillan, 1990, 
Abalos et al, 1996). Indeed, this was confirmed by the experiments 
reported in Chapter 3 where calfhood-vaccinated animals maintained 
diagnostically significant titres for over 200 days. Strategies have been 
developed to minimise this effect, such as limiting vaccination to young 
stock, using the conjunctival route or vaccinating animals with reduced 
numbers of organisms (Duffield et al, 1994, El Gibali et al, 1996). 
There remains, however, a significant proportion of vaccinated animals 
that are serologically positive at the time of routine testing, and these 
reactions compromise the diagnostic interpretation resulting in 
unnecessary slaughter (Nielsen 1992, El Gibali et al, 1996).
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Thus, serological testing, the principle means of identifying reactors 
for removal from the herd by slaughtering or to assess disease 
prevalence, is severely compromised by vaccination. Whilst large scale 
vaccination of stock is recognised to be the most effective means of 
rapidly reducing the incidence of disease, authorities often will not use it 
it (except for calfhood vaccination) for fear of compromising diagnosis. 
If however, a simple serological test was available, that could reliably 
distinguish infected animals, S19 vaccine could be used widely, thus 
protecting the population whilst enabling the detection of disease.
Attempts to develop discriminatory tests have been previously 
reported. A radial immunodiffusion test has been reported to be 
effective in distinguishing vaccinated from infected animals (Jones et ah, 
1980, Lord and Cherwonogrodsky, 1991). It had very good specificity 
although it’s sensitivity was less than the CFT. The nature of the test, 
however, was not appropriate for use with large numbers of samples and 
the poor sensitivity would make it unsuitable for diagnosis. Nielsen et 
ah, (1989, 1991, 1995a) which showed a similar, good, discrimination in 
laboratory trials. These tests used 0-polysaccharide rather than LPS as 
antigen, requiring chemical modification to facilitate adsorption to 
polystyrene. Although initially promising, field trials in several 
countries have failed to confirm such discrimination as the test lacked 
sensitivity and specificity, particularly immediately following
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vaccination. Problems with the adsorption of the 0-polysaccharide 
antigen led to poor repeatability (unpublished observations, Nielsen et 
al, 1995, Herr et a l,  1998, Gall et a l,  1998, Rojas and Alonso, 1995).
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8.2 Aims and objectives
The aim of this work was to develop a serological test for the 
diagnosis of brucellosis in cattle that was highly sensitive and specific 
and would discriminate between animals infected with Brucella from 
animals vaccinated with S19 vaccine.
8.2.1 Experimental infection and vaccination
Experiments were designed to mimic vaccination and infection as it 
occurs in the field. Thus, five-month-old female heifer calves were 
vaccinated with the standard dose of S19 vaccine by the conventional 
route and infection with a standard challenge of a virulent strain of 
B.abortus was carried out in 18-month-old non-pregnant heifers via a 
mucosal route.
8.2.2 Conventional serological response
All the animals responded to the classical tests as would be expected 
from reports in the literature (reviewed by MacMillan, 1990) and from 
previous observations at this laboratory. Both following infection and 
vaccination there was a rapid rise in titre which fell over a period of 
weeks (except in one infected animal). Titres in vaccinated animals fell 
eventually to below diagnostically significant levels whilst those of 
infected animals remained elevated until the end of the observation 
period. Nevertheless, animals under surveillance in the field are usually
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monitored by a single blood sampling and the reactions given by 
individual samples from vaccinated or infected animals in this 
experiment were indistinguishable by classical tests.
8.2.3 Isotype response
There was a substantial IgM response in some animals following 
infection, but in others this was somewhat reduced. It was usually the 
first isotype to become detectable, although it was preceded by IgA in 
one animal. The response was consistent with that reported previously 
(Chappel 1980, Plackett 1984, Rice et ah, 1966). There was a 
significant difference between the IgM response following infection and 
vaccination which was much greater in the latter. In the main, the SAT 
response mirrored that of IgM which was to be expected as this is the 
predominant isotype active in this test (MacMillan et al, 1990). There 
were differences too in the IgA responses following vaccination and 
infection which may be explained by the different routes of 
administration.
Mucosal tissues of various organs show similar responses to invading 
pathogens although there are also organ specific variations. Antigen 
handling at ocular surfaces appears to mediated by dendritic cells in the 
conjunctival epithelium leading to a local lachrimal S-IgA response to 
protect against residual bacteria. Drainage via the naso-lachrimal duct
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also results in stimulation of pharyngeal lymphoid tissue, adding to the 
IgA response. If the local response fails, a powerful macrophage/T-cell 
response of deeper layers elicits the production (mediated by a complex 
array of cytokines) of antibodies of other isotypes (reviewed by Zierhut 
et al, 1998).
The wide range of responses and individual variation within each 
group, and in field-infected animals ruled out the use of these differences 
as a basis for a discriminatory test. The study did, nevertheless, confirm 
that the anti-bovine IgG(H+L) conjugate gave the optimum sensitivity 
and specificity, probably as the anti-light chain specificity conferred a 
broader spectrum of activity. This confirms other reports in the 
literature reviewed by MacMillan (1990)
8.2.4 Antigen specificity
Semi-purified LPS antigens were extracted by three different methods: 
extraction with SDS (PK2), extraction with phenol (BIO), and extraction 
by autoclaving (AS2). Differences were observed in the responses of 
both vaccinated and infected animals to each antigen. Each extraction 
method results in a preparation of varying purity. Responses of infected 
animals to antigen PK2 tended to be higher than to BIO and AS2, and a 
unique second peak was observed in one animal. In vaccinated animals 
the reverse was true; responses to PK2 were less than those to BIO and
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AS2. The range of PP of the culture-positive animals was greater with 
PK2 so that animals giving PP values in the higher part of the range with 
AS2 or BIO gave even higher PP values with PK2 and vice versa. The 
PP values of the vaccinated sera were lower than when they had been 
tested on a previous occasion. Re-examination of the data showed that 
different concentrations of antigen had been used on each occasion.
8.2.5 Antigen concentration
Experiments were designed to attempt to confirm this observation that 
using different concentrations of antigen has a profound effect on the 
binding of antibodies arising following vaccination. There was reduced 
binding of antibodies (a sigmoid relationship) from both vaccinated and 
infected animals as the antigen concentration was reduced. However, the 
reduction occurred at lower antigen concentrations and with a greater 
slope with the serum collected from an infected animal. If at each 
antigen concentration, the PP value of the vaccinate serum was 
calculated, it fell from a diagnostically significant level at a high antigen 
concentration to one that was diagnostically not significant at a low 
antigen concentration.
Using two antigen concentrations selected to maximise this effect, the 
reactions of serial serum samples collected from vaccinated and infected 
animals were compared. Using the lower antigen concentration, the peak
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PP response of experimentally infected animals was higher (although not 
significantly) than with the higher antigen concentration used and the 
range of PP values of the field infected group was greater. When serial 
serum samples from vaccinated animals were tested however, the peak 
responses observed using the lower concentration of antigen were 
significantly lower than those with the higher concentration. Despite 
substantial titres to the classical tests, in many animals, this peak did not 
exceed 10%PP (the value currently accepted as diagnostically 
significant) whilst in others it exceeded this level for a short time only. 
This unique observation provided an opportunity to develop a 
differential test for vaccinated and infected animals.
Validation studies carried out on the modified ELISA reported below 
indicated that the diagnostic threshold could be increased above 10%PP 
whilst retaining reasonable sensitivity in infected animals. This would 
therefore offer the possibility that even if animals were blood sampled 
within the first month following 819 vaccination, the vast majority 
would be negative. Even those ELISAs reported as being discriminatory 
in the literature, have given diagnostically significant titres in the first 
weeks following S I9 vaccination (Carrasco et al, 1995).
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8.2.6 Avidity
The observation mentioned above of the reduced slope of the titration 
curve of vaccinated serum could indicate that the effect was due to a 
reduced avidity of the serum following vaccination (van Heyningen et 
ah, 1983). This may offer less stimulus for antibody maturation than 
infection with a virulent challenge (Furesz et al, 1997). The high levels 
of IgM in vaccinates may indicate that there is little drive for maturation 
and hence towards higher avidity. Van Heyningen proposed a method for 
the measurement of antibody affinity (for MAbs) using ELISA 
technology and so it was ideal for the measurement of avidity in the 
ELISA system used throughout this study. Although the avidity of 
serum collected from vaccinated animals was generally lower than that 
collected from infected animals, there was considerable overlap. In 
other words, there were some samples from vaccinated animals 
(particularly later in the response) that did not bind well (evidenced by 
low PP) to low concentration antigen but which were of relatively high 
avidity. These results were largely confirmed using the measurement of 
sensitivity to the thiocyanate ion (Pullen et ah, 1986) where the overlap 
between the relative avidity of serum from vaccinated and infected 
animals was again observed. Indeed, relative avidity appeared to fall 
over the course of infection in some infected animals whilst it should be 
expected to increase as the immune response matured. This may be
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explained as a high proportion of the antibodies active in the response to 
LPS epitopes are of the IgM class which do not increase in affinity over 
time. When the sera were tested on plates coated with a low 
concentration of antigen, samples from vaccinated animals appeared to 
have a lower relative avidity than when measured on plates with a high 
concentration. This would be consistent with the hypothesis that 
following vaccination, a repertoire of antibodies arose with a range of 
affinities. Antibodies of fairly high affinity appeared, but they were 
directed against a reduced repertoire of epitopes which were only 
presented when plates were coated with a high antigen concentration. 
Those epitopes presented when ELISA plates were coated with a low 
concentration of antigen only elicited low affinity antibodies. Following 
infection however, antibodies directed to these epitopes were of high 
affinity giving rise to detectable ELISA reactions.
Within the first two days after challenge, activation of antigen specific 
B-cell clones occurs in extra-follicular sites. These differentiate to 
produce unmutated, low affinity IgM or IgG over the next 10-12 days 
(Kosco-Vilbois et al, 1997). This complexes with circulating antigen 
and is sequestered by the follicular dendritic cells residing in the primary 
B-cell follicles. Over the course of the next 14 days B-cell activation 
and differentiation gives rise to a germinal centre. Here, through a 
process of maturation and selection, isotype switches (under cytokine
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control) clonal expansion and somatic hypermutation, high affinity, 
specific antibodies arise which require continued antigen stimulation 
(Caligaris-Cappio and Ferarini, 1996). Thus, the repertoire and avidity 
of an antibody response is a result of the continuing presentation of 
antigen. Perhaps following vaccination, the range of epitopes providing 
continuing stimulation of B-cells is more restricted than that following 
infection. Thus the drive towards specificity and isotype switching is 
less.
8.2.7 Epitope presentation
These experiments provided little support for the hypothesis that the 
difference in binding of antibodies following vaccination and infection 
was due to differences in relative avidity. An alternative explanations is 
that as the antigen concentration in the test is reduced, there is a change 
in the presentation of some epitopes or in their conformation, so that 
they are no longer accessible. These explanations are consistent with the 
observations by Cloeckaert et ah, (1998) and Weynants et al. (1997) that 
under some circumstances epitopes are no longer expressed. This is an 
extension of Nielsen’s (1990) ‘tip and length’ hypothesis which 
proposed that vaccinated animals were responding to an epitope on the 
tip of the 0-polysaccharide which was only accessible if LPS (rather 
than PS) was used to coat the plate. Alternatively, it may be too that
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high levels of IgM (not detected by the conjugate used) may bind and 
sterically inhibit the binding of IgG.
The ELISA was carried out on a reducing concentration of Brucella 
LPS, but replacing this with LPS extracted from Aeromonas salmonicida 
(which is not known to infect cattle) such that the overall concentration 
of LPS remained constant. Whether the Brucella LPS was diluted in 
buffer or in buffer containing Aeromonas LPS, there was a similar 
sigmoidal reduction in OD, although the presence of Aeromonas LPS 
depressed the OD of both serum from the vaccinated and infected 
animal. If at each antigen concentration however, the OD of the 
vaccinate serum was expressed as a percentage of the OD of the infected 
animal (e.g. the PP) to show relative binding, the PP reduced as the 
antigen concentration is reduced. At the higher antigen concentrations 
the PP of the vaccinate serum tested on Brucella LPS diluted in buffer 
was higher than when it was diluted in Aeromonas LPS. At the lower 
antigen concentrations the reverse was true. This could be explained if 
the presence of the Aeromonas LPS is preventing changes in the 
conformation of the Brucella LPS which may be leading to the obscuring 
of some epitopes.
Using a panel of MAbs specific for the seven Brucella O- 
polysaccharide so far identified, marked differences were observed in
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their binding to plates coated with high and low antigen concentrations. 
The MAbs whose binding to the low antigen concentration was most 
markedly reduced were those specific for the (M>A) or M type epitopes. 
It is these epitopes that are presumed to involve a - 1,3 bonds and it is 
these that are suggested to be involved in changes in the direction of 
chain propagation (Bundle et ah, 1987a, Bundle et ah, 1987b , Bundle et 
ah, 1987c, Bundle et al, 1989) and it may be that the topology of this 
epitope is changed when binding to polystyrene under some 
circumstances (Weynants et ah, 1997).
The avidity of vaccinate serum was significantly lower when 
measured on the low rather than the high concentration of antigen. This 
could suggest that if, as in the second hypothesis, some epitopes are 
obscured at the lower antigen concentration, antibody affinities to those 
epitopes that are presented is lower than to those epitopes that are lost.
The proposed overlapping nature of the epitopes (indeed some are 
internal to others) means that the individual epitopes can never exist in 
isolation, even as synthesised oligosaccharides. Consequently, it has not 
been possible to study binding to each alone.
Some organisms however, express a more limited repertoire of 
epitopes than most Brucella species. M or (M>A) type epitopes are 
absent on the 0-polysaccharide of Y.enterocolitica 0:9 and are absent or
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reduced on B.suis biovar 2 (Cloeckaert et a l, 1998). E.hermannii 
possesses an 0-polysaccharide with close structural similarities to the 
Brucella M epitope (and presumably (M>A) type epitopes) (Perry and 
Bundle, 1990).
Serum collected from infected animals bound to antigens prepared 
from Y.enterocolitica 0:9, B.suis biovar 2 and E.hermannii as would be 
expected from previous observations in this laboratory whilst serum 
from vaccinated animals bound to Y.enterocolitica 0:9 only slightly. 
These observations were consistent with the hypothesis that serum from 
vaccinated animals only contains antibodies specific for epitopes 
containing a-1,3 bonds. Unfortunately, this antigen cannot be used as 
the general population contains a high proportion of animals infected 
with Yersinia.
Thus it may be that conditions at the surface of the polystyrene matrix 
are such that when antigen is coated at low concentrations, the topology 
of the 0-polysaccharide chain at the 1,3 linkages alters sufficiently to 
hide associated epitopes. Although reduced avidity could not entirely 
explain the difference in binding of serum from vaccinated and infected 
cattle, it is entirely possible that it contributes in some animals. Support 
for this proposal is given by the observation that the avidity of vaccinate 
sera was lower on plates coated with a low compared to a high antigen
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concentration. Perhaps there are some antibodies in the serum with M or 
(M>A) type specificity, but these are of low avidity. Avidity is, in part, 
a summation of individual affinities for individual epitopes. The avidity 
measured in the ELISA system used throughout this study would be a 
sum of the individual affinities for epitopes expressed (which may vary 
with high and low concentration coating).
8.2.8 F ield trials
The validation of a newly developed test is an essential process to 
estimate the confidence that should be placed in its ability to predict the 
infection status of animals from its results. Due to the impossibility of 
obtaining suitable material from the United Kingdom, it was necessary to 
collect samples from a range of geographical locations. This situation is 
not ideal, but nevertheless, sufficient numbers were obtained for 
estimates of test performance to be made with reasonable confidence.
The initial trial reported in Chapter 4 indicated that as a starting point 
a cut-off of 10%PP was suitable. There was a clear overlap of PP 
values of infected and uninfected animals so that no cut-off value would 
achieve both 100% DSn and DSp. A modified ROC analysis (Greiner et 
ah, 1995) of data from both the conventional and the modified ELISA 
confirmed the choice of a cut-off of lOPP for testing of non-vaccinated 
animals. At this cut-off the modified ELISA gave a DSp of 98.8% and a
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DSn of 95.7% which compares to values for the conventional ELISA of 
98.5% and 96.4%. Differences in criteria for sample selection and their 
source have a profound effect on estimates of DSn and DSp and 
therefore comparisons between studies must be treated with caution. 
Nevertheless the performance of the modified ELISA was comparable to 
those reported for recently published studies (Gall et al., 1998, Vanzini 
et ah, 1998).
When used to test samples from recently vaccinated animals, there 
was a significant difference in the specificities of the modified and 
conventional ELISAs. At a cut-off of lOPP, the DSp’ for the former was 
88.4% and 17% for the latter. If however, a cut-off of 15PP was 
selected, the DSp’ of the modified ELISA was 98.6% which resulted in a 
DSn of 92.9%. At the sample sizes analysed in this study, these 
estimates have a maximum error of 1% with a confidence of 99%.
In routine use, it would be appropriate to designate two cut-off values. 
A value of 1OPP could be used when the animals are known not to have 
been vaccinated, but a level of 15PP could be used in those cases when 
they are known to have been vaccinated or when their status is unknown. 
In the latter case, animals giving a PP of between 10 and 15 could be 
retested after a period of time so that a rise in titre (suggestive of 
infection) would be apparent.
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8.3 Conclusions
Antibodies in the serum of recently vaccinated animals bound less 
well to Brucella LPS antigen coated at a low concentration than that 
coated at a high concentration.
This test, using plates coated with a low concentration of antigen, 
appears to be the first ELISA shown in field trials to enable the 
discrimination of recently vaccinated from infected cattle.
The widespread use of S I9 vaccine suggests that the test will have a 
world-wide application.
A possible molecular basis for this differentiation is that some O- 
polysaccharide epitopes are becoming obscured or their conformation is 
changing at low antigen concentrations.
In field trials, the modified ELISA gave a DSn of 95.7% and a DSp of 
98.8% at the cut-off suitable for use with non-vaccinated animals. At a 
cut-off suitable for use with recently vaccinated animals, the DSp’ was 
98.6% and the DSn was 92.9%.
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8.4 Future work
Future work should concentrate on confirming the molecular basis for 
discrimination. Is the apparent Toss’ of epitopes due to them being 
obscured by an altered antigen presentation at the polystyrene matrix 
surface or is it due to their altered conformation? The synthesis of 
oligosaccharides (or potentially peptides) representing ‘isolated’ 
epitopes would enable more detailed examinations of the mechanisms 
operating in this system.
On the other hand, if vaccinated animals are responding to a reduced 
repertoire of epitopes (although it aids discrimination), is this limiting 
the protection that they confer?
The confidence in the conclusions drawn from these studies is reduced 
due to the small sizes of the groups of experimental animals. The 
experiments should be repeated using numbers of experimental animals 
which will facilitate obtaining more statistically significant results.
The real benefits of vaccination are only achieved if coverage of the 
population at risk is as complete as possible. This can only be achieved 
by vaccinating adults. Therefore, to gain the maximum benefit, the 
modified ELISA should be evaluated for use in adults.
XI
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